Cancer-specific neoantigens

Recurrent mutations ranked by cancer-type specificity: the share of carrying samples that fall in a single most-frequent cancer type. High specificity = concentrated in one cancer type (a stronger, more targeted vaccine/immunotherapy candidate) rather than smeared pan-cancer. Counts collapse transcript isoforms (peptide-based); catch-all buckets are excluded from the ranking.

Gene	Mutation	Specific to	Specificity	Samples	CL / Tissue	Cancer types
IDH1	p.R132H	Glioma	87%	667	2 / 665	17
KRAS	p.G12R	Pancreatic Carcinoma	75%	291	12 / 279	22
EGFR	p.L858R	Non-Small Cell Lung Carcinoma	90%	127	7 / 120	4
H3F3A	p.K28M	Glioma	88%	121	1 / 120	4
CYFIP2	p.S573T	Esophageal Squamous Cell Carcinoma	70%	100	0 / 100	2
SNCAIP	p.P701L	Esophageal Squamous Cell Carcinoma	70%	100	0 / 100	3
RAC1	p.P29S	Melanoma	82%	98	9 / 89	12
CSF1R	p.Q426K	Esophageal Squamous Cell Carcinoma	71%	98	0 / 98	2
DPYSL4	p.A193S	Esophageal Squamous Cell Carcinoma	71%	98	0 / 98	3
TPSG1	p.R267H	Esophageal Squamous Cell Carcinoma	70%	95	0 / 95	2
ARHGAP33	p.P965L	Esophageal Squamous Cell Carcinoma	77%	93	0 / 93	2
TGOLN2	p.G287E	Esophageal Squamous Cell Carcinoma	75%	93	0 / 93	3
CHAT	p.D273H	Esophageal Squamous Cell Carcinoma	71%	93	0 / 93	2
CHAT	p.D12H	Esophageal Squamous Cell Carcinoma	71%	93	0 / 93	2
ZNF608	p.H1036Y	Esophageal Squamous Cell Carcinoma	71%	93	0 / 93	2
SLC30A2	p.P14R	Esophageal Squamous Cell Carcinoma	70%	92	0 / 92	2
FGFR3	p.S249C	Bladder Carcinoma	86%	91	3 / 88	6
RNF214	p.S134C	Esophageal Squamous Cell Carcinoma	71%	91	0 / 91	2
NKAIN3	p.D141N	Esophageal Squamous Cell Carcinoma	73%	89	0 / 89	2
ROR2	p.R736Q	Esophageal Squamous Cell Carcinoma	80%	88	0 / 88	2
MICAL3	p.I651M	Esophageal Squamous Cell Carcinoma	73%	88	0 / 88	2
DGCR8	p.G217V	Esophageal Squamous Cell Carcinoma	73%	87	0 / 87	2
MGAM	p.V1569I	Esophageal Squamous Cell Carcinoma	70%	85	0 / 85	2
BRAF	p.V600K	Melanoma	98%	84	3 / 81	2
N4BP3	p.R338W	Esophageal Squamous Cell Carcinoma	72%	84	0 / 84	2
ANKRD35	p.A722S	Esophageal Squamous Cell Carcinoma	85%	83	0 / 83	2
LTC4S	p.Y86F	Esophageal Squamous Cell Carcinoma	72%	82	0 / 82	2
LTC4S	p.Y29F	Esophageal Squamous Cell Carcinoma	72%	82	0 / 82	2
NPAP1	p.T697A	Esophageal Squamous Cell Carcinoma	79%	81	0 / 81	2
CANX	p.E327G	Esophageal Squamous Cell Carcinoma	70%	79	0 / 79	2
ZFHX4	p.C1103R	Esophageal Squamous Cell Carcinoma	82%	78	0 / 78	2
BRD4	p.Q209H	Esophageal Squamous Cell Carcinoma	100%	72	0 / 72	1
GNA11	p.Q209L	Melanoma	84%	72	5 / 67	7
MLST8	p.A236T	Esophageal Squamous Cell Carcinoma	98%	71	0 / 71	2
RASD2	p.K3N	Esophageal Squamous Cell Carcinoma	78%	70	0 / 70	2
RALGAPA1	p.S1234L	Esophageal Squamous Cell Carcinoma	100%	68	0 / 68	1
ANKIB1	p.D799H	Esophageal Squamous Cell Carcinoma	75%	68	0 / 68	2
MUC16	p.S13577G	Non-Small Cell Lung Carcinoma	72%	68	62 / 6	9
MPEG1	p.R71K	Esophageal Squamous Cell Carcinoma	83%	66	0 / 66	2
SPTB	p.A1440S	Esophageal Squamous Cell Carcinoma	84%	65	0 / 65	2
TP53	p.Y87H	Esophageal Squamous Cell Carcinoma	92%	64	0 / 64	6
MUC16	p.D13563N	Non-Small Cell Lung Carcinoma	73%	64	58 / 6	10
FANCA	p.G809D	Gastrointestinal Stromal Tumour	70%	64	0 / 64	8
HIST1H4E	p.E54K	Esophageal Squamous Cell Carcinoma	100%	61	0 / 61	1
GOLGA3	p.E1114Q	Esophageal Squamous Cell Carcinoma	100%	59	0 / 59	1
RIPOR3	p.E900K	Esophageal Squamous Cell Carcinoma	91%	59	3 / 56	5
AIP	p.Q228K	Gastrointestinal Stromal Tumour	79%	59	0 / 59	7
APC	p.V1822D	Gastrointestinal Stromal Tumour	78%	59	0 / 59	7
LAMA4	p.Y491H	Gastrointestinal Stromal Tumour	78%	59	0 / 59	7
CREBBP	p.Y1444C	Esophageal Squamous Cell Carcinoma	94%	58	0 / 58	3
NFE2L2	p.E63V	Esophageal Squamous Cell Carcinoma	94%	58	0 / 58	3
TTN	p.A20775P	Gastrointestinal Stromal Tumour	81%	58	0 / 58	6
ALK	p.I1461V	Gastrointestinal Stromal Tumour	81%	58	0 / 58	6
LAMA4	p.G1110S	Gastrointestinal Stromal Tumour	79%	58	0 / 58	7
FANCA	p.T266A	Gastrointestinal Stromal Tumour	77%	58	0 / 58	8
BRIP1	p.S919P	Gastrointestinal Stromal Tumour	74%	58	0 / 58	7
KCNMA1	p.S52F	Esophageal Squamous Cell Carcinoma	70%	58	0 / 58	2
TTN	p.S1295L	Gastrointestinal Stromal Tumour	80%	57	0 / 57	6
SEMA3D	p.E635D	Esophageal Squamous Cell Carcinoma	80%	57	0 / 57	2
CHRNB1	p.D120N	Esophageal Squamous Cell Carcinoma	78%	57	0 / 57	2
ALK	p.D1529E	Gastrointestinal Stromal Tumour	78%	57	0 / 57	9
PPP6C	p.R301C	Melanoma	78%	57	0 / 57	3
ZBTB38	p.S773G	Esophageal Squamous Cell Carcinoma	75%	57	0 / 57	2
KCNE1	p.S38G	Gastrointestinal Stromal Tumour	75%	57	0 / 57	10
RRP12	p.P1187L	Esophageal Squamous Cell Carcinoma	98%	56	1 / 55	2
GRIN3B	p.A589V	Esophageal Squamous Cell Carcinoma	96%	56	0 / 56	3
PCBP1	p.L100Q	Colorectal Carcinoma	87%	56	0 / 56	4
EPCAM	p.M115T	Gastrointestinal Stromal Tumour	80%	56	0 / 56	8
ALK	p.K1491R	Gastrointestinal Stromal Tumour	78%	56	0 / 56	9
TTN	p.I27775V	Gastrointestinal Stromal Tumour	73%	56	0 / 56	8
BNC2	p.C134Y	Esophageal Squamous Cell Carcinoma	100%	55	0 / 55	1
BNC2	p.C25Y	Esophageal Squamous Cell Carcinoma	100%	55	0 / 55	1
RAET1L	p.M85I	Esophageal Squamous Cell Carcinoma	100%	55	0 / 55	1
RHBDF2	p.G507R	Esophageal Squamous Cell Carcinoma	100%	55	0 / 55	1
RNF43	p.V353A	Esophageal Squamous Cell Carcinoma	100%	55	0 / 55	1
SLC25A29	p.G99D	Esophageal Squamous Cell Carcinoma	100%	55	0 / 55	1
SOGA1	p.K1574N	Esophageal Squamous Cell Carcinoma	100%	55	0 / 55	1
CHKB	p.N256I	Esophageal Squamous Cell Carcinoma	100%	55	0 / 55	1
DIP2B	p.C650F	Esophageal Squamous Cell Carcinoma	100%	55	0 / 55	1
ADGRB2	p.F157Y	Esophageal Squamous Cell Carcinoma	100%	55	0 / 55	1
HCN1	p.S684C	Esophageal Squamous Cell Carcinoma	100%	55	0 / 55	1
LINGO2	p.G319W	Esophageal Squamous Cell Carcinoma	100%	55	0 / 55	1
GGA2	p.P548L	Esophageal Squamous Cell Carcinoma	98%	55	0 / 55	2
EPHB3	p.R803H	Esophageal Squamous Cell Carcinoma	98%	55	0 / 55	2
BRCA2	p.V2466A	Gastrointestinal Stromal Tumour	80%	55	0 / 55	6
TTN	p.V3261M	Gastrointestinal Stromal Tumour	78%	55	0 / 55	6
PKD1L3	p.G1052D	Esophageal Squamous Cell Carcinoma	74%	55	0 / 55	2
ZFYVE21	p.A191D	Esophageal Squamous Cell Carcinoma	100%	54	0 / 54	1
ASTN1	p.S841T	Esophageal Squamous Cell Carcinoma	100%	54	0 / 54	1
CDH23	p.G2947V	Esophageal Squamous Cell Carcinoma	100%	54	0 / 54	1
DIO3	p.D63N	Esophageal Squamous Cell Carcinoma	100%	54	0 / 54	1
HIST1H4L	p.A77S	Esophageal Squamous Cell Carcinoma	100%	54	0 / 54	1
NBPF20	p.G5467D	Thyroid Gland Carcinoma	100%	54	0 / 54	1
OR52W1	p.L192M	Esophageal Squamous Cell Carcinoma	100%	54	0 / 54	1
PCDH15	p.I807N	Esophageal Squamous Cell Carcinoma	100%	54	0 / 54	1
PCDH15	p.I812N	Esophageal Squamous Cell Carcinoma	100%	54	0 / 54	1
R3HDM2	p.D268E	Esophageal Squamous Cell Carcinoma	100%	54	0 / 54	1
R3HDM2	p.D268E	Esophageal Squamous Cell Carcinoma	100%	54	0 / 54	1
TNFRSF11A	p.L290V	Esophageal Squamous Cell Carcinoma	100%	54	0 / 54	1
USH1G	p.P453S	Esophageal Squamous Cell Carcinoma	100%	54	0 / 54	1
OLIG1	p.T153M	Esophageal Squamous Cell Carcinoma	98%	54	0 / 54	2
SIGLEC11	p.G496E	Esophageal Squamous Cell Carcinoma	98%	54	0 / 54	2
POTEE	p.V909M	Esophageal Squamous Cell Carcinoma	96%	54	0 / 54	3
TSHR	p.E727D	Gastrointestinal Stromal Tumour	79%	54	0 / 54	6
WRN	p.L1074F	Gastrointestinal Stromal Tumour	77%	54	0 / 54	7
TTN	p.I20331T	Gastrointestinal Stromal Tumour	75%	54	0 / 54	8
TTN	p.T18835I	Gastrointestinal Stromal Tumour	75%	54	0 / 54	8
TTN	p.A8355E	Gastrointestinal Stromal Tumour	75%	54	0 / 54	7
ABCC8	p.W430L	Esophageal Squamous Cell Carcinoma	100%	53	0 / 53	1
COQ6	p.V346I	Esophageal Squamous Cell Carcinoma	100%	53	0 / 53	1
DDX11	p.Q486H	Esophageal Squamous Cell Carcinoma	100%	53	0 / 53	1
GBF1	p.V342L	Esophageal Squamous Cell Carcinoma	100%	53	0 / 53	1
OR2A25	p.F61I	Esophageal Squamous Cell Carcinoma	100%	53	0 / 53	1
SLC32A1	p.R181C	Esophageal Squamous Cell Carcinoma	100%	53	0 / 53	1
SOX11	p.Q241E	Esophageal Squamous Cell Carcinoma	100%	53	0 / 53	1
LAMB3	p.Q1035H	Esophageal Squamous Cell Carcinoma	100%	53	0 / 53	1
LARGE1	p.E560Q	Esophageal Squamous Cell Carcinoma	100%	53	0 / 53	1
LOXHD1	p.R207K	Esophageal Squamous Cell Carcinoma	100%	53	0 / 53	1
NXN	p.L347R	Esophageal Squamous Cell Carcinoma	100%	53	0 / 53	1
HCRTR2	p.R404Q	Esophageal Squamous Cell Carcinoma	96%	53	0 / 53	3
TTN	p.S3419N	Gastrointestinal Stromal Tumour	79%	53	0 / 53	6
TTN	p.N18701D	Gastrointestinal Stromal Tumour	77%	53	0 / 53	7
PRRT2	p.E107Q	Esophageal Squamous Cell Carcinoma	100%	52	0 / 52	1
MEGF6	p.N324S	Esophageal Squamous Cell Carcinoma	100%	52	0 / 52	1
PES1	p.E579K	Esophageal Squamous Cell Carcinoma	100%	52	0 / 52	1
PRRT2	p.E107Q	Esophageal Squamous Cell Carcinoma	100%	52	0 / 52	1
DNAJB12	p.A159V	Esophageal Squamous Cell Carcinoma	96%	52	0 / 52	3
RNF19A	p.R189C	Esophageal Squamous Cell Carcinoma	88%	52	1 / 51	4
TMEM43	p.M179T	Gastrointestinal Stromal Tumour	84%	52	0 / 52	6
STAT3	p.Y640F	B-Cell Non-Hodgkins Lymphoma	84%	52	2 / 50	3
SF3B1	p.G742D	B-Cell Non-Hodgkins Lymphoma	94%	51	0 / 51	4
BICD2	p.A17E	Biliary Tract Carcinoma	82%	51	0 / 51	7
MEN1	p.T541A	Gastrointestinal Stromal Tumour	74%	51	0 / 51	8
CNOT4	p.A413V	Esophageal Squamous Cell Carcinoma	100%	50	0 / 50	1
ZFHX4	p.D3048V	Esophageal Squamous Cell Carcinoma	100%	50	0 / 50	1
KMT2B	p.R1477W	Esophageal Squamous Cell Carcinoma	100%	50	0 / 50	1
LRP1B	p.A1495V	Esophageal Squamous Cell Carcinoma	100%	50	0 / 50	1
ALK	p.F1174L	Neuroblastoma	98%	50	10 / 40	2
ESR1	p.D538G	Breast Carcinoma	94%	50	0 / 50	2
GNAQ	p.Q209P	Melanoma	90%	50	4 / 46	3
TTN	p.I9278V	Gastrointestinal Stromal Tumour	78%	50	0 / 50	7
TTN	p.T17556M	Gastrointestinal Stromal Tumour	72%	50	0 / 50	7
MUC6	p.T2027P	B-Cell Non-Hodgkins Lymphoma	70%	50	0 / 50	6
ZNF439	p.I201L	Esophageal Squamous Cell Carcinoma	100%	49	0 / 49	1
MGAM	p.R1396K	Esophageal Squamous Cell Carcinoma	100%	49	0 / 49	1
TTN	p.V19791I	Gastrointestinal Stromal Tumour	73%	49	0 / 49	8
ZNF426	p.E236K	Esophageal Squamous Cell Carcinoma	100%	48	0 / 48	1
TRPA1	p.L102M	Esophageal Squamous Cell Carcinoma	100%	48	0 / 48	1
SLC34A2	p.V581I	Esophageal Squamous Cell Carcinoma	100%	48	0 / 48	1
PHF13	p.K20N	Esophageal Squamous Cell Carcinoma	100%	48	0 / 48	1
RBL1	p.H235R	Esophageal Squamous Cell Carcinoma	100%	48	0 / 48	1
CUX1	p.R1195Q	Esophageal Squamous Cell Carcinoma	100%	48	0 / 48	1
DNM2	p.R297C	Esophageal Squamous Cell Carcinoma	100%	48	0 / 48	1
NBPF20	p.T4595I	Thyroid Gland Carcinoma	87%	48	0 / 48	3
AURKA	p.F31I	Gastrointestinal Stromal Tumour	79%	48	0 / 48	7
TTN	p.R328C	Gastrointestinal Stromal Tumour	77%	48	0 / 48	7
KMT2C	p.G838S	B-Cell Non-Hodgkins Lymphoma	75%	48	0 / 48	9
NPIPB5	p.K531N	B-Cell Non-Hodgkins Lymphoma	72%	48	2 / 46	9
MUC4	p.V3177A	B-Cell Non-Hodgkins Lymphoma	70%	48	4 / 44	7
MYH8	p.R1178S	Esophageal Squamous Cell Carcinoma	100%	47	0 / 47	1
RBL1	p.D221G	Esophageal Squamous Cell Carcinoma	97%	47	0 / 47	2
MUC4	p.S3248P	B-Cell Non-Hodgkins Lymphoma	74%	47	6 / 41	8
MUC4	p.V3742A	B-Cell Non-Hodgkins Lymphoma	72%	47	0 / 47	5
MUC4	p.S3813G	B-Cell Non-Hodgkins Lymphoma	72%	47	1 / 46	9
ARFGEF1	p.T658I	Esophageal Squamous Cell Carcinoma	100%	46	0 / 46	1
CNTD2	p.G312E	Esophageal Squamous Cell Carcinoma	100%	46	0 / 46	1
ALK	p.R1275Q	Neuroblastoma	97%	46	4 / 42	2
MUC4	p.D2115V	B-Cell Non-Hodgkins Lymphoma	78%	46	2 / 44	7
FGFR2	p.S252W	Endometrial Carcinoma	73%	46	4 / 42	9
ACOT2	p.H328R	B-Cell Non-Hodgkins Lymphoma	73%	46	5 / 41	10
TMEM43	p.K168N	Gastrointestinal Stromal Tumour	73%	46	0 / 46	7
ACOT2	p.H266R	B-Cell Non-Hodgkins Lymphoma	73%	46	5 / 41	10
MUC4	p.S2661N	B-Cell Non-Hodgkins Lymphoma	73%	46	3 / 43	9
MUC4	p.D3261H	B-Cell Non-Hodgkins Lymphoma	73%	46	3 / 43	8
BORCS6	p.Q140R	Esophageal Squamous Cell Carcinoma	100%	45	0 / 45	1
SPHKAP	p.D1559H	Esophageal Squamous Cell Carcinoma	100%	45	0 / 45	1
SART1	p.E58D	Esophageal Squamous Cell Carcinoma	95%	45	1 / 44	3
SPOP	p.F133L	Prostate Carcinoma	91%	45	0 / 45	4
EGFR	p.A289V	Glioma	91%	45	3 / 42	5
MUC4	p.S3264P	B-Cell Non-Hodgkins Lymphoma	80%	45	3 / 42	6
MUC6	p.S2085T	B-Cell Non-Hodgkins Lymphoma	80%	45	0 / 45	4
MUC4	p.T3262A	B-Cell Non-Hodgkins Lymphoma	75%	45	3 / 42	7
MUC4	p.A1990T	B-Cell Non-Hodgkins Lymphoma	71%	45	0 / 45	9
CDKN1A	p.S31R	Gastrointestinal Stromal Tumour	71%	45	0 / 45	11
ZNF729	p.K1077Q	Esophageal Squamous Cell Carcinoma	100%	44	0 / 44	1
IFT172	p.R685Q	Esophageal Squamous Cell Carcinoma	90%	44	0 / 44	3
MUC20	p.R136K	B-Cell Non-Hodgkins Lymphoma	75%	44	0 / 44	5
FGFR2	p.S24W	Endometrial Carcinoma	72%	44	2 / 42	9
JPH2	p.A396T	Gastrointestinal Stromal Tumour	72%	44	0 / 44	6
MRPL34	p.Q54E	Esophageal Squamous Cell Carcinoma	100%	43	0 / 43	1
PRKCE	p.V695I	Esophageal Squamous Cell Carcinoma	100%	43	0 / 43	1
MRPL34	p.I20M	Esophageal Squamous Cell Carcinoma	100%	43	0 / 43	1
HYDIN	p.T5120N	Esophageal Squamous Cell Carcinoma	100%	43	0 / 43	1
SPATA31D1	p.V737G	Esophageal Squamous Cell Carcinoma	100%	43	0 / 43	1
BRAF	p.V600M	Melanoma	97%	43	2 / 41	2
FRG1	p.T98M	B-Cell Non-Hodgkins Lymphoma	81%	43	0 / 43	5
MUC6	p.P1569L	B-Cell Non-Hodgkins Lymphoma	79%	43	0 / 43	5
MGAM	p.R1304C	Esophageal Squamous Cell Carcinoma	76%	43	2 / 41	4
MUC4	p.A2310P	B-Cell Non-Hodgkins Lymphoma	74%	43	0 / 43	6
MUC20	p.R136G	B-Cell Non-Hodgkins Lymphoma	74%	43	0 / 43	5
FRG2B	p.R162Q	B-Cell Non-Hodgkins Lymphoma	74%	43	0 / 43	7
TTN	p.N8803S	Gastrointestinal Stromal Tumour	72%	43	0 / 43	6
SLC26A5	p.L185F	Esophageal Squamous Cell Carcinoma	100%	42	0 / 42	1
RET	p.M918T	Thyroid Gland Carcinoma	90%	42	0 / 42	4
MSH2	p.Q915R	Gastrointestinal Stromal Tumour	83%	42	0 / 42	4
MSH2	p.Q915R	Gastrointestinal Stromal Tumour	83%	42	0 / 42	4
FAM120A	p.A1073P	B-Cell Non-Hodgkins Lymphoma	81%	42	0 / 42	4
IGFN1	p.R2043G	B-Cell Non-Hodgkins Lymphoma	81%	42	0 / 42	6
SF3B1	p.R625H	Melanoma	81%	42	0 / 42	7
OR4M2	p.S268F	Melanoma	78%	42	2 / 40	3
KRTAP9-8	p.S151Y	B-Cell Non-Hodgkins Lymphoma	76%	42	0 / 42	7
MUC4	p.A3654T	B-Cell Non-Hodgkins Lymphoma	76%	42	0 / 42	9
FAM86B2	p.D43Y	B-Cell Non-Hodgkins Lymphoma	76%	42	0 / 42	8
TTN	p.S8108N	Gastrointestinal Stromal Tumour	73%	42	0 / 42	6
MUC4	p.D3797N	B-Cell Non-Hodgkins Lymphoma	71%	42	0 / 42	8
DSPP	p.N1140D	B-Cell Non-Hodgkins Lymphoma	85%	41	0 / 41	5
MUC4	p.A3782T	B-Cell Non-Hodgkins Lymphoma	85%	41	0 / 41	5
MUC4	p.R3616P	B-Cell Non-Hodgkins Lymphoma	80%	41	0 / 41	5
MUC4	p.L3542F	B-Cell Non-Hodgkins Lymphoma	78%	41	0 / 41	7
ANKRD36B	p.E902K	B-Cell Non-Hodgkins Lymphoma	75%	41	0 / 41	6
AXIN2	p.P50S	Gastrointestinal Stromal Tumour	75%	41	0 / 41	8
AHCTF1	p.G2239E	Esophageal Squamous Cell Carcinoma	97%	40	0 / 40	2
MUC4	p.E2149D	B-Cell Non-Hodgkins Lymphoma	90%	40	0 / 40	3
DSPP	p.N1092D	B-Cell Non-Hodgkins Lymphoma	85%	40	0 / 40	5
MUC4	p.L2614I	B-Cell Non-Hodgkins Lymphoma	85%	40	1 / 39	4
FRG2B	p.R158Q	B-Cell Non-Hodgkins Lymphoma	80%	40	0 / 40	7
YIF1A	p.I110S	Esophageal Squamous Cell Carcinoma	100%	39	0 / 39	1
MUC4	p.V2745A	B-Cell Non-Hodgkins Lymphoma	92%	39	0 / 39	3
MUC6	p.A2083T	B-Cell Non-Hodgkins Lymphoma	92%	39	0 / 39	4
HNRNPCL2	p.Q208H	B-Cell Non-Hodgkins Lymphoma	92%	39	0 / 39	3
MUC6	p.V2066L	B-Cell Non-Hodgkins Lymphoma	92%	39	0 / 39	4
CLEC18B	p.I360T	B-Cell Non-Hodgkins Lymphoma	89%	39	0 / 39	5
NDUFV1	p.R224L	Biliary Tract Carcinoma	82%	39	0 / 39	6
FAM186A	p.E1586A	B-Cell Non-Hodgkins Lymphoma	82%	39	0 / 39	7
ZNF429	p.R672H	Glioma	82%	39	4 / 35	7
MUC4	p.F2826S	B-Cell Non-Hodgkins Lymphoma	76%	39	0 / 39	8
CDKN2A	p.P114L	Melanoma	71%	39	7 / 32	6
DIABLO	p.D83G	Esophageal Squamous Cell Carcinoma	100%	38	0 / 38	1
HNRNPCL2	p.E212G	B-Cell Non-Hodgkins Lymphoma	94%	38	0 / 38	2
MUC4	p.Y2714S	B-Cell Non-Hodgkins Lymphoma	92%	38	0 / 38	3
MUC6	p.V2066A	B-Cell Non-Hodgkins Lymphoma	92%	38	0 / 38	4
NOTCH1	p.L1678P	B-Lymphoblastic Leukemia	89%	38	2 / 36	4
PWWP3B	p.E234K	Esophageal Squamous Cell Carcinoma	89%	38	0 / 38	2
MUC4	p.D3653N	B-Cell Non-Hodgkins Lymphoma	81%	38	0 / 38	6
DSG2	p.R773K	Gastrointestinal Stromal Tumour	78%	38	0 / 38	6
MBD3L2	p.G124S	B-Cell Non-Hodgkins Lymphoma	78%	38	0 / 38	5
MUC4	p.H3741Q	B-Cell Non-Hodgkins Lymphoma	76%	38	0 / 38	7
MUC4	p.P3846L	B-Cell Non-Hodgkins Lymphoma	73%	38	0 / 38	5
KMT2C	p.R909K	B-Cell Non-Hodgkins Lymphoma	71%	38	0 / 38	6
MUC4	p.A3753V	B-Cell Non-Hodgkins Lymphoma	71%	38	1 / 37	8
NUTM2A	p.G545S	B-Cell Non-Hodgkins Lymphoma	71%	38	0 / 38	7
DSPP	p.S960G	B-Cell Non-Hodgkins Lymphoma	71%	38	9 / 29	10
EGFL6	p.G253D	Esophageal Squamous Cell Carcinoma	100%	37	0 / 37	1
CHEK2	p.Y433C	Glioma	100%	37	0 / 37	1
DNAH11	p.F3281Y	Esophageal Squamous Cell Carcinoma	100%	37	0 / 37	1
HNRNPCL2	p.S225T	B-Cell Non-Hodgkins Lymphoma	97%	37	0 / 37	2
HNRNPCL2	p.S209C	B-Cell Non-Hodgkins Lymphoma	97%	37	0 / 37	2
MUC4	p.E2741D	B-Cell Non-Hodgkins Lymphoma	94%	37	0 / 37	3
MUC4	p.Q3693H	B-Cell Non-Hodgkins Lymphoma	91%	37	0 / 37	4
HNRNPCL2	p.E245D	B-Cell Non-Hodgkins Lymphoma	91%	37	0 / 37	4
PRB3	p.G107E	Esophageal Squamous Cell Carcinoma	91%	37	0 / 37	3
IKZF3	p.L162R	B-Cell Non-Hodgkins Lymphoma	89%	37	3 / 34	3
EGFR	p.G598V	Glioma	89%	37	3 / 34	3
ISX	p.R86C	Melanoma	86%	37	2 / 35	4
MUC4	p.L2738P	B-Cell Non-Hodgkins Lymphoma	86%	37	1 / 36	6
MUC4	p.Q2605H	B-Cell Non-Hodgkins Lymphoma	86%	37	1 / 36	5
MUC4	p.T1670N	B-Cell Non-Hodgkins Lymphoma	86%	37	1 / 36	5
CNTNAP3B	p.V420I	B-Cell Non-Hodgkins Lymphoma	78%	37	0 / 37	5
FAM163A	p.A92G	B-Cell Non-Hodgkins Lymphoma	75%	37	0 / 37	3
GATA2	p.A164T	Gastrointestinal Stromal Tumour	75%	37	0 / 37	6
KNSTRN	p.S24F	Melanoma	73%	37	4 / 33	5
HNRNPCL2	p.M229L	B-Cell Non-Hodgkins Lymphoma	100%	36	0 / 36	1
HNRNPCL2	p.M229T	B-Cell Non-Hodgkins Lymphoma	100%	36	0 / 36	1
PAX7	p.R268C	Esophageal Squamous Cell Carcinoma	97%	36	0 / 36	2
CNTNAP3	p.G714V	B-Cell Non-Hodgkins Lymphoma	97%	36	0 / 36	2
CD177	p.M205R	B-Cell Non-Hodgkins Lymphoma	91%	36	0 / 36	4
MAP2K1	p.P124S	Melanoma	91%	36	3 / 33	3
CNOT9	p.P131L	Melanoma	88%	36	3 / 33	2
ESR1	p.Y537S	Breast Carcinoma	88%	36	0 / 36	3
EPS8L2	p.A657S	Biliary Tract Carcinoma	88%	36	0 / 36	4
MUC4	p.A3689V	B-Cell Non-Hodgkins Lymphoma	86%	36	0 / 36	4
HNF1A	p.R503H	Gastrointestinal Stromal Tumour	83%	36	0 / 36	5
FOXD4L5	p.P110R	B-Cell Non-Hodgkins Lymphoma	80%	36	0 / 36	5
XPC	p.A499V	Gastrointestinal Stromal Tumour	77%	36	0 / 36	8
MUC4	p.S3707T	B-Cell Non-Hodgkins Lymphoma	75%	36	0 / 36	5
MCF2	p.D127V	Esophageal Squamous Cell Carcinoma	75%	36	0 / 36	2
MUC4	p.V3529A	B-Cell Non-Hodgkins Lymphoma	75%	36	0 / 36	6
DSPP	p.E1149D	B-Cell Non-Hodgkins Lymphoma	72%	36	0 / 36	6
REG3A	p.H50P	Esophageal Squamous Cell Carcinoma	72%	36	0 / 36	7
MUC4	p.I3845S	B-Cell Non-Hodgkins Lymphoma	72%	36	0 / 36	5
SULT2B1	p.S342P	Esophageal Squamous Cell Carcinoma	100%	35	0 / 35	1
FNDC1	p.R1519Q	Esophageal Squamous Cell Carcinoma	97%	35	0 / 35	2
CTNND2	p.R610H	Esophageal Squamous Cell Carcinoma	97%	35	0 / 35	2
RXRA	p.S427F	Bladder Carcinoma	94%	35	2 / 33	3
PHACTR3	p.V394M	Esophageal Squamous Cell Carcinoma	94%	35	0 / 35	3
CD177	p.D204N	B-Cell Non-Hodgkins Lymphoma	94%	35	0 / 35	3
MUC4	p.L3586P	B-Cell Non-Hodgkins Lymphoma	91%	35	0 / 35	4
TCAF2	p.C311R	B-Cell Non-Hodgkins Lymphoma	88%	35	0 / 35	3
MUC6	p.T1552P	B-Cell Non-Hodgkins Lymphoma	88%	35	0 / 35	2
PPP2R1A	p.P179R	Endometrial Carcinoma	88%	35	0 / 35	3
HNRNPCL2	p.D255G	B-Cell Non-Hodgkins Lymphoma	85%	35	0 / 35	4
MUC4	p.V1145A	B-Cell Non-Hodgkins Lymphoma	85%	35	0 / 35	6
MUC4	p.S2864P	B-Cell Non-Hodgkins Lymphoma	85%	35	0 / 35	4
MUC4	p.V3657A	B-Cell Non-Hodgkins Lymphoma	82%	35	0 / 35	3
FGFR3	p.Y375C	Bladder Carcinoma	82%	35	2 / 33	5
JCAD	p.R174Q	Pancreatic Carcinoma	80%	35	0 / 35	5
MUC4	p.D3621N	B-Cell Non-Hodgkins Lymphoma	80%	35	2 / 33	6
BMP5	p.R321Q	Melanoma	80%	35	4 / 31	7
CNTNAP3B	p.R414S	B-Cell Non-Hodgkins Lymphoma	80%	35	0 / 35	5
MAGEC1	p.S253P	B-Cell Non-Hodgkins Lymphoma	80%	35	0 / 35	6
BARD1	p.P24S	Gastrointestinal Stromal Tumour	74%	35	0 / 35	6
CSMD2	p.G2826E	Esophageal Squamous Cell Carcinoma	100%	34	0 / 34	1
EMILIN3	p.P714R	Esophageal Squamous Cell Carcinoma	100%	34	0 / 34	1
CACUL1	p.Y13N	Esophageal Squamous Cell Carcinoma	100%	34	0 / 34	1
HUWE1	p.L3846V	Esophageal Squamous Cell Carcinoma	100%	34	0 / 34	1
TBC1D10C	p.G175S	Esophageal Squamous Cell Carcinoma	100%	34	0 / 34	1
C16orf71	p.A416T	Esophageal Squamous Cell Carcinoma	100%	34	0 / 34	1
PRAME	p.G453C	Esophageal Squamous Cell Carcinoma	100%	34	0 / 34	1
DDX11	p.V644M	Esophageal Squamous Cell Carcinoma	100%	34	0 / 34	1
DUSP27	p.I242T	Esophageal Squamous Cell Carcinoma	100%	34	0 / 34	1
HNRNPCL2	p.A248V	B-Cell Non-Hodgkins Lymphoma	94%	34	0 / 34	3
MUC6	p.P1608S	B-Cell Non-Hodgkins Lymphoma	88%	34	0 / 34	5
FRMPD2	p.S874G	B-Cell Non-Hodgkins Lymphoma	85%	34	0 / 34	5
FAM86B1	p.D43Y	B-Cell Non-Hodgkins Lymphoma	85%	34	1 / 33	6
SPANXN1	p.L34V	Pancreatic Carcinoma	82%	34	0 / 34	5
CNTNAP3B	p.C573G	B-Cell Non-Hodgkins Lymphoma	82%	34	1 / 33	6
HRNR	p.P2099S	B-Cell Non-Hodgkins Lymphoma	82%	34	0 / 34	4
IGFN1	p.E1988G	B-Cell Non-Hodgkins Lymphoma	82%	34	0 / 34	5
ZFR	p.R681C	Pancreatic Carcinoma	82%	34	0 / 34	5
OR5B17	p.S215F	Melanoma	76%	34	0 / 34	2
TRPV3	p.A218E	Biliary Tract Carcinoma	76%	34	0 / 34	8
MTRR	p.I49M	Gastrointestinal Stromal Tumour	70%	34	0 / 34	5
SLC45A4	p.S56F	Esophageal Squamous Cell Carcinoma	100%	33	0 / 33	1
RIMBP2	p.V581G	Esophageal Squamous Cell Carcinoma	100%	33	0 / 33	1
STAT5A	p.N50K	Esophageal Squamous Cell Carcinoma	100%	33	0 / 33	1
DPH1	p.R52W	Esophageal Squamous Cell Carcinoma	97%	33	0 / 33	2
HIST1H3B	p.K28M	Glioma	90%	33	0 / 33	3
HNRNPCL2	p.D255Y	B-Cell Non-Hodgkins Lymphoma	90%	33	0 / 33	3
MUC4	p.D3677H	B-Cell Non-Hodgkins Lymphoma	87%	33	0 / 33	5
MAGEC1	p.F252S	B-Cell Non-Hodgkins Lymphoma	84%	33	0 / 33	6
HS3ST2	p.R210H	Pancreatic Carcinoma	84%	33	0 / 33	5
MUC4	p.L3202P	B-Cell Non-Hodgkins Lymphoma	81%	33	0 / 33	4
MUC6	p.P1878S	B-Cell Non-Hodgkins Lymphoma	81%	33	0 / 33	4
FAM153A	p.T134M	B-Cell Non-Hodgkins Lymphoma	78%	33	1 / 32	7
MUC4	p.P3664S	B-Cell Non-Hodgkins Lymphoma	78%	33	2 / 31	5
OPRD1	p.C27F	Colorectal Carcinoma	72%	33	0 / 33	5
IMPDH1	p.D28N	Esophageal Squamous Cell Carcinoma	100%	32	0 / 32	1
RUNX1T1	p.R149P	Esophageal Squamous Cell Carcinoma	100%	32	0 / 32	1
RPGRIP1L	p.D826G	Esophageal Squamous Cell Carcinoma	100%	32	0 / 32	1
RCC1	p.S179L	Esophageal Squamous Cell Carcinoma	100%	32	0 / 32	1
PRR4	p.P48S	Esophageal Squamous Cell Carcinoma	96%	32	0 / 32	2
TEAD2	p.R373H	Esophageal Squamous Cell Carcinoma	93%	32	1 / 31	3
EGR2	p.E356K	B-Cell Non-Hodgkins Lymphoma	90%	32	0 / 32	4
DNAH5	p.E1756K	Pancreatic Carcinoma	87%	32	0 / 32	4
MUC4	p.Q3565H	B-Cell Non-Hodgkins Lymphoma	84%	32	0 / 32	3
MUC4	p.H3730P	B-Cell Non-Hodgkins Lymphoma	81%	32	0 / 32	5
MUC4	p.L2753V	B-Cell Non-Hodgkins Lymphoma	81%	32	0 / 32	4
LRRC4	p.A123P	B-Cell Non-Hodgkins Lymphoma	81%	32	0 / 32	3
MUC6	p.R1737P	B-Cell Non-Hodgkins Lymphoma	78%	32	0 / 32	3
FRG2B	p.T30S	B-Cell Non-Hodgkins Lymphoma	71%	32	0 / 32	7
SLC27A5	p.T554I	Melanoma	71%	32	6 / 26	3
TRIM46	p.N6T	Esophageal Squamous Cell Carcinoma	100%	31	0 / 31	1
LRRTM1	p.A485S	Esophageal Squamous Cell Carcinoma	100%	31	0 / 31	1
NBPF20	p.R2837C	Thyroid Gland Carcinoma	96%	31	0 / 31	2
NOTCH1	p.L1585P	B-Lymphoblastic Leukemia	93%	31	0 / 31	3
DSPP	p.E1083D	B-Cell Non-Hodgkins Lymphoma	90%	31	0 / 31	3
BNC2	p.R486H	Pancreatic Carcinoma	90%	31	0 / 31	4
C10orf71	p.A426V	Pancreatic Carcinoma	90%	31	0 / 31	4
SRRM4	p.E370K	Pancreatic Carcinoma	90%	31	0 / 31	4
ANKRD36B	p.I877M	B-Cell Non-Hodgkins Lymphoma	90%	31	0 / 31	3
MUC4	p.D1621N	B-Cell Non-Hodgkins Lymphoma	80%	31	1 / 30	6
MUC4	p.D1228G	B-Cell Non-Hodgkins Lymphoma	80%	31	2 / 29	5
LAMA4	p.P1112R	Gastrointestinal Stromal Tumour	80%	31	0 / 31	5
MUC4	p.L4099V	B-Cell Non-Hodgkins Lymphoma	80%	31	0 / 31	4
CNTNAP2	p.G362E	Melanoma	77%	31	2 / 29	3
PRB3	p.H179R	Gastric Carcinoma	74%	31	3 / 28	5
MUC4	p.D3669N	B-Cell Non-Hodgkins Lymphoma	74%	31	3 / 28	6
HRNR	p.R1977C	B-Cell Non-Hodgkins Lymphoma	74%	31	0 / 31	7
PRR36	p.A748P	Gastric Carcinoma	71%	31	0 / 31	4
MUC4	p.S2720P	B-Cell Non-Hodgkins Lymphoma	96%	30	0 / 30	2
AR	p.L702H	Prostate Carcinoma	96%	30	1 / 29	2
MUC6	p.N1686S	B-Cell Non-Hodgkins Lymphoma	93%	30	0 / 30	3
MYO15A	p.R72C	Pancreatic Carcinoma	93%	30	0 / 30	3
PCDH18	p.R752W	Pancreatic Carcinoma	93%	30	1 / 29	3
ZMYM3	p.R736C	Pancreatic Carcinoma	93%	30	0 / 30	2
ZNF521	p.R991Q	Pancreatic Carcinoma	93%	30	0 / 30	2
BPIFB6	p.V203I	Pancreatic Carcinoma	93%	30	0 / 30	3
STARD9	p.R1954H	Pancreatic Carcinoma	93%	30	0 / 30	2
AGO3	p.P324L	Pancreatic Carcinoma	93%	30	1 / 29	3
GAD2	p.R514C	Pancreatic Carcinoma	93%	30	0 / 30	3
GLP1R	p.R414Q	Pancreatic Carcinoma	93%	30	0 / 30	3
TRIP11	p.E1210K	Esophageal Squamous Cell Carcinoma	93%	30	0 / 30	2
HIST1H2AA	p.R12C	Pancreatic Carcinoma	93%	30	0 / 30	3
AHNAK2	p.A3995V	Pancreatic Carcinoma	93%	30	0 / 30	3
ANTXR1	p.T478M	Pancreatic Carcinoma	93%	30	0 / 30	3
MUC6	p.P1654A	B-Cell Non-Hodgkins Lymphoma	93%	30	0 / 30	2
KCNJ12	p.D256N	Esophageal Squamous Cell Carcinoma	90%	30	0 / 30	3
MUC4	p.D3261E	B-Cell Non-Hodgkins Lymphoma	86%	30	1 / 29	5
ANKRD36	p.G465R	B-Cell Non-Hodgkins Lymphoma	73%	30	0 / 30	6
BRINP1	p.R700W	Esophageal Squamous Cell Carcinoma	73%	30	2 / 28	5
GRID2	p.E392K	Melanoma	73%	30	1 / 29	6
MUC5B	p.R2211P	B-Cell Non-Hodgkins Lymphoma	73%	30	0 / 30	7
ANHX	p.A346V	B-Cell Non-Hodgkins Lymphoma	73%	30	0 / 30	4
NUTM2F	p.G731R	B-Cell Non-Hodgkins Lymphoma	70%	30	4 / 26	7
FRG2B	p.H11Y	B-Cell Non-Hodgkins Lymphoma	70%	30	0 / 30	6
MUC4	p.D3293H	B-Cell Non-Hodgkins Lymphoma	70%	30	0 / 30	5
MUC5B	p.T2506I	B-Cell Non-Hodgkins Lymphoma	70%	30	0 / 30	7
ABCA7	p.A2045S	Colorectal Carcinoma	70%	30	0 / 30	5
TTN	p.R4525K	Gastrointestinal Stromal Tumour	70%	30	0 / 30	6
TTN	p.L4362F	Gastrointestinal Stromal Tumour	70%	30	0 / 30	6
TRIT1	p.R122T	Esophageal Squamous Cell Carcinoma	100%	29	0 / 29	1
RGMA	p.V278I	Pancreatic Carcinoma	100%	29	0 / 29	1
INTS7	p.M700L	Esophageal Squamous Cell Carcinoma	100%	29	0 / 29	1
INTS7	p.M749L	Esophageal Squamous Cell Carcinoma	100%	29	0 / 29	1
HEXD	p.R484C	Pancreatic Carcinoma	96%	29	0 / 29	2
HEXD	p.T511M	Pancreatic Carcinoma	96%	29	0 / 29	2
AJAP1	p.G202S	Pancreatic Carcinoma	96%	29	0 / 29	2
CD1C	p.L222F	Pancreatic Carcinoma	96%	29	0 / 29	2
CELF4	p.G204S	Pancreatic Carcinoma	96%	29	1 / 28	2
FAM200A	p.G219R	Pancreatic Carcinoma	96%	29	0 / 29	2
IST1	p.R109Q	Pancreatic Carcinoma	96%	29	0 / 29	2
NEB	p.T7195I	Pancreatic Carcinoma	96%	29	0 / 29	2
RTL1	p.V816I	Pancreatic Carcinoma	96%	29	0 / 29	2
SSX5	p.R75W	Pancreatic Carcinoma	96%	29	0 / 29	2
TRIM33	p.P810S	Esophageal Squamous Cell Carcinoma	96%	29	0 / 29	2
TRIML2	p.E177D	Pancreatic Carcinoma	96%	29	0 / 29	2
ZSWIM8	p.R1459W	Pancreatic Carcinoma	96%	29	0 / 29	2
BAZ2B	p.R235W	Pancreatic Carcinoma	93%	29	0 / 29	3
BAZ2B	p.R431W	Pancreatic Carcinoma	93%	29	0 / 29	3
NBPF20	p.V4654A	Thyroid Gland Carcinoma	89%	29	0 / 29	3
SIDT1	p.P32T	Biliary Tract Carcinoma	89%	29	0 / 29	4
MUC4	p.V3961A	B-Cell Non-Hodgkins Lymphoma	86%	29	0 / 29	4
CTNNB1	p.H36P	Hepatocellular Carcinoma	79%	29	1 / 28	5
TUBB8	p.H105R	Non-Small Cell Lung Carcinoma	75%	29	23 / 6	7
TUBB8	p.T113A	Non-Small Cell Lung Carcinoma	75%	29	23 / 6	7
MUC4	p.I3701S	B-Cell Non-Hodgkins Lymphoma	75%	29	0 / 29	4
MUC12	p.S1921L	B-Cell Non-Hodgkins Lymphoma	72%	29	0 / 29	6
OR10X1	p.M310I	Melanoma	72%	29	4 / 25	3
NT5C1A	p.A344S	Biliary Tract Carcinoma	72%	29	2 / 27	6
ZBTB20	p.C47Y	Pancreatic Carcinoma	100%	28	0 / 28	1
ACVR1B	p.K234R	Pancreatic Carcinoma	100%	28	0 / 28	1
AHSG	p.K237N	Pancreatic Carcinoma	100%	28	0 / 28	1
MUC6	p.K2053M	B-Cell Non-Hodgkins Lymphoma	100%	28	0 / 28	1
NGEF	p.A165T	Pancreatic Carcinoma	100%	28	0 / 28	1
PARN	p.R444C	Pancreatic Carcinoma	100%	28	0 / 28	1
MRVI1	p.A307T	Pancreatic Carcinoma	100%	28	0 / 28	1
PLXNA2	p.A1819T	Pancreatic Carcinoma	100%	28	0 / 28	1
SIPA1L3	p.R1633C	Pancreatic Carcinoma	100%	28	0 / 28	1
ST6GALNAC1	p.F34C	Pancreatic Carcinoma	100%	28	0 / 28	1
ST6GALNAC1	p.F34C	Pancreatic Carcinoma	100%	28	0 / 28	1
TM4SF18	p.P16L	Pancreatic Carcinoma	100%	28	0 / 28	1
TMEM132D	p.E376V	Pancreatic Carcinoma	100%	28	0 / 28	1
UCP2	p.G281C	Pancreatic Carcinoma	100%	28	0 / 28	1
UCP2	p.W220C	Pancreatic Carcinoma	100%	28	0 / 28	1
WDFY4	p.S68R	Pancreatic Carcinoma	100%	28	0 / 28	1
AANAT	p.L189V	Pancreatic Carcinoma	100%	28	0 / 28	1
BCL2L10	p.T106M	Pancreatic Carcinoma	100%	28	0 / 28	1
CAV1	p.V124I	Pancreatic Carcinoma	100%	28	0 / 28	1
CSMD3	p.F1198L	Pancreatic Carcinoma	100%	28	0 / 28	1
CFI	p.L382H	Pancreatic Carcinoma	100%	28	0 / 28	1
MUC6	p.S1644Y	B-Cell Non-Hodgkins Lymphoma	100%	28	0 / 28	1
DNAH6	p.R3288C	Pancreatic Carcinoma	100%	28	0 / 28	1
ECPAS	p.L1306V	Pancreatic Carcinoma	100%	28	0 / 28	1
EDRF1	p.P923L	Pancreatic Carcinoma	100%	28	0 / 28	1
FRAS1	p.G3106D	Pancreatic Carcinoma	100%	28	0 / 28	1
GALNT17	p.G20S	Pancreatic Carcinoma	100%	28	0 / 28	1
GIGYF1	p.G20S	Pancreatic Carcinoma	100%	28	0 / 28	1
GK2	p.N277I	Pancreatic Carcinoma	100%	28	0 / 28	1
GOPC	p.I213V	Pancreatic Carcinoma	100%	28	0 / 28	1
GREB1L	p.V526L	Pancreatic Carcinoma	100%	28	0 / 28	1
IL1RL1	p.R385Q	Pancreatic Carcinoma	100%	28	0 / 28	1
KRTAP13-1	p.L87V	Pancreatic Carcinoma	100%	28	0 / 28	1
KYAT1	p.A251T	Pancreatic Carcinoma	100%	28	0 / 28	1
MACROD2	p.S121L	Pancreatic Carcinoma	100%	28	0 / 28	1
MACROD2	p.S7L	Pancreatic Carcinoma	100%	28	0 / 28	1
MAP3K21	p.E471D	Pancreatic Carcinoma	100%	28	0 / 28	1
MROH9	p.A34V	Pancreatic Carcinoma	100%	28	0 / 28	1
AKAP12	p.A1590T	Esophageal Squamous Cell Carcinoma	89%	28	0 / 28	3
ARID2	p.R314C	Melanoma	89%	28	1 / 27	3
OR51B2	p.S163L	Melanoma	89%	28	1 / 27	4
MUC4	p.D3461G	B-Cell Non-Hodgkins Lymphoma	89%	28	0 / 28	4
DNAH5	p.D3236N	Melanoma	85%	28	1 / 27	4
PDCL3	p.R225W	Pancreatic Carcinoma	85%	28	0 / 28	3
MUC4	p.T3798A	B-Cell Non-Hodgkins Lymphoma	85%	28	0 / 28	4
RHOA	p.Y42C	Gastric Carcinoma	82%	28	2 / 26	4
CHEK2	p.P507L	Glioma	78%	28	0 / 28	2
LAG3	p.T332P	B-Cell Non-Hodgkins Lymphoma	75%	28	0 / 28	4
ERICH6B	p.E138G	Colorectal Carcinoma	75%	28	0 / 28	7
MUC12	p.K1254T	B-Cell Non-Hodgkins Lymphoma	71%	28	0 / 28	5
TVP23C	p.S199T	B-Cell Non-Hodgkins Lymphoma	71%	28	0 / 28	6
TLR4	p.A16S	Biliary Tract Carcinoma	71%	28	4 / 24	8
COL23A1	p.G220R	Pancreatic Carcinoma	100%	27	0 / 27	1
BCAT2	p.R127W	Pancreatic Carcinoma	100%	27	0 / 27	1
HIF1A	p.K237Q	Glioma	100%	27	0 / 27	1
ARID2	p.S297F	Melanoma	96%	27	0 / 27	2
ANKRD9	p.E17A	Esophageal Squamous Cell Carcinoma	96%	27	0 / 27	2
HNRNPCL2	p.H268Q	B-Cell Non-Hodgkins Lymphoma	96%	27	0 / 27	2
NOTCH1	p.L1600P	B-Lymphoblastic Leukemia	88%	27	3 / 24	2
MUC4	p.P2514H	B-Cell Non-Hodgkins Lymphoma	85%	27	0 / 27	5
AR	p.T878A	Prostate Carcinoma	85%	27	3 / 24	3
TCAF2	p.R101W	B-Cell Non-Hodgkins Lymphoma	85%	27	0 / 27	4
JAK2	p.R683G	B-Lymphoblastic Leukemia	81%	27	1 / 26	4
ANKRD36	p.G280D	B-Cell Non-Hodgkins Lymphoma	77%	27	0 / 27	4
OR4M1	p.S268F	Melanoma	77%	27	6 / 21	3
XPC	p.L16V	Gastrointestinal Stromal Tumour	77%	27	0 / 27	6
CEP170	p.G213S	B-Cell Non-Hodgkins Lymphoma	74%	27	0 / 27	5
AQP12A	p.A158T	B-Cell Non-Hodgkins Lymphoma	74%	27	2 / 25	4
ARHGEF5	p.T347I	B-Cell Non-Hodgkins Lymphoma	70%	27	0 / 27	6
SCN1B	p.R250T	Gastrointestinal Stromal Tumour	70%	27	0 / 27	7
FCGR3A	p.I106V	B-Cell Non-Hodgkins Lymphoma	70%	27	0 / 27	7
WBP11	p.Q132E	Esophageal Squamous Cell Carcinoma	100%	26	0 / 26	1
NACA	p.K937T	Esophageal Squamous Cell Carcinoma	100%	26	0 / 26	1
ZNF410	p.E7Q	Esophageal Squamous Cell Carcinoma	100%	26	0 / 26	1
ZNF429	p.K556N	Glioma	96%	26	0 / 26	2
THSD7B	p.E1178K	Melanoma	96%	26	4 / 22	2
HNRNPCL2	p.N272D	B-Cell Non-Hodgkins Lymphoma	96%	26	0 / 26	2
MUC4	p.G1685D	B-Cell Non-Hodgkins Lymphoma	92%	26	0 / 26	3
HIST1H2BK	p.R87C	Burkitts Lymphoma	92%	26	0 / 26	3
RHOA	p.Y42C	Gastric Carcinoma	84%	26	1 / 25	4
FBN1	p.P1148A	Gastrointestinal Stromal Tumour	80%	26	0 / 26	4
HACD1	p.E64K	Colorectal Carcinoma	80%	26	0 / 26	4
MUC6	p.P1841T	B-Cell Non-Hodgkins Lymphoma	80%	26	0 / 26	6
MUC4	p.S3968P	B-Cell Non-Hodgkins Lymphoma	76%	26	0 / 26	5
MUC4	p.V4033L	B-Cell Non-Hodgkins Lymphoma	76%	26	0 / 26	7
KIT	p.L576P	Melanoma	73%	26	1 / 25	5
TXNRD3	p.S22L	Esophageal Squamous Cell Carcinoma	100%	25	0 / 25	1
MUC6	p.H2075L	B-Cell Non-Hodgkins Lymphoma	96%	25	0 / 25	2
MUC4	p.L3638F	B-Cell Non-Hodgkins Lymphoma	96%	25	0 / 25	2
EGR2	p.H384N	B-Cell Non-Hodgkins Lymphoma	96%	25	0 / 25	2
SPOP	p.F133V	Prostate Carcinoma	96%	25	0 / 25	2
MUC6	p.H2008Y	B-Cell Non-Hodgkins Lymphoma	92%	25	0 / 25	3
HIST1H2BK	p.T120I	Burkitts Lymphoma	92%	25	0 / 25	2
PAX5	p.P80R	B-Lymphoblastic Leukemia	92%	25	0 / 25	2
PCDHA7	p.L352I	Colorectal Carcinoma	88%	25	0 / 25	3
NBPF20	p.L2456V	Thyroid Gland Carcinoma	88%	25	0 / 25	4
CD1C	p.R89C	Melanoma	88%	25	1 / 24	3
MUC4	p.T3611S	B-Cell Non-Hodgkins Lymphoma	88%	25	0 / 25	3
AR	p.H733R	Prostate Carcinoma	84%	25	1 / 24	3
CBWD3	p.D132Y	B-Cell Non-Hodgkins Lymphoma	84%	25	0 / 25	5
GIMAP8	p.E654K	Melanoma	84%	25	2 / 23	5
METTL5	p.R233G	B-Cell Non-Hodgkins Lymphoma	84%	25	0 / 25	5
MUC4	p.A3206T	B-Cell Non-Hodgkins Lymphoma	84%	25	0 / 25	3
NPAP1	p.G210E	Melanoma	80%	25	2 / 23	2
NUTM2D	p.G473S	B-Cell Non-Hodgkins Lymphoma	76%	25	0 / 25	6
MUC16	p.P5119S	Melanoma	76%	25	0 / 25	3
BRINP1	p.R630Q	Melanoma	76%	25	1 / 24	5
ASTN1	p.E502K	Melanoma	76%	25	1 / 24	4
TTN	p.R1526Q	Gastrointestinal Stromal Tumour	72%	25	0 / 25	5
OTOG	p.Y2538S	Esophageal Squamous Cell Carcinoma	100%	24	0 / 24	1
TINAG	p.N285Y	Esophageal Squamous Cell Carcinoma	100%	24	0 / 24	1
GRM4	p.R15G	B-Cell Non-Hodgkins Lymphoma	100%	24	0 / 24	1
TMEM247	p.E145K	Esophageal Squamous Cell Carcinoma	95%	24	0 / 24	2
P3H1	p.A70S	Biliary Tract Carcinoma	95%	24	0 / 24	2
DNAH5	p.G920E	Melanoma	91%	24	1 / 23	3
DNAH3	p.R2576H	Colorectal Carcinoma	87%	24	0 / 24	4
MUC4	p.L2992F	Gastric Carcinoma	87%	24	0 / 24	2
PRKCB	p.D427N	B-Cell Non-Hodgkins Lymphoma	83%	24	0 / 24	5
CNTN5	p.S379F	Melanoma	83%	24	1 / 23	4
AADACL3	p.R152H	Colorectal Carcinoma	79%	24	1 / 23	6
THSD7B	p.R1445Q	Melanoma	79%	24	3 / 21	5
MUC4	p.T3670P	B-Cell Non-Hodgkins Lymphoma	79%	24	0 / 24	4
MUC4	p.T3294A	B-Cell Non-Hodgkins Lymphoma	79%	24	0 / 24	5
MMP16	p.C571G	Colorectal Carcinoma	75%	24	0 / 24	2
MUC4	p.T4182I	Gastric Carcinoma	75%	24	0 / 24	2
PRDM2	p.I880L	Esophageal Squamous Cell Carcinoma	100%	23	0 / 23	1
ZNF429	p.K528R	Glioma	100%	23	0 / 23	1
TFG	p.A256V	Esophageal Squamous Cell Carcinoma	95%	23	0 / 23	2
ATPAF1	p.E57A	Esophageal Squamous Cell Carcinoma	95%	23	0 / 23	2
TFG	p.A256V	Esophageal Squamous Cell Carcinoma	95%	23	0 / 23	2
STAT6	p.N417Y	Hodgkins Lymphoma	95%	23	2 / 21	2
AR	p.H875Y	Prostate Carcinoma	95%	23	2 / 21	2
FGFR3	p.R248C	Bladder Carcinoma	82%	23	3 / 20	5
CSMD1	p.R1076C	Melanoma	82%	23	5 / 18	2
MGAM	p.P2410S	Melanoma	78%	23	4 / 19	4
MUC4	p.S2729A	B-Cell Non-Hodgkins Lymphoma	78%	23	1 / 22	4
TENM3	p.V775I	Esophageal Squamous Cell Carcinoma	78%	23	1 / 22	4
GOLGA8B	p.S502N	B-Cell Non-Hodgkins Lymphoma	73%	23	0 / 23	5
ANKRD36	p.P469L	Esophageal Squamous Cell Carcinoma	73%	23	0 / 23	6
ZNF91	p.A354T	Non-Small Cell Lung Carcinoma	73%	23	21 / 2	6
IRS4	p.A640G	Glioma	100%	22	0 / 22	1
ASAP2	p.D978E	Pancreatic Carcinoma	100%	22	0 / 22	1
RPL10	p.R98S	B-Lymphoblastic Leukemia	100%	22	0 / 22	1
CCDC14	p.T511A	Esophageal Squamous Cell Carcinoma	100%	22	0 / 22	1
MUC6	p.L1659V	B-Cell Non-Hodgkins Lymphoma	100%	22	0 / 22	1
FKBP10	p.R13W	Pancreatic Carcinoma	100%	22	0 / 22	1
MUC4	p.L1686I	B-Cell Non-Hodgkins Lymphoma	100%	22	0 / 22	1
LDLRAD2	p.F115V	Esophageal Squamous Cell Carcinoma	100%	22	0 / 22	1
MYC	p.V7M	Burkitts Lymphoma	100%	22	1 / 21	1
MYC	p.V7M	Burkitts Lymphoma	100%	22	1 / 21	1
CHRDL1	p.P92T	Esophageal Squamous Cell Carcinoma	95%	22	0 / 22	2
CHRDL1	p.P92T	Esophageal Squamous Cell Carcinoma	95%	22	0 / 22	2
CHRDL1	p.P92T	Esophageal Squamous Cell Carcinoma	95%	22	0 / 22	2
AR	p.A730V	Prostate Carcinoma	95%	22	1 / 21	2
MUC4	p.P3250H	B-Cell Non-Hodgkins Lymphoma	90%	22	0 / 22	3
MUC4	p.P3682L	B-Cell Non-Hodgkins Lymphoma	90%	22	0 / 22	3
MUC4	p.D3605V	B-Cell Non-Hodgkins Lymphoma	90%	22	0 / 22	3
COL22A1	p.R76H	Colorectal Carcinoma	86%	22	0 / 22	4
C1orf198	p.A10D	Biliary Tract Carcinoma	81%	22	1 / 21	3
KIT	p.K642E	Melanoma	81%	22	1 / 21	4
GNAQ	p.Q209L	Melanoma	81%	22	4 / 18	4
MUC16	p.N13594D	Non-Small Cell Lung Carcinoma	77%	22	21 / 1	5
MUC4	p.H2685Q	B-Cell Non-Hodgkins Lymphoma	77%	22	4 / 18	5
MUC4	p.L3314H	B-Cell Non-Hodgkins Lymphoma	77%	22	0 / 22	6
PAPPA2	p.E1443K	Melanoma	77%	22	2 / 20	4
DUSP5	p.A220M	Esophageal Carcinoma	72%	22	6 / 16	2
TPTE2	p.S40R	Colorectal Carcinoma	72%	22	5 / 17	5
HNRNPCL1	p.G114S	B-Cell Non-Hodgkins Lymphoma	72%	22	0 / 22	4
KRTAP4-7	p.R116S	B-Cell Non-Hodgkins Lymphoma	72%	22	1 / 21	6
ENPP5	p.P350T	Esophageal Squamous Cell Carcinoma	72%	22	0 / 22	2
HIST1H2BK	p.A18V	Burkitts Lymphoma	100%	21	0 / 21	1
IGLL5	p.G109R	B-Cell Non-Hodgkins Lymphoma	100%	21	0 / 21	1
SALL3	p.A246V	Esophageal Squamous Cell Carcinoma	100%	21	0 / 21	1
MUC4	p.R3616C	B-Cell Non-Hodgkins Lymphoma	95%	21	1 / 20	2
NOTCH1	p.R1598P	B-Lymphoblastic Leukemia	95%	21	0 / 21	2
MUC4	p.D2693G	B-Cell Non-Hodgkins Lymphoma	95%	21	0 / 21	2
IKZF1	p.R135L	Biliary Tract Carcinoma	95%	21	0 / 21	2
ADCY8	p.V633M	Pancreatic Carcinoma	90%	21	0 / 21	3
ASXL3	p.P1370S	Melanoma	90%	21	1 / 20	2
FRMPD2	p.G912E	B-Cell Non-Hodgkins Lymphoma	90%	21	0 / 21	3
CR1	p.S1042P	Esophageal Squamous Cell Carcinoma	90%	21	0 / 21	2
DSCAML1	p.R686W	Colorectal Carcinoma	85%	21	0 / 21	4
KCNQ2	p.A265T	Esophageal Squamous Cell Carcinoma	85%	21	0 / 21	4
ST6GAL2	p.R11Q	Melanoma	85%	21	4 / 17	4
CTNNB1	p.I35S	Hepatocellular Carcinoma	85%	21	1 / 20	4
MUC16	p.R13910W	Colorectal Carcinoma	85%	21	0 / 21	3
FCGR2B	p.V134G	Thyroid Gland Carcinoma	85%	21	0 / 21	3
ADAM7	p.G302E	Melanoma	81%	21	6 / 15	3
ARMC9	p.I180E	Esophageal Carcinoma	81%	21	4 / 17	2
FBXW7	p.S582L	Colorectal Carcinoma	81%	21	0 / 21	4
FGFR3	p.R248C	Bladder Carcinoma	81%	21	1 / 20	5
LRRC4B	p.H111N	Biliary Tract Carcinoma	81%	21	0 / 21	4
MUC4	p.V4169A	B-Cell Non-Hodgkins Lymphoma	81%	21	2 / 19	5
OR4N2	p.G41E	Melanoma	81%	21	0 / 21	2
SLC35G4	p.T104A	Esophageal Carcinoma	81%	21	0 / 21	3
ZSCAN18	p.S33T	Bladder Carcinoma	76%	21	0 / 21	3
NBPF10	p.T3401I	Thyroid Gland Carcinoma	76%	21	0 / 21	5
FOXD4	p.G250R	B-Cell Non-Hodgkins Lymphoma	76%	21	0 / 21	6
OR5T2	p.G80E	Melanoma	76%	21	6 / 15	3
ROBO2	p.R245C	Melanoma	76%	21	0 / 21	5
HTR2C	p.R183C	Melanoma	76%	21	1 / 20	4
SI	p.P579S	Melanoma	71%	21	1 / 20	2
HNRNPCL1	p.G114D	B-Cell Non-Hodgkins Lymphoma	71%	21	0 / 21	4
MUC4	p.T4198A	B-Cell Non-Hodgkins Lymphoma	71%	21	0 / 21	7
FRG1	p.L150S	Colorectal Carcinoma	71%	21	2 / 19	5
DSP	p.Y1512C	Gastrointestinal Stromal Tumour	71%	21	0 / 21	5
IGFN1	p.G1655S	Gastric Carcinoma	71%	21	0 / 21	5
C4A	p.L1210R	Non-Small Cell Lung Carcinoma	71%	21	17 / 4	6
CCDC170	p.K442E	Esophageal Squamous Cell Carcinoma	100%	20	0 / 20	1
SIX1	p.Q177R	Wilms Tumour	100%	20	0 / 20	1
NDUFB7	p.Y95S	Esophageal Squamous Cell Carcinoma	100%	20	0 / 20	1
ABCA5	p.I731V	Esophageal Squamous Cell Carcinoma	100%	20	0 / 20	1
MUC6	p.G1663R	B-Cell Non-Hodgkins Lymphoma	100%	20	0 / 20	1
MUC6	p.L1673V	B-Cell Non-Hodgkins Lymphoma	100%	20	0 / 20	1
MUC4	p.L1686H	B-Cell Non-Hodgkins Lymphoma	95%	20	0 / 20	2
MUC4	p.S4069I	B-Cell Non-Hodgkins Lymphoma	95%	20	0 / 20	2
ENPP2	p.D783N	Colorectal Carcinoma	95%	20	0 / 20	2
MUC4	p.D3253N	B-Cell Non-Hodgkins Lymphoma	95%	20	0 / 20	2
GNAS	p.R216Q	Esophageal Squamous Cell Carcinoma	95%	20	0 / 20	2
SPOP	p.F102C	Prostate Carcinoma	95%	20	0 / 20	2
SH3GLB2	p.I201S	Esophageal Squamous Cell Carcinoma	95%	20	0 / 20	2
OR2L13	p.H164R	Esophageal Squamous Cell Carcinoma	95%	20	0 / 20	2
MUC4	p.T3254A	B-Cell Non-Hodgkins Lymphoma	95%	20	0 / 20	2
ZFP36L2	p.C206Y	Colorectal Carcinoma	90%	20	0 / 20	3
DGCR8	p.E518K	Wilms Tumour	90%	20	0 / 20	2
MUC4	p.S3226Y	B-Cell Non-Hodgkins Lymphoma	90%	20	0 / 20	2
MUC6	p.Q2073P	B-Cell Non-Hodgkins Lymphoma	90%	20	0 / 20	2
NOTCH1	p.L1574P	B-Lymphoblastic Leukemia	90%	20	2 / 18	3
SLCO3A1	p.S481F	Esophageal Squamous Cell Carcinoma	90%	20	0 / 20	2
TP63	p.E605K	Melanoma	90%	20	1 / 19	2
TP63	p.R379C	Melanoma	90%	20	2 / 18	3
TTN	p.M2564I	Gastrointestinal Stromal Tumour	90%	20	0 / 20	3
OR5V1	p.T48M	Colorectal Carcinoma	85%	20	2 / 18	4
MUC4	p.T3691R	B-Cell Non-Hodgkins Lymphoma	85%	20	0 / 20	4
TTN	p.S3271F	Melanoma	85%	20	1 / 19	2
CACNA1E	p.R1249W	Colorectal Carcinoma	85%	20	0 / 20	4
ADAMTS18	p.R172Q	Melanoma	80%	20	0 / 20	3
DNAH5	p.R3620Q	Melanoma	80%	20	0 / 20	4
CUBN	p.T1175M	Esophageal Squamous Cell Carcinoma	80%	20	0 / 20	3
MUC4	p.P2519S	B-Cell Non-Hodgkins Lymphoma	80%	20	1 / 19	5
BAALC	p.G50V	Biliary Tract Carcinoma	80%	20	2 / 18	5
PCDHA12	p.S278F	Melanoma	80%	20	2 / 18	3
SIGLEC7	p.R124C	Melanoma	80%	20	0 / 20	3
MAGEC1	p.A170S	B-Cell Non-Hodgkins Lymphoma	80%	20	0 / 20	4
DSPP	p.D1128E	B-Cell Non-Hodgkins Lymphoma	80%	20	0 / 20	4
MUC4	p.D3277H	B-Cell Non-Hodgkins Lymphoma	80%	20	3 / 17	5
HCRTR2	p.R248C	Melanoma	75%	20	1 / 19	5
BTNL8	p.H311Q	B-Cell Non-Hodgkins Lymphoma	75%	20	0 / 20	4
MUC16	p.G3177E	Melanoma	75%	20	0 / 20	2
BTNL8	p.H186D	B-Cell Non-Hodgkins Lymphoma	75%	20	0 / 20	4
AKAP9	p.M463I	Gastrointestinal Stromal Tumour	75%	20	0 / 20	5
AKAP9	p.M471I	Gastrointestinal Stromal Tumour	75%	20	0 / 20	5
ADAMTS10	p.R182H	Kidney Carcinoma	75%	20	2 / 18	5
CLIP1	p.L271F	Bladder Carcinoma	70%	20	0 / 20	4
OR4E2	p.R226Q	Melanoma	70%	20	3 / 17	6
RBMX	p.F97I	Non-Small Cell Lung Carcinoma	70%	20	18 / 2	6
RBMX	p.V205D	Non-Small Cell Lung Carcinoma	70%	20	18 / 2	6
MUC16	p.G138E	Melanoma	70%	20	1 / 19	2
NBPF1	p.H873Y	Thyroid Gland Carcinoma	70%	20	0 / 20	5
ST6GAL2	p.E313K	Melanoma	70%	20	9 / 11	4
HSD17B1	p.G313S	Colorectal Carcinoma	70%	20	0 / 20	4
THAP3	p.E160K	Glioma	100%	19	0 / 19	1
C22orf42	p.Y226C	Colorectal Carcinoma	100%	19	0 / 19	1
NR1D1	p.M513I	Esophageal Squamous Cell Carcinoma	100%	19	0 / 19	1
MUC4	p.P3250L	B-Cell Non-Hodgkins Lymphoma	100%	19	0 / 19	1
RTEL1	p.G984A	Esophageal Squamous Cell Carcinoma	100%	19	0 / 19	1
RTEL1	p.G1207A	Esophageal Squamous Cell Carcinoma	100%	19	0 / 19	1
TLE4	p.S205F	Esophageal Squamous Cell Carcinoma	100%	19	0 / 19	1
PIBF1	p.H523R	Esophageal Squamous Cell Carcinoma	100%	19	0 / 19	1
TBC1D8	p.T355R	Esophageal Squamous Cell Carcinoma	100%	19	0 / 19	1
KLC2	p.H278L	Esophageal Squamous Cell Carcinoma	100%	19	0 / 19	1
RREB1	p.A800T	Esophageal Squamous Cell Carcinoma	100%	19	0 / 19	1
GID4	p.R199Q	Colorectal Carcinoma	94%	19	0 / 19	2
RHBDF2	p.R815H	Colorectal Carcinoma	94%	19	0 / 19	2
IFNA4	p.R184K	Colorectal Carcinoma	94%	19	0 / 19	2
JAM2	p.A303E	Colorectal Carcinoma	94%	19	0 / 19	2
TKTL2	p.G558S	Colorectal Carcinoma	94%	19	0 / 19	2
MDGA2	p.D21Y	Colorectal Carcinoma	94%	19	0 / 19	2
CCDC9	p.S521F	Esophageal Squamous Cell Carcinoma	94%	19	0 / 19	2
CCDC9	p.S521F	Esophageal Squamous Cell Carcinoma	94%	19	0 / 19	2
SPOP	p.W131G	Prostate Carcinoma	94%	19	0 / 19	2
CFH	p.R83K	Colorectal Carcinoma	94%	19	0 / 19	2
SLC35D1	p.L283V	Esophageal Squamous Cell Carcinoma	94%	19	0 / 19	2
DROSHA	p.E1110K	Wilms Tumour	94%	19	0 / 19	2
ADAM9	p.C493F	Esophageal Squamous Cell Carcinoma	94%	19	0 / 19	2
RIMS1	p.D153Y	Colorectal Carcinoma	94%	19	0 / 19	2
FRMPD4	p.R1198W	Colorectal Carcinoma	94%	19	1 / 18	2
GID4	p.R199Q	Colorectal Carcinoma	94%	19	0 / 19	2
EGFR	p.A289T	Glioma	89%	19	0 / 19	3
IL37	p.S176L	Melanoma	89%	19	6 / 13	3
MFHAS1	p.V106G	Esophageal Squamous Cell Carcinoma	89%	19	0 / 19	2
MUC4	p.L2902F	B-Cell Non-Hodgkins Lymphoma	89%	19	0 / 19	3
MUC4	p.T3254P	B-Cell Non-Hodgkins Lymphoma	89%	19	0 / 19	3
TP63	p.R281C	Melanoma	89%	19	1 / 18	3
ZNF534	p.H305Y	Melanoma	89%	19	4 / 15	2
MUC4	p.D2733E	B-Cell Non-Hodgkins Lymphoma	84%	19	0 / 19	3
MUC20	p.L409P	B-Cell Non-Hodgkins Lymphoma	84%	19	0 / 19	4
ZNF585B	p.S354L	Melanoma	84%	19	1 / 18	4
PLCG1	p.R48W	B-Cell Non-Hodgkins Lymphoma	84%	19	0 / 19	2
DNAH9	p.E2368K	Melanoma	84%	19	0 / 19	2
ZNF585B	p.S409L	Melanoma	84%	19	1 / 18	4
SETD6	p.C29F	Biliary Tract Carcinoma	78%	19	0 / 19	5
CFH	p.G1107E	Melanoma	78%	19	3 / 16	3
NWD1	p.A212P	Bladder Carcinoma	78%	19	0 / 19	2
FES	p.E651G	B-Cell Non-Hodgkins Lymphoma	78%	19	0 / 19	5
FES	p.E510G	B-Cell Non-Hodgkins Lymphoma	78%	19	0 / 19	5
DSPP	p.D1074G	B-Cell Non-Hodgkins Lymphoma	78%	19	0 / 19	4
SETD6	p.C29F	Biliary Tract Carcinoma	78%	19	0 / 19	5
ATP5MC3	p.S53C	Esophageal Squamous Cell Carcinoma	78%	19	0 / 19	2
ADSL	p.A47G	B-Cell Non-Hodgkins Lymphoma	78%	19	0 / 19	2
TNR	p.E930K	Melanoma	78%	19	1 / 18	5
TUBGCP2	p.K219E	B-Cell Non-Hodgkins Lymphoma	78%	19	0 / 19	4
ZNF804A	p.R97Q	Melanoma	73%	19	0 / 19	4
MGAM	p.R98Q	Melanoma	73%	19	2 / 17	5
INO80E	p.L203P	B-Cell Non-Hodgkins Lymphoma	73%	19	0 / 19	6
CETN1	p.R164Q	Colorectal Carcinoma	73%	19	0 / 19	5
EFNA4	p.R27L	Biliary Tract Carcinoma	73%	19	0 / 19	5
AL691442.1	p.R27L	Biliary Tract Carcinoma	73%	19	0 / 19	5
HACD1	p.V70F	Colorectal Carcinoma	73%	19	0 / 19	4
ALPI	p.P463L	Colorectal Carcinoma	100%	18	0 / 18	1
ASPM	p.L125F	Colorectal Carcinoma	100%	18	0 / 18	1
HOXB7	p.T173M	Esophageal Squamous Cell Carcinoma	100%	18	0 / 18	1
LOXL2	p.V341M	Esophageal Squamous Cell Carcinoma	100%	18	0 / 18	1
LCMT2	p.I52S	Esophageal Squamous Cell Carcinoma	100%	18	0 / 18	1
IRX5	p.A369T	Colorectal Carcinoma	100%	18	0 / 18	1
ATP8B2	p.D1218A	Colorectal Carcinoma	100%	18	0 / 18	1
ALPP	p.A495T	Colorectal Carcinoma	100%	18	0 / 18	1
ANK1	p.T670I	Colorectal Carcinoma	100%	18	0 / 18	1
MUC6	p.M2064V	B-Cell Non-Hodgkins Lymphoma	100%	18	0 / 18	1
GABRG1	p.A376I	Colorectal Carcinoma	100%	18	0 / 18	1
MBD3L3	p.R134C	Esophageal Squamous Cell Carcinoma	100%	18	0 / 18	1
GNS	p.V60L	Esophageal Squamous Cell Carcinoma	100%	18	0 / 18	1
GNS	p.V60L	Esophageal Squamous Cell Carcinoma	100%	18	0 / 18	1
MAGEL2	p.P449L	Esophageal Squamous Cell Carcinoma	100%	18	0 / 18	1
POTEB2	p.G391V	Colorectal Carcinoma	100%	18	0 / 18	1
PCDHGA4	p.A237E	Esophageal Squamous Cell Carcinoma	100%	18	0 / 18	1
BSN	p.A3140V	Colorectal Carcinoma	100%	18	0 / 18	1
KCNA4	p.G428V	Colorectal Carcinoma	100%	18	0 / 18	1
CHRM5	p.E2K	Colorectal Carcinoma	100%	18	0 / 18	1
GNS	p.V60L	Esophageal Squamous Cell Carcinoma	100%	18	0 / 18	1
CSNK1E	p.A180T	Colorectal Carcinoma	100%	18	0 / 18	1
NWD1	p.Q1038R	Esophageal Squamous Cell Carcinoma	100%	18	0 / 18	1
NUDCD3	p.A60V	Colorectal Carcinoma	100%	18	0 / 18	1
EIF4G1	p.T874I	Colorectal Carcinoma	100%	18	0 / 18	1
EIF4G1	p.T1077I	Colorectal Carcinoma	100%	18	0 / 18	1
MUC6	p.T1543A	B-Cell Non-Hodgkins Lymphoma	100%	18	0 / 18	1
RASGRF1	p.M593I	Colorectal Carcinoma	100%	18	0 / 18	1
RNF213	p.R2265Q	Esophageal Squamous Cell Carcinoma	100%	18	0 / 18	1
RNF213	p.T3540M	Colorectal Carcinoma	100%	18	0 / 18	1
SAMD4A	p.N385S	Colorectal Carcinoma	100%	18	0 / 18	1
SLC27A1	p.E184K	Esophageal Squamous Cell Carcinoma	100%	18	0 / 18	1
SLC4A2	p.D727E	Colorectal Carcinoma	100%	18	0 / 18	1
SLIT3	p.G1086R	Colorectal Carcinoma	100%	18	0 / 18	1
SLIT3	p.G956R	Colorectal Carcinoma	100%	18	0 / 18	1
SYNE1	p.G8682V	Colorectal Carcinoma	100%	18	0 / 18	1
TPTEP2-CSNK1E	p.A180T	Colorectal Carcinoma	100%	18	0 / 18	1
TUBG2	p.F418C	Esophageal Squamous Cell Carcinoma	100%	18	0 / 18	1
UGT2A3	p.I413L	Colorectal Carcinoma	100%	18	0 / 18	1
UTRN	p.D138V	Colorectal Carcinoma	100%	18	0 / 18	1
OBSL1	p.T1244P	Thyroid Gland Carcinoma	94%	18	0 / 18	2
NEUROG3	p.N45T	Esophageal Squamous Cell Carcinoma	94%	18	1 / 17	2
GABRA3	p.S459F	Melanoma	94%	18	0 / 18	2
BIRC6	p.R3284H	Esophageal Squamous Cell Carcinoma	94%	18	0 / 18	2
FAT4	p.S308R	Colorectal Carcinoma	94%	18	0 / 18	2
PRSS48	p.S44I	Biliary Tract Carcinoma	94%	18	0 / 18	2
SNCAIP	p.E348K	Melanoma	88%	18	1 / 17	3
TFAP2A	p.T42P	Thyroid Gland Carcinoma	88%	18	0 / 18	3
PAK5	p.M173I	Melanoma	88%	18	0 / 18	2
NBPF19	p.V1969A	Thyroid Gland Carcinoma	88%	18	0 / 18	3
HERC2	p.S3556L	Biliary Tract Carcinoma	88%	18	0 / 18	3
BAALC	p.G50V	Biliary Tract Carcinoma	88%	18	0 / 18	3
BAALC	p.G50V	Biliary Tract Carcinoma	88%	18	0 / 18	3
BAALC	p.G50V	Biliary Tract Carcinoma	88%	18	0 / 18	3
BAALC	p.G50V	Biliary Tract Carcinoma	88%	18	0 / 18	3
CHST4	p.R95W	Esophageal Squamous Cell Carcinoma	88%	18	0 / 18	3
MYC	p.S132N	Burkitts Lymphoma	83%	18	0 / 18	3
INKA1	p.R239K	Bladder Carcinoma	83%	18	0 / 18	4
LHCGR	p.E206K	Melanoma	83%	18	5 / 13	3
ANKRD36B	p.N1223T	B-Cell Non-Hodgkins Lymphoma	83%	18	0 / 18	4
EGFR	p.R108K	Glioma	83%	18	2 / 16	3
DSPP	p.D1152N	B-Cell Non-Hodgkins Lymphoma	83%	18	0 / 18	3
MUC4	p.A1198T	B-Cell Non-Hodgkins Lymphoma	83%	18	0 / 18	3
PRKG2	p.S143F	Melanoma	83%	18	0 / 18	3
SALL1	p.P578S	Melanoma	83%	18	2 / 16	3
TTN	p.S16508N	Gastrointestinal Stromal Tumour	77%	18	0 / 18	4
SCN7A	p.S174F	Melanoma	77%	18	0 / 18	3
FAM19A5	p.T51M	Biliary Tract Carcinoma	77%	18	0 / 18	4
NBPF20	p.S5436R	Thyroid Gland Carcinoma	77%	18	0 / 18	4
GOLGA6L10	p.H209R	B-Cell Non-Hodgkins Lymphoma	77%	18	0 / 18	4
BRINP3	p.P287S	Melanoma	77%	18	3 / 15	4
CAP1	p.R312G	Bladder Carcinoma	77%	18	0 / 18	3
ARMCX4	p.E1834G	B-Cell Non-Hodgkins Lymphoma	77%	18	0 / 18	2
EPHA6	p.R268C	Melanoma	72%	18	1 / 17	6
MUC4	p.A3481V	B-Cell Non-Hodgkins Lymphoma	72%	18	1 / 17	4
GLRB	p.H154Y	Melanoma	72%	18	1 / 17	4
NPIPA5	p.L298P	Colorectal Carcinoma	72%	18	0 / 18	6
OBSCN	p.R4516W	Colorectal Carcinoma	72%	18	0 / 18	5
CTAGE6	p.T348S	B-Cell Non-Hodgkins Lymphoma	72%	18	0 / 18	5
XIRP2	p.E831K	Melanoma	72%	18	4 / 14	3
CYP2A7	p.N438Y	Non-Small Cell Lung Carcinoma	72%	18	15 / 3	5
SGCZ	p.G40E	Melanoma	72%	18	0 / 18	2
ZNF12	p.R173C	Melanoma	72%	18	2 / 16	4
NUTM2A	p.G309S	B-Cell Non-Hodgkins Lymphoma	72%	18	0 / 18	4
HTR3E	p.E394K	Melanoma	72%	18	0 / 18	3
MYC	p.P57T	Burkitts Lymphoma	72%	18	8 / 10	3
FHL5	p.C276R	Esophageal Squamous Cell Carcinoma	100%	17	0 / 17	1
THSD7B	p.E157K	Melanoma	100%	17	2 / 15	1
ATXN1L	p.V511M	Esophageal Squamous Cell Carcinoma	100%	17	0 / 17	1
FREM3	p.R32W	Esophageal Squamous Cell Carcinoma	100%	17	0 / 17	1
HACD2	p.N13T	Esophageal Squamous Cell Carcinoma	100%	17	0 / 17	1
ANKRD36B	p.Y905C	B-Cell Non-Hodgkins Lymphoma	100%	17	0 / 17	1
NKX1-2	p.R102Q	Esophageal Squamous Cell Carcinoma	100%	17	0 / 17	1
NAA25	p.V153M	Pancreatic Carcinoma	100%	17	0 / 17	1
SAXO2	p.P39L	Esophageal Squamous Cell Carcinoma	100%	17	0 / 17	1
PPHLN1	p.R395Q	Pancreatic Carcinoma	100%	17	0 / 17	1
RFPL4A	p.P245S	Esophageal Squamous Cell Carcinoma	100%	17	0 / 17	1
SALL4	p.T620I	Esophageal Squamous Cell Carcinoma	100%	17	0 / 17	1
COG4	p.E355K	Pancreatic Carcinoma	100%	17	0 / 17	1
DCLK2	p.P748C	Esophageal Carcinoma	100%	17	0 / 17	1
CDHR3	p.L730M	Esophageal Squamous Cell Carcinoma	100%	17	0 / 17	1
OR11H1	p.G68E	Melanoma	100%	17	0 / 17	1
PCSK6	p.D311N	Esophageal Squamous Cell Carcinoma	100%	17	0 / 17	1
SMG7	p.R309H	Esophageal Squamous Cell Carcinoma	94%	17	0 / 17	2
BASP1	p.A75V	Esophageal Squamous Cell Carcinoma	94%	17	0 / 17	2
DNAH5	p.R3539C	Melanoma	94%	17	0 / 17	2
TMEM176A	p.E228K	Melanoma	94%	17	0 / 17	2
MACC1	p.D428E	Thyroid Gland Carcinoma	94%	17	0 / 17	2
CBFA2T2	p.E391D	Biliary Tract Carcinoma	94%	17	0 / 17	2
OR8D1	p.G307E	Melanoma	88%	17	3 / 14	3
CMYA5	p.V3314I	Biliary Tract Carcinoma	88%	17	0 / 17	3
OR51F2	p.R136C	Melanoma	88%	17	0 / 17	3
ZNF189	p.R96H	Esophageal Squamous Cell Carcinoma	88%	17	1 / 16	3
ZFPM2	p.R112Q	Melanoma	88%	17	0 / 17	2
VHL	p.L89H	Kidney Carcinoma	88%	17	3 / 14	2
OR6C2	p.E165K	Melanoma	88%	17	0 / 17	2
CXCR2	p.R322C	Melanoma	88%	17	1 / 16	2
TMC5	p.E690K	Melanoma	88%	17	0 / 17	3
FAM172A	p.E45K	Biliary Tract Carcinoma	88%	17	0 / 17	3
KCNE5	p.E100K	Hepatocellular Carcinoma	88%	17	1 / 16	3
MUC4	p.P3760S	B-Cell Non-Hodgkins Lymphoma	88%	17	0 / 17	3
OR2Z1	p.P167S	Melanoma	82%	17	0 / 17	2
TUBB4B	p.K252N	Biliary Tract Carcinoma	82%	17	0 / 17	4
HYDIN	p.E81K	Melanoma	82%	17	2 / 15	2
DNAJC5B	p.E22K	Melanoma	82%	17	1 / 16	3
MRAP2	p.S34F	Melanoma	82%	17	1 / 16	3
MUC6	p.T1621S	B-Cell Non-Hodgkins Lymphoma	82%	17	0 / 17	3
SEMA6B	p.T363M	Colorectal Carcinoma	82%	17	0 / 17	3
CNTN5	p.P233S	Melanoma	82%	17	4 / 13	2
NLRP13	p.E416K	Melanoma	82%	17	1 / 16	3
OLIG1	p.S50F	B-Cell Non-Hodgkins Lymphoma	82%	17	0 / 17	3
INMT	p.S212F	Melanoma	82%	17	0 / 17	2
BRINP1	p.R552H	Colorectal Carcinoma	76%	17	2 / 15	4
FIGNL2	p.T366P	Colorectal Carcinoma	76%	17	0 / 17	3
GRM3	p.M518I	Melanoma	76%	17	1 / 16	5
HNRNPCL1	p.G93E	Melanoma	76%	17	3 / 14	3
KCNJ8	p.G417E	Melanoma	76%	17	0 / 17	2
A1CF	p.E34K	Melanoma	76%	17	0 / 17	2
MAP1B	p.D591E	Thyroid Gland Carcinoma	76%	17	0 / 17	3
OR4K1	p.S217F	Melanoma	76%	17	2 / 15	2
OR4N4	p.G41E	Melanoma	76%	17	0 / 17	2
PFAS	p.N84S	Colorectal Carcinoma	76%	17	4 / 13	5
SERHL2	p.S46N	Non-Small Cell Lung Carcinoma	76%	17	13 / 4	5
TUBGCP6	p.A1181T	Gastric Carcinoma	76%	17	1 / 16	5
AC134980.3	p.G41E	Melanoma	76%	17	0 / 17	2
A1CF	p.E42K	Melanoma	76%	17	0 / 17	2
KIR3DL1	p.R52H	B-Cell Non-Hodgkins Lymphoma	76%	17	0 / 17	5
DSPP	p.E29K	Melanoma	70%	17	0 / 17	4
CHRD	p.V666G	Thyroid Gland Carcinoma	70%	17	0 / 17	5
PHLDB3	p.A82D	Biliary Tract Carcinoma	70%	17	2 / 15	5
PHF10	p.L212V	Non-Small Cell Lung Carcinoma	70%	17	16 / 1	5
TUSC3	p.R334C	Melanoma	70%	17	0 / 17	3
TUSC3	p.R334C	Melanoma	70%	17	0 / 17	3
VEZF1	p.E14V	Esophageal Squamous Cell Carcinoma	70%	17	0 / 17	2
VEZF1	p.E5V	Esophageal Squamous Cell Carcinoma	70%	17	0 / 17	2
CDH17	p.S706F	Melanoma	70%	17	0 / 17	2
FRYL	p.Q1360K	Thyroid Gland Carcinoma	70%	17	0 / 17	3
FOLH1	p.R266C	Colorectal Carcinoma	70%	17	0 / 17	5
VGF	p.Y576S	Esophageal Squamous Cell Carcinoma	100%	16	0 / 16	1
FKBP9	p.R107H	Glioma	100%	16	0 / 16	1
FOXA1	p.S250F	Breast Carcinoma	100%	16	0 / 16	1
GRM2	p.R467H	Colorectal Carcinoma	100%	16	0 / 16	1
NCOR2	p.I976L	Esophageal Squamous Cell Carcinoma	100%	16	0 / 16	1
MUC6	p.H1927L	B-Cell Non-Hodgkins Lymphoma	100%	16	0 / 16	1
MUC6	p.H1666Y	B-Cell Non-Hodgkins Lymphoma	100%	16	0 / 16	1
CCDC88A	p.E456D	Esophageal Squamous Cell Carcinoma	100%	16	0 / 16	1
CCDC88A	p.E381D	Esophageal Squamous Cell Carcinoma	100%	16	0 / 16	1
CLN6	p.V4G	Esophageal Squamous Cell Carcinoma	100%	16	0 / 16	1
COCH	p.A493E	Esophageal Squamous Cell Carcinoma	100%	16	0 / 16	1
MUC4	p.S2711Y	B-Cell Non-Hodgkins Lymphoma	100%	16	0 / 16	1
LY6G5C	p.S88I	Biliary Tract Carcinoma	100%	16	0 / 16	1
GRM2	p.R467H	Colorectal Carcinoma	100%	16	0 / 16	1
ZNF605	p.S82C	Kidney Carcinoma	100%	16	0 / 16	1
ZNF154	p.A110T	Esophageal Squamous Cell Carcinoma	100%	16	0 / 16	1
TGFB2	p.R34S	Biliary Tract Carcinoma	100%	16	0 / 16	1
TEPSIN	p.I425S	Esophageal Squamous Cell Carcinoma	100%	16	0 / 16	1
SLC45A1	p.A588S	Colorectal Carcinoma	100%	16	0 / 16	1
SLC35G6	p.W326Q	Esophageal Carcinoma	100%	16	0 / 16	1
PRRT2	p.N212T	Esophageal Squamous Cell Carcinoma	100%	16	0 / 16	1
PPM1E	p.E65D	Esophageal Squamous Cell Carcinoma	100%	16	0 / 16	1
OTOP1	p.L104M	Esophageal Squamous Cell Carcinoma	100%	16	0 / 16	1
OBSCN	p.W5995C	Biliary Tract Carcinoma	100%	16	0 / 16	1
LMOD2	p.K483T	Esophageal Squamous Cell Carcinoma	100%	16	0 / 16	1
DHX29	p.I195L	Esophageal Squamous Cell Carcinoma	100%	16	0 / 16	1
LGR4	p.D431V	Biliary Tract Carcinoma	100%	16	0 / 16	1
KRT15	p.L367F	Biliary Tract Carcinoma	100%	16	0 / 16	1
ANKFN1	p.G992S	Biliary Tract Carcinoma	100%	16	0 / 16	1
JAK1	p.Y1059C	Biliary Tract Carcinoma	100%	16	0 / 16	1
HOOK1	p.N347S	Colorectal Carcinoma	100%	16	0 / 16	1
NUTM2F	p.S691P	Thyroid Gland Carcinoma	100%	16	0 / 16	1
HIST1H3H	p.H114Y	Burkitts Lymphoma	100%	16	0 / 16	1
HIP1R	p.A152T	Esophageal Squamous Cell Carcinoma	100%	16	0 / 16	1
ERMN	p.R163G	Biliary Tract Carcinoma	100%	16	0 / 16	1
TTN	p.E4247K	Melanoma	93%	16	3 / 13	2
TSHR	p.R450H	Esophageal Squamous Cell Carcinoma	93%	16	0 / 16	2
OR2T3	p.V197I	Esophageal Squamous Cell Carcinoma	93%	16	0 / 16	2
DTX2	p.W22C	Esophageal Squamous Cell Carcinoma	93%	16	0 / 16	2
SMARCA5	p.S50R	Esophageal Squamous Cell Carcinoma	93%	16	0 / 16	2
EIF4E1B	p.V204I	Pancreatic Carcinoma	93%	16	0 / 16	2
FYB2	p.S335L	Melanoma	93%	16	0 / 16	2
SH3GL1	p.R120C	Kidney Carcinoma	93%	16	0 / 16	2
MUC4	p.D3821H	B-Cell Non-Hodgkins Lymphoma	93%	16	0 / 16	2
NLRP7	p.E593K	Melanoma	93%	16	0 / 16	2
ZFHX4	p.P1723S	Melanoma	93%	16	1 / 15	2
OR13C8	p.G233E	Melanoma	93%	16	3 / 13	2
ZEB2	p.H1014R	B-Lymphoblastic Leukemia	93%	16	0 / 16	2
ZDHHC2	p.V17G	Thyroid Gland Carcinoma	93%	16	0 / 16	2
ADAM29	p.E719K	Melanoma	93%	16	0 / 16	2
ZPLD1	p.Q220K	Thyroid Gland Carcinoma	87%	16	0 / 16	3
NBPF10	p.G1983D	Thyroid Gland Carcinoma	87%	16	0 / 16	2
MYL9	p.R70W	Biliary Tract Carcinoma	87%	16	0 / 16	2
DUSP15	p.S251R	Biliary Tract Carcinoma	87%	16	0 / 16	2
MYL9	p.R124W	Biliary Tract Carcinoma	87%	16	0 / 16	2
MUC4	p.G1148A	B-Cell Non-Hodgkins Lymphoma	87%	16	0 / 16	3
KIAA1614	p.R489C	Biliary Tract Carcinoma	87%	16	0 / 16	2
EBF2	p.G444E	Melanoma	87%	16	0 / 16	2
CCDC50	p.F468L	Biliary Tract Carcinoma	87%	16	2 / 14	2
DNAH3	p.R1274Q	Melanoma	87%	16	0 / 16	3
LGSN	p.G201E	Melanoma	87%	16	0 / 16	3
NR2E3	p.D316E	Thyroid Gland Carcinoma	87%	16	0 / 16	2
NWD1	p.S757F	Melanoma	87%	16	2 / 14	2
PRKCB	p.S660F	Melanoma	87%	16	1 / 15	3
SF3B1	p.E622D	B-Cell Non-Hodgkins Lymphoma	87%	16	0 / 16	3
THAP11	p.A100P	Thyroid Gland Carcinoma	87%	16	0 / 16	3
WDR64	p.R348W	Colorectal Carcinoma	87%	16	1 / 15	3
ZNF717	p.Q26K	Esophageal Squamous Cell Carcinoma	87%	16	0 / 16	3
DNM2	p.V653G	Thyroid Gland Carcinoma	81%	16	0 / 16	3
H3F3A	p.G35R	Glioma	81%	16	0 / 16	2
MUC4	p.T4182P	B-Cell Non-Hodgkins Lymphoma	81%	16	0 / 16	4
WASHC2C	p.M249T	B-Cell Non-Hodgkins Lymphoma	81%	16	0 / 16	3
FUT9	p.G7E	Melanoma	81%	16	2 / 14	2
MUC4	p.Q1165H	B-Cell Non-Hodgkins Lymphoma	81%	16	1 / 15	4
LRRIQ3	p.P379S	Melanoma	81%	16	0 / 16	2
HSPB8	p.R17H	Colorectal Carcinoma	81%	16	0 / 16	4
PDGFRA	p.S478P	Gastrointestinal Stromal Tumour	81%	16	0 / 16	4
ERCC2	p.N238S	Bladder Carcinoma	81%	16	2 / 14	3
ATXN7L2	p.V18G	Thyroid Gland Carcinoma	81%	16	0 / 16	4
TTN	p.V31886I	Gastrointestinal Stromal Tumour	81%	16	0 / 16	4
TTN	p.E3925K	Melanoma	75%	16	2 / 14	2
GAS2	p.R208Q	Melanoma	75%	16	8 / 8	3
MUC6	p.P1449S	Thyroid Gland Carcinoma	75%	16	0 / 16	3
ADAMTS2	p.Y554N	Prostate Carcinoma	75%	16	0 / 16	4
OR4A5	p.S91F	Melanoma	75%	16	1 / 15	3
ERBB3	p.M91I	Bladder Carcinoma	75%	16	2 / 14	4
OR4K15	p.S210F	Melanoma	75%	16	0 / 16	3
PABPC1	p.H144R	Thyroid Gland Carcinoma	75%	16	0 / 16	3
ANKRD30A	p.E1192K	Melanoma	75%	16	0 / 16	2
CYP4A22	p.R96C	Melanoma	75%	16	2 / 14	4
SF3A2	p.V372G	Thyroid Gland Carcinoma	75%	16	0 / 16	2
OBSCN	p.A1366G	Bladder Carcinoma	75%	16	0 / 16	4
SIPA1L2	p.S546L	Melanoma	75%	16	1 / 15	3
ARHGEF26	p.L60S	Esophageal Carcinoma	75%	16	4 / 12	2
MUC4	p.D3525N	B-Cell Non-Hodgkins Lymphoma	75%	16	2 / 14	5
OBSCN	p.A1366G	Bladder Carcinoma	75%	16	0 / 16	4
MXRA5	p.E2006K	Melanoma	75%	16	1 / 15	5
FCRL5	p.H788Y	Melanoma	75%	16	1 / 15	5
ZBED2	p.E157K	Melanoma	100%	15	2 / 13	1
XKR6	p.V222M	Hepatocellular Carcinoma	100%	15	0 / 15	1
VHL	p.S111R	Kidney Carcinoma	100%	15	0 / 15	1
VHL	p.S111R	Kidney Carcinoma	100%	15	0 / 15	1
CHEK2	p.M381V	Glioma	100%	15	0 / 15	1
UBE4A	p.N800H	Kidney Carcinoma	100%	15	0 / 15	1
TCF15	p.V151I	Esophageal Squamous Cell Carcinoma	100%	15	0 / 15	1
ST5	p.I491T	Hepatocellular Carcinoma	100%	15	0 / 15	1
SLK	p.L1134F	Esophageal Squamous Cell Carcinoma	100%	15	0 / 15	1
PCDHGA4	p.G630C	Biliary Tract Carcinoma	100%	15	0 / 15	1
MED13	p.P1012T	Kidney Carcinoma	100%	15	0 / 15	1
GCNT2	p.F107S	Kidney Carcinoma	100%	15	0 / 15	1
MECR	p.V10G	Thyroid Gland Carcinoma	100%	15	0 / 15	1
ACLY	p.G1059V	Hepatocellular Carcinoma	100%	15	0 / 15	1
KIF6	p.D165V	Kidney Carcinoma	100%	15	0 / 15	1
C22orf31	p.A261V	Kidney Carcinoma	100%	15	0 / 15	1
GNG4	p.N7S	Hepatocellular Carcinoma	100%	15	0 / 15	1
MAP2K6	p.T56A	Hepatocellular Carcinoma	100%	15	0 / 15	1
CCT6B	p.M44V	Hepatocellular Carcinoma	100%	15	0 / 15	1
DNHD1	p.L1073Q	Hepatocellular Carcinoma	100%	15	0 / 15	1
CDH5	p.V141D	Kidney Carcinoma	100%	15	0 / 15	1
GUCY1A2	p.Q614K	Hepatocellular Carcinoma	100%	15	0 / 15	1
CDR2L	p.F444V	Hepatocellular Carcinoma	100%	15	0 / 15	1
CENPH	p.K138N	Kidney Carcinoma	100%	15	0 / 15	1
LURAP1L	p.V179M	Hepatocellular Carcinoma	100%	15	0 / 15	1
MUC16	p.E5116K	Melanoma	100%	15	2 / 13	1
COL5A3	p.P176L	Kidney Carcinoma	100%	15	0 / 15	1
HERC1	p.A3233T	Hepatocellular Carcinoma	100%	15	0 / 15	1
MT-CYB	p.T194A	Esophageal Carcinoma	100%	15	0 / 15	1
DMPK	p.K62E	Hepatocellular Carcinoma	100%	15	0 / 15	1
ANPEP	p.A228P	Hepatocellular Carcinoma	100%	15	0 / 15	1
FHOD1	p.A778D	Hepatocellular Carcinoma	100%	15	0 / 15	1
IFT140	p.G832R	Esophageal Squamous Cell Carcinoma	100%	15	0 / 15	1
UGT3A1	p.E37K	Melanoma	93%	15	1 / 14	2
FSHR	p.A541V	Esophageal Squamous Cell Carcinoma	93%	15	0 / 15	2
ARHGAP30	p.R304C	Biliary Tract Carcinoma	93%	15	0 / 15	2
BARHL1	p.A121T	Biliary Tract Carcinoma	93%	15	0 / 15	2
CACNA1I	p.T1450P	Thyroid Gland Carcinoma	93%	15	1 / 14	2
CDH9	p.D574N	Melanoma	93%	15	0 / 15	2
CNTN5	p.E745K	Melanoma	93%	15	0 / 15	2
ADGRF5	p.V783A	Biliary Tract Carcinoma	93%	15	0 / 15	2
FAAH2	p.P257S	Melanoma	93%	15	4 / 11	2
GABRA3	p.R119W	Melanoma	93%	15	0 / 15	2
NBPF10	p.L2970V	Thyroid Gland Carcinoma	93%	15	0 / 15	2
OR4C15	p.S265F	Melanoma	93%	15	0 / 15	2
PREX2	p.G233C	Kidney Carcinoma	93%	15	0 / 15	2
SOGA3	p.E212G	Thyroid Gland Carcinoma	93%	15	0 / 15	2
SPTLC3	p.R97K	Melanoma	93%	15	0 / 15	2
SUN1	p.A602T	Biliary Tract Carcinoma	93%	15	0 / 15	2
TNN	p.R1048H	Biliary Tract Carcinoma	93%	15	0 / 15	2
UGT3A1	p.E71K	Melanoma	93%	15	1 / 14	2
ZBED9	p.E441K	Melanoma	93%	15	0 / 15	2
ZNF429	p.V433A	Glioma	93%	15	0 / 15	2
OR4N2	p.P280S	Melanoma	86%	15	2 / 13	2
FAM104B	p.P88S	Colorectal Carcinoma	86%	15	0 / 15	2
PEX5L	p.A609V	Colorectal Carcinoma	86%	15	0 / 15	3
ADAM28	p.E340K	Melanoma	86%	15	2 / 13	2
CDH10	p.R358C	Colorectal Carcinoma	86%	15	1 / 14	3
TTN	p.I31081F	Gastrointestinal Stromal Tumour	86%	15	0 / 15	3
TTN	p.V34115A	Gastrointestinal Stromal Tumour	86%	15	0 / 15	3
ZNF831	p.R1393Q	Melanoma	86%	15	0 / 15	2
DSCAM	p.R477Q	Colorectal Carcinoma	86%	15	0 / 15	3
AHNAK2	p.V4041M	Colorectal Carcinoma	86%	15	0 / 15	2
C12orf40	p.E522K	Melanoma	86%	15	0 / 15	2
SMAD2	p.R321Q	Colorectal Carcinoma	86%	15	6 / 9	3
WDR49	p.E645K	Melanoma	86%	15	5 / 10	3
HBG2	p.S71F	Melanoma	86%	15	0 / 15	2
ZNF648	p.E64K	Melanoma	80%	15	3 / 12	2
WDR87	p.E1851K	Melanoma	80%	15	6 / 9	3
APOB	p.R1388C	Melanoma	80%	15	1 / 14	2
PKHD1L1	p.T834A	Esophageal Squamous Cell Carcinoma	80%	15	0 / 15	2
RNFT2	p.D347N	Colorectal Carcinoma	80%	15	0 / 15	4
ADAMTS5	p.K450N	Biliary Tract Carcinoma	80%	15	1 / 14	4
KCNB2	p.H895Y	Melanoma	80%	15	1 / 14	2
SYT10	p.E227K	Melanoma	80%	15	4 / 11	3
TAF3	p.V696P	Esophageal Carcinoma	80%	15	2 / 13	3
TRAT1	p.E76K	Melanoma	80%	15	2 / 13	3
C11orf95	p.A179S	Biliary Tract Carcinoma	80%	15	0 / 15	2
CRNKL1	p.S128F	Melanoma	80%	15	1 / 14	3
DYRK1B	p.D608A	Thyroid Gland Carcinoma	80%	15	0 / 15	3
FRG2B	p.K116E	B-Cell Non-Hodgkins Lymphoma	80%	15	0 / 15	3
ABCC9	p.G1522E	Melanoma	80%	15	4 / 11	3
LRP2	p.R2095Q	Melanoma	80%	15	3 / 12	4
MPP7	p.R386Q	Melanoma	80%	15	1 / 14	3
MSTO1	p.K529R	B-Cell Non-Hodgkins Lymphoma	80%	15	0 / 15	3
MUC4	p.D3989G	B-Cell Non-Hodgkins Lymphoma	80%	15	0 / 15	4
TRIM49	p.S327R	Gastric Carcinoma	73%	15	1 / 14	5
TRMT13	p.A48M	Esophageal Carcinoma	73%	15	4 / 11	2
TRRAP	p.E3107K	B-Lymphoblastic Leukemia	73%	15	0 / 15	3
ANKRD30A	p.E1129K	Melanoma	73%	15	0 / 15	2
ARMC4	p.E22K	Melanoma	73%	15	1 / 14	5
WIPI2	p.R324P	Bladder Carcinoma	73%	15	0 / 15	3
BMP4	p.A114S	Biliary Tract Carcinoma	73%	15	0 / 15	4
SLC5A11	p.A348V	Esophageal Squamous Cell Carcinoma	73%	15	1 / 14	4
CASR	p.P39S	Melanoma	73%	15	0 / 15	2
KRTAP9-1	p.C118S	Colorectal Carcinoma	73%	15	3 / 12	3
EGFLAM	p.M219I	Melanoma	73%	15	0 / 15	2
SPDYE16	p.V173A	Gastric Carcinoma	73%	15	0 / 15	4
KCND2	p.G622E	Melanoma	73%	15	0 / 15	2
MUC12	p.V2043L	B-Cell Non-Hodgkins Lymphoma	73%	15	0 / 15	4
ZNF717	p.D41N	Thyroid Gland Carcinoma	73%	15	0 / 15	4
MAP2K4	p.S184L	Breast Carcinoma	73%	15	1 / 14	5
CHEK2	p.R535H	Glioma	73%	15	0 / 15	2
MUC5B	p.A2025T	B-Cell Non-Hodgkins Lymphoma	73%	15	0 / 15	4
GABRG1	p.G33E	Melanoma	73%	15	3 / 12	2
KRTAP9-1	p.C153S	Colorectal Carcinoma	73%	15	3 / 12	3
PNISR	p.S623L	Biliary Tract Carcinoma	100%	14	0 / 14	1
TAOK2	p.T1052P	Thyroid Gland Carcinoma	100%	14	0 / 14	1
CCDC80	p.K37T	Biliary Tract Carcinoma	100%	14	0 / 14	1
HIST1H3H	p.T46I	Burkitts Lymphoma	100%	14	0 / 14	1
OR3A3	p.V250M	Esophageal Squamous Cell Carcinoma	100%	14	0 / 14	1
ADAMTS13	p.F284L	Biliary Tract Carcinoma	100%	14	0 / 14	1
HIST1H1E	p.P201S	Burkitts Lymphoma	100%	14	0 / 14	1
ARMC2	p.R38K	Biliary Tract Carcinoma	100%	14	0 / 14	1
MYC	p.S132T	Burkitts Lymphoma	100%	14	0 / 14	1
BRWD1	p.K2029M	Biliary Tract Carcinoma	100%	14	0 / 14	1
MUC6	p.L1682Q	B-Cell Non-Hodgkins Lymphoma	100%	14	0 / 14	1
MUC6	p.H2075D	B-Cell Non-Hodgkins Lymphoma	100%	14	0 / 14	1
FAM135B	p.H141N	Esophageal Squamous Cell Carcinoma	100%	14	0 / 14	1
ACLY	p.E128K	Biliary Tract Carcinoma	100%	14	0 / 14	1
IGFN1	p.G2094S	B-Cell Non-Hodgkins Lymphoma	100%	14	0 / 14	1
F2RL2	p.C121F	Kidney Carcinoma	100%	14	0 / 14	1
KCNB1	p.R433L	Biliary Tract Carcinoma	100%	14	0 / 14	1
KCNU1	p.R290W	Biliary Tract Carcinoma	100%	14	0 / 14	1
PTPN4	p.R412G	Esophageal Squamous Cell Carcinoma	100%	14	0 / 14	1
ADAMTS13	p.F315L	Biliary Tract Carcinoma	100%	14	0 / 14	1
LRRC31	p.Q160R	Esophageal Squamous Cell Carcinoma	100%	14	0 / 14	1
PXDN	p.R1352S	Biliary Tract Carcinoma	100%	14	0 / 14	1
POU4F2	p.P164T	Biliary Tract Carcinoma	100%	14	0 / 14	1
MT-CYB	p.T7I	Esophageal Carcinoma	100%	14	0 / 14	1
MEGF8	p.Y1183C	Biliary Tract Carcinoma	100%	14	0 / 14	1
PCDHGB4	p.D268H	Biliary Tract Carcinoma	100%	14	0 / 14	1
PTPN6	p.P399L	Colorectal Carcinoma	100%	14	0 / 14	1
ZBTB10	p.G127S	Biliary Tract Carcinoma	100%	14	0 / 14	1
RAP1GAP2	p.K5T	Esophageal Squamous Cell Carcinoma	100%	14	0 / 14	1
OR6N2	p.S265R	Esophageal Squamous Cell Carcinoma	100%	14	0 / 14	1
CHAC2	p.H163Y	Biliary Tract Carcinoma	100%	14	0 / 14	1
HJURP	p.A259V	Biliary Tract Carcinoma	100%	14	0 / 14	1
RPS15	p.S138F	B-Cell Non-Hodgkins Lymphoma	100%	14	0 / 14	1
SPATA2L	p.P143A	Esophageal Squamous Cell Carcinoma	100%	14	0 / 14	1
CCDC78	p.V18G	Thyroid Gland Carcinoma	100%	14	0 / 14	1
SSSCA1	p.T162A	Biliary Tract Carcinoma	100%	14	0 / 14	1
COL21A1	p.G698E	Melanoma	92%	14	0 / 14	2
KRTAP4-7	p.R116L	B-Cell Non-Hodgkins Lymphoma	92%	14	0 / 14	2
PLCB3	p.S916P	Thyroid Gland Carcinoma	92%	14	0 / 14	2
TTN	p.E2571K	Melanoma	92%	14	1 / 13	2
ZNF462	p.Q759H	Kidney Carcinoma	92%	14	1 / 13	2
PNMA8A	p.E412K	Hepatocellular Carcinoma	92%	14	0 / 14	2
PRUNE2	p.G2060C	Esophageal Squamous Cell Carcinoma	92%	14	0 / 14	2
C4A	p.R1072Q	Colorectal Carcinoma	92%	14	0 / 14	2
GGT7	p.R86C	Colorectal Carcinoma	92%	14	0 / 14	2
DSPP	p.D1074E	B-Cell Non-Hodgkins Lymphoma	92%	14	0 / 14	2
C7	p.P590S	Melanoma	92%	14	4 / 10	2
MUCL3	p.T533M	Colorectal Carcinoma	92%	14	1 / 13	2
CDH6	p.E722K	Melanoma	92%	14	0 / 14	2
PSG1	p.R345H	Colorectal Carcinoma	85%	14	1 / 13	2
RNF152	p.P95S	Melanoma	85%	14	4 / 10	2
RP1	p.G254E	Melanoma	85%	14	0 / 14	2
RP1	p.G254E	Melanoma	85%	14	0 / 14	2
ANKRD36	p.T1066S	Esophageal Squamous Cell Carcinoma	85%	14	0 / 14	3
CATSPERB	p.P400S	Melanoma	85%	14	0 / 14	3
CCDC168	p.N2575K	B-Cell Non-Hodgkins Lymphoma	85%	14	0 / 14	3
SORCS3	p.E1175K	Melanoma	85%	14	1 / 13	3
TCF7L2	p.R448C	Colorectal Carcinoma	85%	14	0 / 14	3
CDH5	p.A353V	Colorectal Carcinoma	85%	14	0 / 14	3
TCF7L2	p.R465C	Colorectal Carcinoma	85%	14	0 / 14	3
TCF7L2	p.R471C	Colorectal Carcinoma	85%	14	0 / 14	3
CEACAM5	p.S243F	Melanoma	85%	14	1 / 13	3
CSMD3	p.P3151S	Melanoma	85%	14	5 / 9	3
DPRX	p.R20Q	Melanoma	85%	14	1 / 13	3
GNB4	p.R49H	Colorectal Carcinoma	85%	14	0 / 14	3
GRIN3A	p.E364K	Melanoma	85%	14	2 / 12	2
GUCA1C	p.E39K	Melanoma	85%	14	0 / 14	2
HECW2	p.A1181V	Esophageal Squamous Cell Carcinoma	85%	14	0 / 14	3
ILDR1	p.P358S	Melanoma	85%	14	2 / 12	2
KL	p.P520S	Melanoma	85%	14	2 / 12	2
MGAM	p.E1800K	Melanoma	85%	14	3 / 11	3
MUC4	p.A3766T	B-Cell Non-Hodgkins Lymphoma	85%	14	0 / 14	3
MUC4	p.T3990P	B-Cell Non-Hodgkins Lymphoma	85%	14	0 / 14	3
MUC6	p.H2075P	B-Cell Non-Hodgkins Lymphoma	85%	14	0 / 14	3
MYO7B	p.E512K	Melanoma	85%	14	2 / 12	3
NBPF11	p.L774V	Thyroid Gland Carcinoma	85%	14	0 / 14	3
NSUN6	p.P432L	Colorectal Carcinoma	85%	14	0 / 14	3
OR4C13	p.S55F	Melanoma	85%	14	5 / 9	2
OR4D5	p.S93F	Melanoma	85%	14	0 / 14	3
DSG1	p.D855N	Melanoma	85%	14	0 / 14	3
ACAD10	p.V258L	B-Cell Non-Hodgkins Lymphoma	85%	14	0 / 14	3
ACOD1	p.S326L	Colorectal Carcinoma	85%	14	0 / 14	3
PCLO	p.R1529Q	Melanoma	85%	14	4 / 10	2
ADAMTS17	p.R564C	Colorectal Carcinoma	85%	14	0 / 14	3
ALPI	p.R323C	Colorectal Carcinoma	85%	14	0 / 14	2
PKHD1L1	p.G2188E	Melanoma	85%	14	3 / 11	2
ANGPT1	p.G275E	Melanoma	85%	14	2 / 12	3
BRINP3	p.M497I	Melanoma	78%	14	0 / 14	4
FUT9	p.R10C	Melanoma	78%	14	2 / 12	4
STARD4	p.R202Q	Melanoma	78%	14	0 / 14	3
SPATC1	p.S329P	Thyroid Gland Carcinoma	78%	14	1 / 13	4
FAT4	p.H812Y	Melanoma	78%	14	2 / 12	3
NLRP12	p.G836E	Melanoma	78%	14	0 / 14	3
PDE1A	p.E98K	Melanoma	78%	14	0 / 14	3
CFTR	p.R709Q	Melanoma	78%	14	0 / 14	4
CGB2	p.R28H	B-Cell Non-Hodgkins Lymphoma	78%	14	0 / 14	4
OR11L1	p.M162I	Melanoma	78%	14	0 / 14	3
CHRM2	p.E382K	Melanoma	78%	14	1 / 13	4
SLCO1C1	p.E691K	Melanoma	78%	14	5 / 9	2
PTGER3	p.E361K	Melanoma	78%	14	0 / 14	2
PTGER3	p.E370K	Melanoma	78%	14	0 / 14	2
SH3BP2	p.H100R	Non-Small Cell Lung Carcinoma	78%	14	13 / 1	3
ZNF208	p.H771Y	Melanoma	78%	14	4 / 10	2
TTC24	p.V395G	Thyroid Gland Carcinoma	78%	14	0 / 14	4
PCBP1	p.L100P	Colorectal Carcinoma	78%	14	0 / 14	4
KSR2	p.G604E	Melanoma	78%	14	1 / 13	2
F13B	p.V266L	Biliary Tract Carcinoma	78%	14	0 / 14	2
MED12	p.L1224F	Prostate Carcinoma	78%	14	0 / 14	4
CTNNB1	p.R582W	Colorectal Carcinoma	78%	14	1 / 13	4
PCDHB8	p.E311K	Melanoma	78%	14	5 / 9	4
CNTNAP3	p.G1195R	Esophageal Squamous Cell Carcinoma	78%	14	0 / 14	2
ADAM18	p.G643E	Melanoma	78%	14	0 / 14	3
GRIN2A	p.A60V	Colorectal Carcinoma	78%	14	0 / 14	4
MUC3A	p.W18G	Thyroid Gland Carcinoma	78%	14	0 / 14	3
MUC4	p.D3957N	B-Cell Non-Hodgkins Lymphoma	78%	14	0 / 14	4
MUC4	p.H1197D	B-Cell Non-Hodgkins Lymphoma	78%	14	0 / 14	2
HSPA5	p.D231N	Biliary Tract Carcinoma	78%	14	0 / 14	3
UNC80	p.S1074F	Melanoma	78%	14	0 / 14	2
VEZF1	p.H13Q	Esophageal Squamous Cell Carcinoma	78%	14	0 / 14	2
GNAI2	p.R127C	Melanoma	78%	14	2 / 12	3
VEZF1	p.H4Q	Esophageal Squamous Cell Carcinoma	78%	14	0 / 14	2
GIMAP8	p.R187H	Colorectal Carcinoma	78%	14	0 / 14	4
ZNF676	p.E508G	Esophageal Squamous Cell Carcinoma	71%	14	0 / 14	2
ECT2L	p.R711Q	Melanoma	71%	14	0 / 14	3
CTNNA2	p.R614H	Biliary Tract Carcinoma	71%	14	0 / 14	5
HYDIN	p.S4119F	Melanoma	71%	14	3 / 11	2
C3	p.G906S	Ovarian Carcinoma	71%	14	0 / 14	4
CTNNB1	p.N387K	Hepatocellular Carcinoma	71%	14	0 / 14	5
FBXW7	p.E575K	Biliary Tract Carcinoma	71%	14	0 / 14	4
INSYN1	p.T146M	Colorectal Carcinoma	71%	14	0 / 14	5
ANKRD9	p.A271G	B-Cell Non-Hodgkins Lymphoma	71%	14	0 / 14	2
ADGRL2	p.R179C	Melanoma	71%	14	1 / 13	4
AJAP1	p.A131T	Biliary Tract Carcinoma	71%	14	0 / 14	3
CSMD3	p.R2497Q	Glioma	71%	14	0 / 14	4
MAX	p.H28R	Endometrial Carcinoma	71%	14	2 / 12	4
MUC12	p.T931N	B-Cell Non-Hodgkins Lymphoma	71%	14	0 / 14	5
MUC12	p.T4470I	B-Cell Non-Hodgkins Lymphoma	71%	14	0 / 14	5
MUC3A	p.A15S	Thyroid Gland Carcinoma	71%	14	0 / 14	4
MUC4	p.V3139L	B-Cell Non-Hodgkins Lymphoma	71%	14	0 / 14	4
NEIL1	p.K242R	B-Lymphoblastic Leukemia	71%	14	0 / 14	3
OR10R2	p.E20K	Biliary Tract Carcinoma	71%	14	0 / 14	2
OR10R2	p.E20K	Biliary Tract Carcinoma	71%	14	0 / 14	2
OR4M1	p.G41E	Melanoma	71%	14	0 / 14	2
OR51S1	p.R241C	Melanoma	71%	14	1 / 13	4
OR7D4	p.G227R	Thyroid Gland Carcinoma	71%	14	0 / 14	3
PCLO	p.R4461Q	Melanoma	71%	14	0 / 14	3
PEX5L	p.E24K	Melanoma	71%	14	0 / 14	2
PEX5L	p.E24K	Melanoma	71%	14	0 / 14	2
PPFIA2	p.R376W	Prostate Carcinoma	71%	14	0 / 14	5
SIRPA	p.R54H	Colorectal Carcinoma	71%	14	0 / 14	3
SLC9A3R1	p.V60G	Thyroid Gland Carcinoma	71%	14	0 / 14	4
SMAD4	p.R496H	Colorectal Carcinoma	71%	14	0 / 14	4
TCF7L2	p.R444W	Colorectal Carcinoma	71%	14	0 / 14	5
ZMIZ1	p.A301T	Glioma	71%	14	2 / 12	4
WFDC5	p.S203L	Esophageal Squamous Cell Carcinoma	100%	13	0 / 13	1
TSSK3	p.D249N	Colorectal Carcinoma	100%	13	0 / 13	1
TMTC1	p.G35R	Esophageal Squamous Cell Carcinoma	100%	13	0 / 13	1
SLC2A5	p.P496T	Kidney Carcinoma	100%	13	0 / 13	1
SLC36A2	p.G317V	Kidney Carcinoma	100%	13	0 / 13	1
SHOC2	p.T411S	Hepatocellular Carcinoma	100%	13	0 / 13	1
SERPINA10	p.G294E	Melanoma	100%	13	0 / 13	1
RPS15	p.P131S	B-Cell Non-Hodgkins Lymphoma	100%	13	0 / 13	1
RNF213	p.S3111R	Kidney Carcinoma	100%	13	0 / 13	1
PRR36	p.F1029V	Esophageal Squamous Cell Carcinoma	100%	13	0 / 13	1
PRR36	p.D652E	Esophageal Squamous Cell Carcinoma	100%	13	0 / 13	1
PLCB4	p.E755K	Melanoma	100%	13	0 / 13	1
NEUROG3	p.K60T	Esophageal Squamous Cell Carcinoma	100%	13	0 / 13	1
NCOA6	p.Q632L	Hepatocellular Carcinoma	100%	13	0 / 13	1
MXRA5	p.S1983F	Melanoma	100%	13	2 / 11	1
MUC6	p.T1670I	B-Cell Non-Hodgkins Lymphoma	100%	13	0 / 13	1
MUC4	p.S3749N	B-Cell Non-Hodgkins Lymphoma	100%	13	0 / 13	1
MAGEC1	p.F155S	B-Cell Non-Hodgkins Lymphoma	100%	13	0 / 13	1
CTNNA1	p.R332Q	Hepatocellular Carcinoma	100%	13	0 / 13	1
JAK2	p.R683S	B-Lymphoblastic Leukemia	100%	13	0 / 13	1
C3orf67	p.Q433E	Hepatocellular Carcinoma	100%	13	0 / 13	1
COPG1	p.S170R	Biliary Tract Carcinoma	100%	13	0 / 13	1
GABRE	p.S298F	Melanoma	100%	13	1 / 12	1
FKBP9	p.I42L	Glioma	100%	13	0 / 13	1
ANKRD36B	p.R906K	B-Cell Non-Hodgkins Lymphoma	100%	13	0 / 13	1
IGSF9B	p.P1128H	Colorectal Carcinoma	100%	13	0 / 13	1
ASPM	p.D962E	Esophageal Squamous Cell Carcinoma	100%	13	0 / 13	1
ASTE1	p.T170S	Esophageal Squamous Cell Carcinoma	100%	13	0 / 13	1
ESR1	p.E380Q	Breast Carcinoma	100%	13	0 / 13	1
ATP1A1	p.K3T	Esophageal Squamous Cell Carcinoma	100%	13	0 / 13	1
DCD	p.E43K	Melanoma	100%	13	1 / 12	1
GRIK3	p.G502S	Colorectal Carcinoma	100%	13	0 / 13	1
CYLC2	p.G137E	Melanoma	100%	13	2 / 11	1
CYLC2	p.E181K	Melanoma	100%	13	1 / 12	1
ZNF776	p.V341L	Kidney Carcinoma	100%	13	0 / 13	1
ZCCHC3	p.K12T	Esophageal Squamous Cell Carcinoma	100%	13	0 / 13	1
XPR1	p.T486S	Colorectal Carcinoma	100%	13	0 / 13	1
BRAF	p.S467L	Melanoma	92%	13	0 / 13	2
CNTN5	p.E823K	Melanoma	92%	13	1 / 12	2
ACCSL	p.R214Q	Colorectal Carcinoma	92%	13	0 / 13	2
AMPH	p.P273L	Colorectal Carcinoma	92%	13	0 / 13	2
AP3B2	p.R293Q	Esophageal Squamous Cell Carcinoma	92%	13	0 / 13	2
CFAP54	p.S2372F	Melanoma	92%	13	1 / 12	2
ABCA2	p.R1189H	Colorectal Carcinoma	92%	13	0 / 13	2
CRB1	p.S638L	Melanoma	92%	13	1 / 12	2
MET	p.N375S	Gastrointestinal Stromal Tumour	92%	13	0 / 13	2
DAP	p.H15P	Thyroid Gland Carcinoma	92%	13	0 / 13	2
DPYSL2	p.F20L	Colorectal Carcinoma	92%	13	0 / 13	2
HDAC9	p.P417S	Melanoma	92%	13	0 / 13	2
HGF	p.E174K	Melanoma	92%	13	4 / 9	2
HIST1H1E	p.P138S	Burkitts Lymphoma	92%	13	0 / 13	2
IGSF22	p.T961K	Colorectal Carcinoma	92%	13	0 / 13	2
IRF4	p.S114R	B-Cell Non-Hodgkins Lymphoma	92%	13	0 / 13	2
IRF4	p.L116R	B-Cell Non-Hodgkins Lymphoma	92%	13	0 / 13	2
ITPRIPL1	p.R411H	Colorectal Carcinoma	92%	13	0 / 13	2
KCNQ3	p.P409S	Melanoma	92%	13	3 / 10	2
KRT1	p.R251W	Colorectal Carcinoma	92%	13	0 / 13	2
LINGO2	p.H397N	Colorectal Carcinoma	92%	13	0 / 13	2
LRFN2	p.R705Q	Colorectal Carcinoma	92%	13	0 / 13	2
MAGEC1	p.P154T	B-Cell Non-Hodgkins Lymphoma	92%	13	0 / 13	2
MUC4	p.P3744S	B-Cell Non-Hodgkins Lymphoma	92%	13	0 / 13	2
NBPF1	p.M612V	Thyroid Gland Carcinoma	92%	13	0 / 13	2
NOS1	p.E832K	Melanoma	92%	13	5 / 8	2
NRG3	p.R538Q	Melanoma	92%	13	0 / 13	2
NRG3	p.R341Q	Melanoma	92%	13	0 / 13	2
OR2M5	p.S165F	Melanoma	92%	13	1 / 12	2
OR4K2	p.S217L	Melanoma	92%	13	2 / 11	2
OR51G2	p.G7E	Melanoma	92%	13	1 / 12	2
OR51G2	p.P289S	Melanoma	92%	13	1 / 12	2
PANX2	p.R643P	Thyroid Gland Carcinoma	92%	13	0 / 13	2
POFUT1	p.F261L	Colorectal Carcinoma	92%	13	0 / 13	2
RIMS1	p.K1144N	Esophageal Squamous Cell Carcinoma	92%	13	0 / 13	2
RTEL1	p.Q988H	Colorectal Carcinoma	92%	13	1 / 12	2
SETD1A	p.R311C	Colorectal Carcinoma	92%	13	0 / 13	2
SLC12A6	p.R1113Q	Colorectal Carcinoma	92%	13	0 / 13	2
SNCAIP	p.E627K	Melanoma	92%	13	0 / 13	2
SOX10	p.T244P	Esophageal Squamous Cell Carcinoma	92%	13	1 / 12	2
TACR3	p.A86T	Colorectal Carcinoma	92%	13	0 / 13	2
TRPM6	p.V870F	Bladder Carcinoma	92%	13	0 / 13	2
ZNF653	p.V279M	Colorectal Carcinoma	92%	13	0 / 13	2
ZFP28	p.R465Q	Biliary Tract Carcinoma	84%	13	0 / 13	2
TNR	p.E263K	Melanoma	84%	13	0 / 13	3
MUC6	p.S2020N	B-Cell Non-Hodgkins Lymphoma	84%	13	0 / 13	3
RMDN3	p.V376G	Thyroid Gland Carcinoma	84%	13	0 / 13	3
RNF133	p.R270C	Melanoma	84%	13	0 / 13	3
ASTN2	p.R238H	Colorectal Carcinoma	84%	13	6 / 7	3
DSCAM	p.S1245F	Melanoma	84%	13	0 / 13	2
MUC4	p.A3241V	B-Cell Non-Hodgkins Lymphoma	84%	13	1 / 12	3
OR51B5	p.E49K	Melanoma	84%	13	4 / 9	2
SEC23B	p.R313C	Melanoma	84%	13	1 / 12	3
ANGPT1	p.G74E	Melanoma	84%	13	1 / 12	3
WDR49	p.E673K	Melanoma	84%	13	0 / 13	2
SH3PXD2B	p.V20G	Thyroid Gland Carcinoma	84%	13	0 / 13	3
FOXO1	p.S468A	Prostate Carcinoma	84%	13	0 / 13	2
CNTN5	p.E929K	Melanoma	84%	13	3 / 10	3
DNAH8	p.R4064Q	Melanoma	84%	13	1 / 12	3
HHIP	p.D431N	Melanoma	84%	13	0 / 13	3
MUC16	p.S2193F	Melanoma	84%	13	0 / 13	2
MUC4	p.T2582I	B-Cell Non-Hodgkins Lymphoma	84%	13	0 / 13	3
PCDHB8	p.S17F	Melanoma	84%	13	0 / 13	2
PCLO	p.S1489F	Biliary Tract Carcinoma	84%	13	2 / 11	3
PEG3	p.E446K	Melanoma	84%	13	2 / 11	2
PEG3	p.H583Y	Melanoma	84%	13	0 / 13	3
NOTCH1	p.L1593P	B-Lymphoblastic Leukemia	84%	13	2 / 11	2
USF3	p.S881L	Melanoma	84%	13	0 / 13	3
KCNH6	p.E801K	Melanoma	84%	13	3 / 10	2
SLC25A5	p.R138H	Colorectal Carcinoma	84%	13	0 / 13	2
FKBP9	p.R354Q	Glioma	84%	13	0 / 13	2
ACTB	p.G158R	Bladder Carcinoma	84%	13	0 / 13	3
PPP1R3A	p.E528K	Melanoma	84%	13	3 / 10	2
CLRN3	p.R57C	Melanoma	84%	13	0 / 13	2
LRFN2	p.S95F	Melanoma	84%	13	0 / 13	2
ANKRD18B	p.R282K	B-Cell Non-Hodgkins Lymphoma	84%	13	0 / 13	3
LRRC3B	p.E57K	Melanoma	84%	13	0 / 13	3
PREX2	p.H1404Y	Melanoma	84%	13	0 / 13	3
MAGEC1	p.S150R	B-Cell Non-Hodgkins Lymphoma	84%	13	2 / 11	3
BCL9L	p.R407W	Colorectal Carcinoma	84%	13	0 / 13	3
CYP4F8	p.G417E	Biliary Tract Carcinoma	84%	13	0 / 13	3
PLCZ1	p.E323K	Melanoma	84%	13	4 / 9	2
PRRG3	p.R16Q	Melanoma	84%	13	0 / 13	3
KSR2	p.G575E	Melanoma	76%	13	0 / 13	2
SLC7A8	p.R143Q	Biliary Tract Carcinoma	76%	13	0 / 13	3
ADGRL2	p.V214M	Esophageal Squamous Cell Carcinoma	76%	13	0 / 13	2
MAP2K1	p.P124L	Melanoma	76%	13	1 / 12	4
MAP3K10	p.S779P	Thyroid Gland Carcinoma	76%	13	0 / 13	2
MAX	p.H19R	Endometrial Carcinoma	76%	13	1 / 12	4
MAP3K5	p.R256C	Melanoma	76%	13	4 / 9	4
MECOM	p.P373S	Melanoma	76%	13	3 / 10	2
MED16	p.H449Q	Thyroid Gland Carcinoma	76%	13	0 / 13	4
MEX3B	p.T269P	Thyroid Gland Carcinoma	76%	13	0 / 13	3
MLXIPL	p.T458P	Thyroid Gland Carcinoma	76%	13	0 / 13	4
DBF4B	p.S254Y	Colorectal Carcinoma	76%	13	2 / 11	2
MUC4	p.P3986H	B-Cell Non-Hodgkins Lymphoma	76%	13	0 / 13	3
JAML	p.R145C	Melanoma	76%	13	0 / 13	4
AGBL1	p.R550Q	Melanoma	76%	13	0 / 13	2
MXRA5	p.E2313K	Melanoma	76%	13	3 / 10	4
MYC	p.A146P	Burkitts Lymphoma	76%	13	2 / 11	3
NBPF15	p.P346H	Thyroid Gland Carcinoma	76%	13	0 / 13	3
HNRNPCL1	p.S225T	B-Cell Non-Hodgkins Lymphoma	76%	13	0 / 13	4
CACNA1G	p.T1609P	Thyroid Gland Carcinoma	76%	13	0 / 13	4
THSD7B	p.E90K	Melanoma	76%	13	1 / 12	3
TMPRSS6	p.A700S	Biliary Tract Carcinoma	76%	13	0 / 13	4
OC90	p.D57E	Esophageal Squamous Cell Carcinoma	76%	13	0 / 13	3
TRHR	p.E4K	Melanoma	76%	13	5 / 8	3
OR4M2	p.G41E	Melanoma	76%	13	0 / 13	2
OR6V1	p.S65F	Melanoma	76%	13	0 / 13	3
TUBGCP3	p.S473L	Melanoma	76%	13	0 / 13	3
CD1E	p.S55F	Melanoma	76%	13	1 / 12	4
POU2F2	p.L413P	Thyroid Gland Carcinoma	76%	13	0 / 13	3
PRAMEF11	p.R96H	Thyroid Gland Carcinoma	76%	13	0 / 13	3
RBFOX3	p.Q9P	Thyroid Gland Carcinoma	76%	13	0 / 13	4
RELN	p.E331K	Melanoma	76%	13	2 / 11	3
VIT	p.G307V	Endometrial Carcinoma	76%	13	0 / 13	4
WDR35	p.T580M	Prostate Carcinoma	76%	13	1 / 12	4
SCN5A	p.R1193Q	Gastrointestinal Stromal Tumour	76%	13	0 / 13	3
FAM104B	p.T97I	Colorectal Carcinoma	76%	13	0 / 13	4
FFAR3	p.N77S	B-Cell Non-Hodgkins Lymphoma	76%	13	0 / 13	4
GGTLC2	p.V33D	Esophageal Squamous Cell Carcinoma	76%	13	0 / 13	3
DAB2IP	p.N91T	Esophageal Squamous Cell Carcinoma	76%	13	1 / 12	3
IL36B	p.E57K	Melanoma	76%	13	2 / 11	3
CLCN1	p.R199C	Melanoma	76%	13	0 / 13	4
COL22A1	p.E308K	Melanoma	76%	13	0 / 13	2
JAML	p.R173C	Melanoma	76%	13	0 / 13	4
CRB1	p.E946K	Melanoma	76%	13	0 / 13	3
CDH10	p.D659N	Melanoma	76%	13	0 / 13	3
KRT28	p.S46F	Melanoma	76%	13	5 / 8	3
ZSWIM5	p.W414L	Colorectal Carcinoma	100%	12	0 / 12	1
ACAD11	p.A197T	Colorectal Carcinoma	100%	12	0 / 12	1
ANO1	p.Q403K	Colorectal Carcinoma	100%	12	0 / 12	1
AHNAK	p.P5445S	Kidney Carcinoma	100%	12	0 / 12	1
ALS2CR12	p.K215T	Colorectal Carcinoma	100%	12	0 / 12	1
ANKRD35	p.A539V	Colorectal Carcinoma	100%	12	0 / 12	1
ASPM	p.K1861N	Glioma	100%	12	0 / 12	1
BORCS6	p.A155V	Colorectal Carcinoma	100%	12	0 / 12	1
CATSPERD	p.E493K	Melanoma	100%	12	0 / 12	1
CCDC142	p.E32K	Colorectal Carcinoma	100%	12	0 / 12	1
CCKBR	p.R465C	Kidney Carcinoma	100%	12	0 / 12	1
CLDN22	p.V153I	Colorectal Carcinoma	100%	12	0 / 12	1
COL3A1	p.G882D	Colorectal Carcinoma	100%	12	0 / 12	1
COL3A1	p.G1185D	Colorectal Carcinoma	100%	12	0 / 12	1
COX7A2	p.G64V	Colorectal Carcinoma	100%	12	0 / 12	1
COX7A2	p.G96V	Colorectal Carcinoma	100%	12	0 / 12	1
NBPF11	p.H602Y	Thyroid Gland Carcinoma	100%	12	0 / 12	1
DCDC1	p.A1590V	Colorectal Carcinoma	100%	12	0 / 12	1
DCP1B	p.G544S	Esophageal Squamous Cell Carcinoma	100%	12	0 / 12	1
DEFA5	p.R75C	Colorectal Carcinoma	100%	12	0 / 12	1
DISP1	p.M525V	Colorectal Carcinoma	100%	12	0 / 12	1
DNER	p.S335F	Melanoma	100%	12	0 / 12	1
DNER	p.M189I	Melanoma	100%	12	8 / 4	1
DSG1	p.E788K	Melanoma	100%	12	2 / 10	1
DSP	p.A2296T	Colorectal Carcinoma	100%	12	0 / 12	1
EPHA6	p.F1084L	Colorectal Carcinoma	100%	12	0 / 12	1
ERBB4	p.S1273A	Bladder Carcinoma	100%	12	0 / 12	1
ERBB4	p.S1247A	Bladder Carcinoma	100%	12	0 / 12	1
ESF1	p.K705Q	Colorectal Carcinoma	100%	12	0 / 12	1
EVA1C	p.G333D	Colorectal Carcinoma	100%	12	0 / 12	1
FGF10	p.W169R	Colorectal Carcinoma	100%	12	0 / 12	1
FGF23	p.I173R	Esophageal Squamous Cell Carcinoma	100%	12	0 / 12	1
FKBP9	p.N417S	Glioma	100%	12	0 / 12	1
FKBPL	p.L237P	Colorectal Carcinoma	100%	12	0 / 12	1
FOXD4L5	p.A239P	Thyroid Gland Carcinoma	100%	12	0 / 12	1
FYN	p.P36H	Colorectal Carcinoma	100%	12	0 / 12	1
GABRA2	p.S297I	Colorectal Carcinoma	100%	12	0 / 12	1
GATA3	p.M293K	Breast Carcinoma	100%	12	0 / 12	1
GLRB	p.H394N	Esophageal Squamous Cell Carcinoma	100%	12	0 / 12	1
GPR156	p.V112E	Colorectal Carcinoma	100%	12	0 / 12	1
IL4I1	p.M312T	Esophageal Squamous Cell Carcinoma	100%	12	0 / 12	1
IRAK4	p.I399F	Colorectal Carcinoma	100%	12	0 / 12	1
ISM2	p.P133Q	Colorectal Carcinoma	100%	12	0 / 12	1
KAT14	p.D368A	Colorectal Carcinoma	100%	12	0 / 12	1
KAT14	p.D369A	Colorectal Carcinoma	100%	12	0 / 12	1
KIAA0232	p.L614F	Biliary Tract Carcinoma	100%	12	0 / 12	1
KRT6A	p.R326H	Colorectal Carcinoma	100%	12	0 / 12	1
KRTAP5-10	p.S116F	Melanoma	100%	12	0 / 12	1
LSP1	p.E28K	Esophageal Squamous Cell Carcinoma	100%	12	0 / 12	1
LSP1	p.E156K	Esophageal Squamous Cell Carcinoma	100%	12	0 / 12	1
MADD	p.S333A	Colorectal Carcinoma	100%	12	0 / 12	1
MAG	p.V80I	Colorectal Carcinoma	100%	12	0 / 12	1
MCMDC2	p.Y111F	Kidney Carcinoma	100%	12	0 / 12	1
MED12L	p.C1058G	Colorectal Carcinoma	100%	12	0 / 12	1
MEGF8	p.R2742S	Colorectal Carcinoma	100%	12	0 / 12	1
MEN1	p.F78C	Esophageal Squamous Cell Carcinoma	100%	12	0 / 12	1
MTTP	p.M692I	Colorectal Carcinoma	100%	12	0 / 12	1
MUC4	p.D2709N	B-Cell Non-Hodgkins Lymphoma	100%	12	0 / 12	1
MUC4	p.S2695Y	B-Cell Non-Hodgkins Lymphoma	100%	12	0 / 12	1
MUC6	p.H1921Q	B-Cell Non-Hodgkins Lymphoma	100%	12	0 / 12	1
MUC6	p.G1677R	B-Cell Non-Hodgkins Lymphoma	100%	12	0 / 12	1
MYC	p.A117V	Burkitts Lymphoma	100%	12	0 / 12	1
MYOCD	p.S715L	Melanoma	100%	12	2 / 10	1
NBPF12	p.R36I	Thyroid Gland Carcinoma	100%	12	0 / 12	1
NBPF20	p.L1672V	Thyroid Gland Carcinoma	100%	12	0 / 12	1
NEURL4	p.L674V	Colorectal Carcinoma	100%	12	0 / 12	1
NIPBL	p.N141K	Kidney Carcinoma	100%	12	0 / 12	1
NOTCH1	p.F1592S	B-Lymphoblastic Leukemia	100%	12	0 / 12	1
NUP98	p.N571S	Colorectal Carcinoma	100%	12	0 / 12	1
OAS3	p.R790W	Colorectal Carcinoma	100%	12	0 / 12	1
OPRK1	p.V380E	Kidney Carcinoma	100%	12	0 / 12	1
OR4N4	p.G152V	Colorectal Carcinoma	100%	12	0 / 12	1
SPTB	p.V1837L	Colorectal Carcinoma	100%	12	0 / 12	1
PCNX4	p.M297L	Colorectal Carcinoma	100%	12	0 / 12	1
PIP4K2A	p.R133H	Kidney Carcinoma	100%	12	0 / 12	1
PLCB4	p.E737K	Melanoma	100%	12	0 / 12	1
PLCB4	p.G876E	Melanoma	100%	12	2 / 10	1
PPP1R3A	p.R160I	Colorectal Carcinoma	100%	12	0 / 12	1
PRB3	p.G128E	Melanoma	100%	12	0 / 12	1
PRSS37	p.G169E	Melanoma	100%	12	1 / 11	1
RASSF7	p.V24F	Colorectal Carcinoma	100%	12	0 / 12	1
RIPOR3	p.A164V	Colorectal Carcinoma	100%	12	0 / 12	1
RPL8	p.G153S	Kidney Carcinoma	100%	12	0 / 12	1
SAMD12	p.G51E	Melanoma	100%	12	2 / 10	1
SCNN1B	p.P637S	Colorectal Carcinoma	100%	12	0 / 12	1
SERPINB12	p.L15P	Colorectal Carcinoma	100%	12	0 / 12	1
SLC22A16	p.G173S	Colorectal Carcinoma	100%	12	0 / 12	1
SNED1	p.Q1242H	Thyroid Gland Carcinoma	100%	12	0 / 12	1
SOX17	p.S403I	Endometrial Carcinoma	100%	12	0 / 12	1
SPATA31D1	p.T1251A	Colorectal Carcinoma	100%	12	0 / 12	1
SPINK13	p.R84C	Melanoma	100%	12	0 / 12	1
SPSB4	p.R146C	Colorectal Carcinoma	100%	12	0 / 12	1
SRBD1	p.R464W	Kidney Carcinoma	100%	12	0 / 12	1
STAT1	p.Y203S	Colorectal Carcinoma	100%	12	0 / 12	1
SVEP1	p.A634P	Colorectal Carcinoma	100%	12	0 / 12	1
SYNE1	p.H3252Q	Colorectal Carcinoma	100%	12	0 / 12	1
SYNE1	p.K1383N	Colorectal Carcinoma	100%	12	0 / 12	1
TAAR2	p.G67R	Colorectal Carcinoma	100%	12	0 / 12	1
TEX13C	p.P42L	Colorectal Carcinoma	100%	12	0 / 12	1
THAP6	p.G82S	B-Cell Non-Hodgkins Lymphoma	100%	12	0 / 12	1
TMEM147	p.A196E	Colorectal Carcinoma	100%	12	0 / 12	1
TRIML1	p.R323S	Colorectal Carcinoma	100%	12	0 / 12	1
TSHZ2	p.E23K	Melanoma	100%	12	0 / 12	1
UBALD1	p.F75V	Esophageal Squamous Cell Carcinoma	100%	12	0 / 12	1
VHL	p.C121R	Kidney Carcinoma	100%	12	0 / 12	1
VHL	p.C162R	Kidney Carcinoma	100%	12	0 / 12	1
VPS29	p.L6H	Colorectal Carcinoma	100%	12	0 / 12	1
ZFPM2	p.R884C	Colorectal Carcinoma	100%	12	0 / 12	1
AC134980.3	p.G152V	Colorectal Carcinoma	100%	12	0 / 12	1
ATP5PB	p.R55C	Melanoma	91%	12	0 / 12	2
CAPZA3	p.G136E	Melanoma	91%	12	0 / 12	2
ALG13	p.F276L	Biliary Tract Carcinoma	91%	12	0 / 12	2
IQUB	p.R276K	Biliary Tract Carcinoma	91%	12	0 / 12	2
DCC	p.P726S	Melanoma	91%	12	0 / 12	2
HRNR	p.Q651H	Esophageal Squamous Cell Carcinoma	91%	12	0 / 12	2
ZNF728	p.S200F	Melanoma	91%	12	1 / 11	2
ALPK2	p.E700K	Melanoma	91%	12	2 / 10	2
SORL1	p.R1124C	Melanoma	91%	12	1 / 11	2
KCTD1	p.N28T	Esophageal Squamous Cell Carcinoma	91%	12	1 / 11	2
BCL9L	p.R409W	Colorectal Carcinoma	91%	12	1 / 11	2
COL6A5	p.T705I	Biliary Tract Carcinoma	91%	12	0 / 12	2
RAP1GAP2	p.V406I	Biliary Tract Carcinoma	91%	12	0 / 12	2
CD163L1	p.R99C	Melanoma	91%	12	0 / 12	2
ALG13	p.F354L	Biliary Tract Carcinoma	91%	12	0 / 12	2
SPOP	p.F102V	Prostate Carcinoma	91%	12	0 / 12	2
PAPPA2	p.D1454Y	Biliary Tract Carcinoma	91%	12	0 / 12	2
LRRC4C	p.E211K	Melanoma	91%	12	2 / 10	2
KAT6B	p.Q1251R	Biliary Tract Carcinoma	91%	12	0 / 12	2
FSD2	p.G135R	Colorectal Carcinoma	91%	12	0 / 12	2
SPHKAP	p.S1545R	Biliary Tract Carcinoma	91%	12	1 / 11	2
LRRK1	p.D884N	Biliary Tract Carcinoma	91%	12	1 / 11	2
SCN11A	p.P1418S	Melanoma	91%	12	0 / 12	2
IFITM3	p.V123I	Glioma	91%	12	0 / 12	2
FCRLA	p.L219F	Kidney Carcinoma	91%	12	0 / 12	2
HIST1H1C	p.P200S	Burkitts Lymphoma	91%	12	1 / 11	2
GRIA1	p.P349S	Melanoma	91%	12	4 / 8	2
SH3RF2	p.E166K	Melanoma	91%	12	1 / 11	2
SLC12A4	p.G658V	Biliary Tract Carcinoma	91%	12	0 / 12	2
FBXL4	p.E398D	Biliary Tract Carcinoma	91%	12	0 / 12	2
SLC6A18	p.T212P	Non-Small Cell Lung Carcinoma	91%	12	0 / 12	2
RFX3	p.I519V	Kidney Carcinoma	91%	12	0 / 12	2
EPHB1	p.R905H	Colorectal Carcinoma	91%	12	0 / 12	2
MTA3	p.R48L	Biliary Tract Carcinoma	91%	12	0 / 12	2
PGM5	p.R504W	Esophageal Squamous Cell Carcinoma	91%	12	0 / 12	2
MUC16	p.S2253F	Melanoma	91%	12	0 / 12	2
PDE2A	p.A652S	Biliary Tract Carcinoma	91%	12	0 / 12	2
BPTF	p.R266H	Biliary Tract Carcinoma	91%	12	0 / 12	2
RASA3	p.V316M	Biliary Tract Carcinoma	91%	12	0 / 12	2
RIMBP2	p.G827R	Ovarian Carcinoma	83%	12	0 / 12	3
UGT2A2	p.G121E	Melanoma	83%	12	2 / 10	3
KCNJ3	p.S332F	Melanoma	83%	12	2 / 10	2
SALL1	p.S373L	Melanoma	83%	12	1 / 11	3
KIF14	p.M578I	Melanoma	83%	12	0 / 12	2
KRTAP4-7	p.C118S	B-Cell Non-Hodgkins Lymphoma	83%	12	0 / 12	2
SCN11A	p.R1641C	Melanoma	83%	12	0 / 12	3
PCDH18	p.E569K	Melanoma	83%	12	0 / 12	3
LRRC7	p.R110Q	Melanoma	83%	12	0 / 12	3
USH2A	p.E4671K	Melanoma	83%	12	0 / 12	3
TDP1	p.A258V	Biliary Tract Carcinoma	83%	12	0 / 12	3
SFRP4	p.K324N	Thyroid Gland Carcinoma	83%	12	0 / 12	3
MORC1	p.E857K	Melanoma	83%	12	0 / 12	3
MUC4	p.A1161V	B-Cell Non-Hodgkins Lymphoma	83%	12	0 / 12	2
MUC4	p.T1110S	B-Cell Non-Hodgkins Lymphoma	83%	12	0 / 12	2
SMURF2	p.R427C	Melanoma	83%	12	0 / 12	2
MYH1	p.R1479C	Colorectal Carcinoma	83%	12	0 / 12	3
THSD7B	p.R1023Q	Melanoma	83%	12	2 / 10	3
NFKBIZ	p.R614C	Colorectal Carcinoma	83%	12	0 / 12	3
NGF	p.E132K	Melanoma	83%	12	1 / 11	3
SPATA31D1	p.R1316H	Biliary Tract Carcinoma	83%	12	0 / 12	3
SPATC1	p.T328P	Thyroid Gland Carcinoma	83%	12	0 / 12	3
OR4A15	p.M292I	Melanoma	83%	12	4 / 8	2
OR4K1	p.S148F	Melanoma	83%	12	0 / 12	3
OR51S1	p.R194C	Melanoma	83%	12	0 / 12	3
PAX6	p.Q416E	Esophageal Squamous Cell Carcinoma	83%	12	2 / 10	2
PCDHA6	p.R480Q	Prostate Carcinoma	83%	12	0 / 12	2
ATXN1	p.P672S	Kidney Carcinoma	83%	12	0 / 12	3
C12orf54	p.E33K	Melanoma	83%	12	7 / 5	3
CSMD1	p.S374L	Melanoma	83%	12	0 / 12	2
CSMD1	p.S375L	Melanoma	83%	12	0 / 12	2
CD6	p.A466S	Biliary Tract Carcinoma	83%	12	1 / 11	3
CDC27	p.V201F	B-Cell Non-Hodgkins Lymphoma	83%	12	0 / 12	3
CHL1	p.T840A	Prostate Carcinoma	83%	12	0 / 12	3
CNGB3	p.S78F	Melanoma	83%	12	0 / 12	3
COL21A1	p.R220Q	Melanoma	83%	12	1 / 11	3
ADGRB2	p.E513K	Ovarian Carcinoma	83%	12	0 / 12	3
ADH1B	p.E257K	Melanoma	83%	12	1 / 11	2
AHDC1	p.T71P	Thyroid Gland Carcinoma	83%	12	2 / 10	3
COL4A3	p.G43R	Rhabdomyosarcoma	83%	12	0 / 12	3
COL7A1	p.R2338Q	Biliary Tract Carcinoma	83%	12	0 / 12	3
APOBEC3G	p.V33I	Prostate Carcinoma	83%	12	0 / 12	2
DNAH5	p.E3549K	Melanoma	83%	12	0 / 12	2
ATF5	p.S126P	Thyroid Gland Carcinoma	83%	12	0 / 12	2
EGFR	p.R222C	Glioma	83%	12	1 / 11	3
ENPP2	p.R175H	Biliary Tract Carcinoma	83%	12	0 / 12	3
EP300	p.D1485Y	Esophageal Squamous Cell Carcinoma	83%	12	0 / 12	3
STAB2	p.R243Q	Melanoma	83%	12	0 / 12	2
ERCC2	p.K751Q	Gastrointestinal Stromal Tumour	83%	12	0 / 12	3
WDR37	p.R303Q	Ovarian Carcinoma	83%	12	0 / 12	2
POTED	p.T13A	Thyroid Gland Carcinoma	83%	12	0 / 12	2
STON2	p.S167L	Melanoma	83%	12	0 / 12	3
GABRA3	p.S328F	Melanoma	83%	12	0 / 12	3
GPR68	p.F265L	Esophageal Squamous Cell Carcinoma	83%	12	2 / 10	2
HHLA2	p.G117E	Melanoma	83%	12	3 / 9	3
RHOB	p.E47K	Bladder Carcinoma	83%	12	3 / 9	2
SYNE1	p.R31Q	Melanoma	83%	12	0 / 12	2
TTLL2	p.R279W	Melanoma	75%	12	0 / 12	4
LRRC7	p.R572Q	Melanoma	75%	12	1 / 11	2
PTGER2	p.E294K	Melanoma	75%	12	0 / 12	2
LIN7A	p.R204Q	Melanoma	75%	12	2 / 10	3
RP1	p.P1282S	Melanoma	75%	12	0 / 12	3
KRTAP12-4	p.T4P	Thyroid Gland Carcinoma	75%	12	0 / 12	3
GLRB	p.R167C	Melanoma	75%	12	4 / 8	4
XRCC5	p.E621K	Colorectal Carcinoma	75%	12	4 / 8	2
SYVN1	p.H358P	Thyroid Gland Carcinoma	75%	12	0 / 12	4
IL7R	p.S240L	Melanoma	75%	12	1 / 11	4
GPX6	p.G148E	Melanoma	75%	12	3 / 9	3
KIR3DL2	p.R362C	Melanoma	75%	12	0 / 12	3
ARHGEF3	p.R26W	Colorectal Carcinoma	75%	12	0 / 12	4
CLVS1	p.E171K	Melanoma	75%	12	1 / 11	4
DOCK10	p.R1994W	Esophageal Squamous Cell Carcinoma	75%	12	0 / 12	4
C8B	p.E499K	Melanoma	75%	12	0 / 12	2
BRINP1	p.E37K	Melanoma	75%	12	2 / 10	3
AMN	p.A19V	Esophageal Squamous Cell Carcinoma	75%	12	0 / 12	2
CNTN5	p.G195E	Melanoma	75%	12	2 / 10	3
PCDH15	p.S1703L	Neuroendocrine Tumour	75%	12	0 / 12	3
DMBT1	p.D560N	Melanoma	75%	12	5 / 7	2
ADAMTS16	p.V877M	Colorectal Carcinoma	75%	12	0 / 12	4
DCHS1	p.R2127H	Ovarian Carcinoma	75%	12	0 / 12	3
ADCY8	p.G1163E	Melanoma	75%	12	1 / 11	2
AP3B2	p.R127C	Melanoma	75%	12	5 / 7	4
DNAH5	p.R1245C	Melanoma	75%	12	2 / 10	3
PCDH15	p.S1636L	Neuroendocrine Tumour	75%	12	0 / 12	3
DPYD	p.E415K	Melanoma	75%	12	1 / 11	3
TPRX1	p.P305S	Colorectal Carcinoma	75%	12	0 / 12	4
SLC9C1	p.R554C	Melanoma	75%	12	0 / 12	3
GUCY2C	p.D179N	Melanoma	75%	12	0 / 12	3
HCN1	p.E620K	Melanoma	75%	12	5 / 7	3
IMPDH1	p.R198H	Kidney Carcinoma	75%	12	0 / 12	3
SLC7A13	p.R192Q	Melanoma	75%	12	0 / 12	4
MORC1	p.E503K	Melanoma	75%	12	0 / 12	2
VWA5A	p.P46S	Melanoma	75%	12	1 / 11	2
NUTM2D	p.E474K	B-Cell Non-Hodgkins Lymphoma	75%	12	0 / 12	3
NYAP2	p.T220M	Prostate Carcinoma	75%	12	0 / 12	3
ZNF676	p.M66I	Melanoma	75%	12	0 / 12	4
OBSCN	p.R4025C	Melanoma	75%	12	1 / 11	3
OBSCN	p.R4025C	Melanoma	75%	12	1 / 11	3
TNFSF12	p.R90W	Esophageal Squamous Cell Carcinoma	75%	12	1 / 11	4
OR2G3	p.G41E	Melanoma	75%	12	0 / 12	3
KIR3DL1	p.S107L	B-Cell Non-Hodgkins Lymphoma	75%	12	0 / 12	4
OR4E2	p.S93F	Melanoma	75%	12	3 / 9	2
KCNJ3	p.R499C	Esophageal Squamous Cell Carcinoma	75%	12	0 / 12	4
OR4M2	p.P167S	Melanoma	75%	12	2 / 10	2
SPOCK3	p.D404N	Melanoma	75%	12	0 / 12	3
OR51F1	p.R272C	Melanoma	75%	12	1 / 11	4
HRNR	p.R1697H	Ovarian Carcinoma	75%	12	0 / 12	3
OTOF	p.E643K	Melanoma	75%	12	0 / 12	3
SPANXC	p.L80V	Non-Small Cell Lung Carcinoma	75%	12	9 / 3	4
PLCB4	p.S682L	Melanoma	75%	12	1 / 11	3
SPAM1	p.D198N	Melanoma	75%	12	1 / 11	2
ZBTB45	p.T138P	Thyroid Gland Carcinoma	75%	12	0 / 12	4
PCDHB6	p.E291K	Melanoma	75%	12	0 / 12	3
SPAG16	p.P488S	Melanoma	75%	12	0 / 12	2
MYOCD	p.S63F	Melanoma	75%	12	1 / 11	2
MYLK	p.E1599K	Melanoma	75%	12	0 / 12	4
MYLK	p.A1030T	Endometrial Carcinoma	75%	12	0 / 12	2
MUC7	p.P219S	Gastric Carcinoma	75%	12	1 / 11	4
SLC9C2	p.R203W	Melanoma	75%	12	0 / 12	3
MUC4	p.P1190L	B-Cell Non-Hodgkins Lymphoma	75%	12	0 / 12	3
MUC4	p.A3982T	B-Cell Non-Hodgkins Lymphoma	75%	12	0 / 12	3
MUC4	p.H3981D	B-Cell Non-Hodgkins Lymphoma	75%	12	0 / 12	4
MUC4	p.S3080L	B-Cell Non-Hodgkins Lymphoma	75%	12	0 / 12	4
LTBP3	p.E251K	Esophageal Squamous Cell Carcinoma	75%	12	0 / 12	3
KCNH5	p.S449L	Melanoma	75%	12	0 / 12	4
IGSF3	p.D126E	Thyroid Gland Carcinoma	75%	12	1 / 11	4
STPG2	p.G448E	Melanoma	75%	12	0 / 12	2
PRKAG1	p.R308Q	Colorectal Carcinoma	75%	12	2 / 10	3
IFITM3	p.G133R	Glioma	100%	11	0 / 11	1
ZNF641	p.G127R	Biliary Tract Carcinoma	100%	11	0 / 11	1
IGSF10	p.A2283G	Biliary Tract Carcinoma	100%	11	0 / 11	1
PLEKHG5	p.C472W	Biliary Tract Carcinoma	100%	11	0 / 11	1
SIPA1L2	p.D382Y	Biliary Tract Carcinoma	100%	11	0 / 11	1
CEP295NL	p.R278S	Biliary Tract Carcinoma	100%	11	0 / 11	1
CFAP65	p.G1402A	Biliary Tract Carcinoma	100%	11	0 / 11	1
IRF4	p.K59R	B-Cell Non-Hodgkins Lymphoma	100%	11	0 / 11	1
TRMT1L	p.D711N	Biliary Tract Carcinoma	100%	11	0 / 11	1
ITGA9	p.D798V	Biliary Tract Carcinoma	100%	11	0 / 11	1
CFHR5	p.S88F	Melanoma	100%	11	2 / 9	1
CHERP	p.K872T	Biliary Tract Carcinoma	100%	11	0 / 11	1
PAQR8	p.A244V	Biliary Tract Carcinoma	100%	11	0 / 11	1
KCNK13	p.G123E	Melanoma	100%	11	1 / 10	1
ZNF382	p.E11Q	Colorectal Carcinoma	100%	11	0 / 11	1
TRIM64B	p.S291R	Biliary Tract Carcinoma	100%	11	0 / 11	1
KCNV1	p.P190S	Melanoma	100%	11	0 / 11	1
ZNF382	p.E60Q	Colorectal Carcinoma	100%	11	0 / 11	1
ZFYVE26	p.Y2170C	Biliary Tract Carcinoma	100%	11	0 / 11	1
COL12A1	p.S1096Y	Biliary Tract Carcinoma	100%	11	0 / 11	1
CAMKK2	p.C62F	Biliary Tract Carcinoma	100%	11	0 / 11	1
KLF4	p.S411Y	Pancreatic Carcinoma	100%	11	0 / 11	1
KLHL13	p.G353E	Melanoma	100%	11	0 / 11	1
KLHL13	p.G388E	Melanoma	100%	11	0 / 11	1
COL21A1	p.E877K	Melanoma	100%	11	2 / 9	1
ZFYVE26	p.C1835F	Biliary Tract Carcinoma	100%	11	0 / 11	1
ZFAND4	p.E644V	Biliary Tract Carcinoma	100%	11	0 / 11	1
PCDHB7	p.V243M	Biliary Tract Carcinoma	100%	11	0 / 11	1
C5orf49	p.H143R	Biliary Tract Carcinoma	100%	11	0 / 11	1
LAMA1	p.G1116V	Biliary Tract Carcinoma	100%	11	0 / 11	1
LCP2	p.R9G	Biliary Tract Carcinoma	100%	11	0 / 11	1
TSHZ2	p.E23K	Melanoma	100%	11	0 / 11	1
TINAG	p.S359C	Biliary Tract Carcinoma	100%	11	0 / 11	1
LIX1L	p.S297T	Biliary Tract Carcinoma	100%	11	0 / 11	1
LMNTD2	p.R632C	Biliary Tract Carcinoma	100%	11	0 / 11	1
ZFAND4	p.R191S	Biliary Tract Carcinoma	100%	11	0 / 11	1
CSPP1	p.I723N	Biliary Tract Carcinoma	100%	11	0 / 11	1
TCF23	p.Q53K	Biliary Tract Carcinoma	100%	11	0 / 11	1
CUBN	p.A45V	Biliary Tract Carcinoma	100%	11	0 / 11	1
MAGEC1	p.E620K	Melanoma	100%	11	0 / 11	1
MAP1A	p.V2062G	Esophageal Squamous Cell Carcinoma	100%	11	0 / 11	1
MAP3K19	p.L166F	Biliary Tract Carcinoma	100%	11	0 / 11	1
TACSTD2	p.D216E	Gastrointestinal Stromal Tumour	100%	11	0 / 11	1
MCCC2	p.A211V	Kidney Carcinoma	100%	11	0 / 11	1
MCCC2	p.A249V	Kidney Carcinoma	100%	11	0 / 11	1
PABPC1	p.Q510H	Biliary Tract Carcinoma	100%	11	0 / 11	1
PPP6R1	p.M518I	Kidney Carcinoma	100%	11	0 / 11	1
MGA	p.L1679F	Biliary Tract Carcinoma	100%	11	0 / 11	1
MGAM	p.S1550F	Melanoma	100%	11	0 / 11	1
NDFIP2	p.N58T	Esophageal Squamous Cell Carcinoma	100%	11	0 / 11	1
MORC2	p.Q99L	Melanoma	100%	11	0 / 11	1
SYN3	p.S300F	Biliary Tract Carcinoma	100%	11	0 / 11	1
C4orf54	p.R945Q	Biliary Tract Carcinoma	100%	11	0 / 11	1
STXBP5L	p.G503E	Melanoma	100%	11	3 / 8	1
MT-ATP6	p.T112A	Esophageal Carcinoma	100%	11	0 / 11	1
STRA8	p.E212D	Rhabdomyosarcoma	100%	11	0 / 11	1
CYP4Z1	p.P47S	Melanoma	100%	11	3 / 8	1
AKR1E2	p.T73P	Thyroid Gland Carcinoma	100%	11	0 / 11	1
SSH1	p.Q1019H	Biliary Tract Carcinoma	100%	11	0 / 11	1
DDX49	p.R180M	Biliary Tract Carcinoma	100%	11	0 / 11	1
MUC4	p.S3749G	B-Cell Non-Hodgkins Lymphoma	100%	11	0 / 11	1
DENND3	p.K458T	Biliary Tract Carcinoma	100%	11	0 / 11	1
DENND4A	p.G713V	Biliary Tract Carcinoma	100%	11	0 / 11	1
DHX57	p.K473R	Biliary Tract Carcinoma	100%	11	0 / 11	1
SFTPA1	p.A101S	Biliary Tract Carcinoma	100%	11	0 / 11	1
XRN1	p.A1194T	Biliary Tract Carcinoma	100%	11	0 / 11	1
MUC4	p.T2518A	B-Cell Non-Hodgkins Lymphoma	100%	11	0 / 11	1
RBFOX1	p.A448V	Biliary Tract Carcinoma	100%	11	0 / 11	1
MUC5B	p.N5174K	Biliary Tract Carcinoma	100%	11	0 / 11	1
SPATS2L	p.M349I	Biliary Tract Carcinoma	100%	11	0 / 11	1
WDR49	p.E414K	Melanoma	100%	11	0 / 11	1
WDR17	p.Y835C	Biliary Tract Carcinoma	100%	11	0 / 11	1
ADAM7	p.H505Y	Melanoma	100%	11	0 / 11	1
DPP10	p.M55V	Biliary Tract Carcinoma	100%	11	0 / 11	1
WBP11	p.D547Y	Biliary Tract Carcinoma	100%	11	0 / 11	1
ABCB7	p.I583V	Biliary Tract Carcinoma	100%	11	0 / 11	1
MYO1A	p.M735I	Biliary Tract Carcinoma	100%	11	0 / 11	1
DSG1	p.G315E	Melanoma	100%	11	1 / 10	1
NBPF10	p.H3351R	Thyroid Gland Carcinoma	100%	11	0 / 11	1
CARMIL2	p.S1029F	Hepatocellular Carcinoma	100%	11	0 / 11	1
NDST1	p.Q793H	Biliary Tract Carcinoma	100%	11	0 / 11	1
NKIRAS2	p.P117S	B-Cell Non-Hodgkins Lymphoma	100%	11	0 / 11	1
SOGA3	p.E172D	Esophageal Squamous Cell Carcinoma	100%	11	0 / 11	1
EDC4	p.I450V	Kidney Carcinoma	100%	11	0 / 11	1
ADAM7	p.H733Y	Melanoma	100%	11	0 / 11	1
PSMB8	p.M48L	Esophageal Squamous Cell Carcinoma	100%	11	0 / 11	1
NPEPL1	p.C189R	Biliary Tract Carcinoma	100%	11	0 / 11	1
ELAVL1	p.I17T	Biliary Tract Carcinoma	100%	11	0 / 11	1
ELOVL7	p.N58I	Biliary Tract Carcinoma	100%	11	0 / 11	1
SLC17A5	p.T107A	Biliary Tract Carcinoma	100%	11	0 / 11	1
NTN1	p.R540L	Biliary Tract Carcinoma	100%	11	0 / 11	1
SMARCB1	p.R376M	Biliary Tract Carcinoma	100%	11	0 / 11	1
NUDCD1	p.N439D	Biliary Tract Carcinoma	100%	11	0 / 11	1
SLITRK5	p.S64R	Biliary Tract Carcinoma	100%	11	0 / 11	1
FAM3A	p.V33A	B-Cell Non-Hodgkins Lymphoma	100%	11	0 / 11	1
ANK3	p.T3978I	Biliary Tract Carcinoma	100%	11	0 / 11	1
NVL	p.V424L	Biliary Tract Carcinoma	100%	11	0 / 11	1
SETX	p.R1214K	Biliary Tract Carcinoma	100%	11	0 / 11	1
C1orf141	p.F317S	Biliary Tract Carcinoma	100%	11	0 / 11	1
CCDC141	p.E1204K	Melanoma	100%	11	0 / 11	1
ACO2	p.I146F	Biliary Tract Carcinoma	100%	11	0 / 11	1
OR11H4	p.P79T	Kidney Carcinoma	100%	11	0 / 11	1
BEST3	p.Q328K	Biliary Tract Carcinoma	100%	11	0 / 11	1
FAT3	p.S1958P	Biliary Tract Carcinoma	100%	11	0 / 11	1
SLC9A9	p.D356N	Biliary Tract Carcinoma	100%	11	0 / 11	1
ARSI	p.R541W	Biliary Tract Carcinoma	100%	11	0 / 11	1
OR51T1	p.V227D	Biliary Tract Carcinoma	100%	11	0 / 11	1
SETD1A	p.T1185I	Biliary Tract Carcinoma	100%	11	0 / 11	1
ACOXL	p.R201W	Biliary Tract Carcinoma	100%	11	0 / 11	1
CELSR1	p.V983L	Biliary Tract Carcinoma	100%	11	0 / 11	1
ACVR1	p.G328E	Glioma	100%	11	0 / 11	1
SLC7A13	p.E268K	Melanoma	100%	11	0 / 11	1
SLC5A4	p.M413L	Biliary Tract Carcinoma	100%	11	0 / 11	1
OTOG	p.N54T	Esophageal Squamous Cell Carcinoma	100%	11	0 / 11	1
FBXL7	p.G338C	Biliary Tract Carcinoma	100%	11	0 / 11	1
FCRLA	p.L213F	Kidney Carcinoma	100%	11	0 / 11	1
FCRLA	p.L73F	Kidney Carcinoma	100%	11	0 / 11	1
FILIP1	p.L547Q	Biliary Tract Carcinoma	100%	11	0 / 11	1
ADAM7	p.H733Y	Melanoma	100%	11	0 / 11	1
PDE4D	p.S5I	Biliary Tract Carcinoma	100%	11	0 / 11	1
PDZRN3	p.C18G	Biliary Tract Carcinoma	100%	11	0 / 11	1
USP9X	p.T2352P	Ovarian Carcinoma	100%	11	0 / 11	1
ABCB7	p.I624V	Biliary Tract Carcinoma	100%	11	0 / 11	1
PER1	p.T870P	Thyroid Gland Carcinoma	100%	11	0 / 11	1
FRMPD4	p.S1227I	Esophageal Squamous Cell Carcinoma	100%	11	0 / 11	1
FRY	p.D1789N	Biliary Tract Carcinoma	100%	11	0 / 11	1
PHC2	p.S150N	Biliary Tract Carcinoma	100%	11	0 / 11	1
FZD9	p.A110S	Biliary Tract Carcinoma	100%	11	0 / 11	1
RFX2	p.E208K	Esophageal Squamous Cell Carcinoma	100%	11	0 / 11	1
RFX2	p.E183K	Esophageal Squamous Cell Carcinoma	100%	11	0 / 11	1
PICK1	p.E274D	Esophageal Squamous Cell Carcinoma	100%	11	0 / 11	1
CEP290	p.N258I	Biliary Tract Carcinoma	100%	11	0 / 11	1
GAD2	p.G24S	Biliary Tract Carcinoma	100%	11	0 / 11	1
GBGT1	p.H190R	Biliary Tract Carcinoma	100%	11	0 / 11	1
GBGT1	p.T184A	Biliary Tract Carcinoma	100%	11	0 / 11	1
GCFC2	p.S47C	Biliary Tract Carcinoma	100%	11	0 / 11	1
GCNA	p.S295T	Esophageal Squamous Cell Carcinoma	100%	11	0 / 11	1
RHOB	p.E172K	Bladder Carcinoma	100%	11	0 / 11	1
GFPT2	p.N605K	Biliary Tract Carcinoma	100%	11	0 / 11	1
SEC61A1	p.W34L	Biliary Tract Carcinoma	100%	11	0 / 11	1
GIMAP8	p.E649K	Melanoma	100%	11	0 / 11	1
GLTPD2	p.L115V	Kidney Carcinoma	100%	11	0 / 11	1
GOPC	p.E160K	B-Cell Non-Hodgkins Lymphoma	100%	11	0 / 11	1
GOPC	p.E168K	B-Cell Non-Hodgkins Lymphoma	100%	11	0 / 11	1
PLCH1	p.Q1002K	Biliary Tract Carcinoma	100%	11	0 / 11	1
RNASE9	p.T4N	Biliary Tract Carcinoma	100%	11	0 / 11	1
RNASE9	p.T9N	Biliary Tract Carcinoma	100%	11	0 / 11	1
SLC12A4	p.G650V	Biliary Tract Carcinoma	100%	11	0 / 11	1
GRIP2	p.A705T	Biliary Tract Carcinoma	100%	11	0 / 11	1
GRM3	p.E724K	Melanoma	100%	11	0 / 11	1
ROBO1	p.N1005S	Biliary Tract Carcinoma	100%	11	0 / 11	1
ROBO1	p.N960S	Biliary Tract Carcinoma	100%	11	0 / 11	1
RPS9	p.L25H	Kidney Carcinoma	100%	11	0 / 11	1
HDAC9	p.R583H	Ovarian Carcinoma	100%	11	0 / 11	1
PKP2	p.L366P	Gastrointestinal Stromal Tumour	100%	11	0 / 11	1
ZNF831	p.A728S	Biliary Tract Carcinoma	100%	11	0 / 11	1
HIF1A	p.D238N	Glioma	100%	11	0 / 11	1
ADCY6	p.A702T	Biliary Tract Carcinoma	100%	11	0 / 11	1
HMCN1	p.A1437E	Biliary Tract Carcinoma	100%	11	0 / 11	1
PLCH2	p.E819G	Biliary Tract Carcinoma	100%	11	0 / 11	1
HRNR	p.R567S	Ovarian Carcinoma	100%	11	0 / 11	1
TTN	p.E6145K	Melanoma	100%	11	0 / 11	1
PLEKHG5	p.C528W	Biliary Tract Carcinoma	100%	11	0 / 11	1
ZNF654	p.R160I	Biliary Tract Carcinoma	100%	11	0 / 11	1
NBPF20	p.G4110S	Thyroid Gland Carcinoma	90%	11	0 / 11	2
PGLYRP3	p.V83M	Prostate Carcinoma	90%	11	0 / 11	2
KIAA0355	p.A1000E	Kidney Carcinoma	90%	11	0 / 11	2
PCDHAC1	p.E451K	Melanoma	90%	11	0 / 11	2
PCDHB7	p.R785C	Melanoma	90%	11	0 / 11	2
POM121L12	p.E79K	Melanoma	90%	11	1 / 10	2
SHISA9	p.S253L	Melanoma	90%	11	0 / 11	2
SGO1	p.I389T	Kidney Carcinoma	90%	11	0 / 11	2
PSG9	p.E404K	Melanoma	90%	11	0 / 11	2
PSG9	p.E311K	Melanoma	90%	11	0 / 11	2
PSG9	p.E404K	Melanoma	90%	11	0 / 11	2
SFRP4	p.R133H	Biliary Tract Carcinoma	90%	11	0 / 11	2
PTPRZ1	p.K1341R	Kidney Carcinoma	90%	11	0 / 11	2
PXDNL	p.G259E	Melanoma	90%	11	3 / 8	2
QDPR	p.R158Q	Biliary Tract Carcinoma	90%	11	0 / 11	2
RALGDS	p.I171V	Kidney Carcinoma	90%	11	0 / 11	2
RBBP9	p.V27G	Thyroid Gland Carcinoma	90%	11	0 / 11	2
RGS18	p.R215Q	Melanoma	90%	11	0 / 11	2
ZNF850	p.G47D	Thyroid Gland Carcinoma	90%	11	0 / 11	2
RNF34	p.R388Q	Kidney Carcinoma	90%	11	0 / 11	2
RTN1	p.L144P	Ovarian Carcinoma	90%	11	0 / 11	2
ZNF681	p.H304Y	Melanoma	90%	11	0 / 11	2
SCUBE1	p.M857I	Biliary Tract Carcinoma	90%	11	0 / 11	2
ZNF676	p.S50F	Melanoma	90%	11	2 / 9	2
ZNF536	p.D606N	Melanoma	90%	11	0 / 11	2
ZNF519	p.N99D	Kidney Carcinoma	90%	11	0 / 11	2
CLASP1	p.A1280S	Ovarian Carcinoma	90%	11	1 / 10	2
CSMD1	p.G1014E	Melanoma	90%	11	5 / 6	2
CYLC2	p.S257L	Melanoma	90%	11	4 / 7	2
ZDHHC17	p.G113S	Colorectal Carcinoma	90%	11	1 / 10	2
ZC3HC1	p.L217I	Kidney Carcinoma	90%	11	0 / 11	2
WNK4	p.E584K	Biliary Tract Carcinoma	90%	11	0 / 11	2
DOP1A	p.K1526Q	Kidney Carcinoma	90%	11	0 / 11	2
EGFLAM	p.G319E	Melanoma	90%	11	0 / 11	2
VHL	p.L117V	Kidney Carcinoma	90%	11	0 / 11	2
EXT1	p.Q674H	Kidney Carcinoma	90%	11	0 / 11	2
FAM98B	p.W376G	Thyroid Gland Carcinoma	90%	11	0 / 11	2
VHL	p.L158V	Kidney Carcinoma	90%	11	0 / 11	2
FLOT2	p.T79M	Colorectal Carcinoma	90%	11	0 / 11	2
FLOT2	p.T79M	Colorectal Carcinoma	90%	11	0 / 11	2
CASD1	p.S40P	Thyroid Gland Carcinoma	90%	11	0 / 11	2
UNC80	p.T303N	Kidney Carcinoma	90%	11	0 / 11	2
UGT2A2	p.S522F	Melanoma	90%	11	0 / 11	2
UGT2A1	p.S679F	Melanoma	90%	11	0 / 11	2
ADAMDEC1	p.E54K	Melanoma	90%	11	1 / 10	2
ALB	p.A49G	Ovarian Carcinoma	90%	11	0 / 11	2
ALB	p.A241G	Ovarian Carcinoma	90%	11	0 / 11	2
TXLNA	p.N130S	Colorectal Carcinoma	90%	11	0 / 11	2
TTN	p.G20544S	Colorectal Carcinoma	90%	11	0 / 11	2
ANGPT1	p.G413E	Melanoma	90%	11	0 / 11	2
TTN	p.E3597K	Melanoma	90%	11	2 / 9	2
ANKRD17	p.H2338Q	Biliary Tract Carcinoma	90%	11	1 / 10	2
ANKRD30A	p.E1110K	Melanoma	90%	11	3 / 8	2
GRM3	p.R282W	Colorectal Carcinoma	90%	11	0 / 11	2
ANO6	p.D17E	Colorectal Carcinoma	90%	11	0 / 11	2
ANO6	p.D17E	Colorectal Carcinoma	90%	11	0 / 11	2
HECTD1	p.R1323H	Prostate Carcinoma	90%	11	0 / 11	2
HGF	p.E169K	Melanoma	90%	11	2 / 9	2
APEX2	p.A184S	Biliary Tract Carcinoma	90%	11	0 / 11	2
ARMC4	p.R244C	Melanoma	90%	11	0 / 11	2
HYDIN	p.E2201K	Melanoma	90%	11	0 / 11	2
IDO2	p.T136M	Biliary Tract Carcinoma	90%	11	1 / 10	2
TTN	p.E15959K	Melanoma	90%	11	1 / 10	2
IL12RB2	p.Y245H	Kidney Carcinoma	90%	11	0 / 11	2
TRPM7	p.H1171N	Ovarian Carcinoma	90%	11	0 / 11	2
IL4R	p.D37N	Prostate Carcinoma	90%	11	0 / 11	2
BAD	p.P153L	Melanoma	90%	11	0 / 11	2
BCAS2	p.V137I	Kidney Carcinoma	90%	11	0 / 11	2
TRIML2	p.R164H	Ovarian Carcinoma	90%	11	1 / 10	2
KCNA2	p.R73Q	Esophageal Squamous Cell Carcinoma	90%	11	0 / 11	2
C11orf68	p.G212D	Kidney Carcinoma	90%	11	0 / 11	2
KCTD1	p.T497P	Thyroid Gland Carcinoma	90%	11	0 / 11	2
KDM2B	p.R1261C	Kidney Carcinoma	90%	11	0 / 11	2
KEL	p.R428C	Melanoma	90%	11	0 / 11	2
KIAA0355	p.G168V	Ovarian Carcinoma	90%	11	1 / 10	2
KLHL18	p.D533N	Kidney Carcinoma	90%	11	0 / 11	2
KLK4	p.D40N	Kidney Carcinoma	90%	11	0 / 11	2
TMEM200A	p.S387F	Melanoma	90%	11	3 / 8	2
KRT10	p.G490S	Thyroid Gland Carcinoma	90%	11	0 / 11	2
KRTAP4-7	p.P117S	B-Cell Non-Hodgkins Lymphoma	90%	11	0 / 11	2
TLR4	p.E485K	Melanoma	90%	11	1 / 10	2
TCF7L2	p.G393V	Colorectal Carcinoma	90%	11	0 / 11	2
C6	p.E265K	Melanoma	90%	11	4 / 7	2
TCF12	p.C419Y	Kidney Carcinoma	90%	11	0 / 11	2
METTL3	p.P577R	Kidney Carcinoma	90%	11	0 / 11	2
MEX3B	p.S271R	Thyroid Gland Carcinoma	90%	11	0 / 11	2
SUN3	p.E35K	Melanoma	90%	11	0 / 11	2
MUC12	p.A4317T	B-Cell Non-Hodgkins Lymphoma	90%	11	0 / 11	2
MUC16	p.P1219S	Melanoma	90%	11	0 / 11	2
C7	p.E799K	Melanoma	90%	11	1 / 10	2
SRCAP	p.P580L	Melanoma	90%	11	0 / 11	2
MUC4	p.H2765Q	B-Cell Non-Hodgkins Lymphoma	90%	11	0 / 11	2
SRCAP	p.P777L	Melanoma	90%	11	0 / 11	2
SPTA1	p.E1627D	Prostate Carcinoma	90%	11	0 / 11	2
MUC4	p.T4038P	B-Cell Non-Hodgkins Lymphoma	90%	11	0 / 11	2
MUC4	p.D3317N	B-Cell Non-Hodgkins Lymphoma	90%	11	0 / 11	2
CALD1	p.A367S	Colorectal Carcinoma	90%	11	0 / 11	2
CAPN13	p.P405S	Melanoma	90%	11	0 / 11	2
SERPINB3	p.E250K	Melanoma	90%	11	3 / 8	2
MYC	p.L181F	Burkitts Lymphoma	90%	11	0 / 11	2
CBLN2	p.P223S	Melanoma	90%	11	0 / 11	2
SPAM1	p.G340E	Melanoma	90%	11	4 / 7	2
MYOM3	p.R346W	Prostate Carcinoma	90%	11	0 / 11	2
SOGA1	p.A1318V	Prostate Carcinoma	90%	11	0 / 11	2
NLRP7	p.M291R	Kidney Carcinoma	90%	11	0 / 11	2
SMOC2	p.V261I	Colorectal Carcinoma	90%	11	0 / 11	2
NPIPA7	p.R132C	Thyroid Gland Carcinoma	90%	11	0 / 11	2
NRAS	p.A146T	B-Lymphoblastic Leukemia	90%	11	2 / 9	2
NSD2	p.S194I	Kidney Carcinoma	90%	11	0 / 11	2
CCR6	p.L241M	Kidney Carcinoma	90%	11	0 / 11	2
NXPE1	p.E75K	Melanoma	90%	11	1 / 10	2
SLIT2	p.S373F	Melanoma	90%	11	0 / 11	2
SLC9A4	p.H752Y	Melanoma	90%	11	2 / 9	2
OR52N4	p.S263F	Melanoma	90%	11	2 / 9	2
ZP1	p.R224Q	Melanoma	81%	11	2 / 9	2
BMS1	p.R1083W	B-Cell Non-Hodgkins Lymphoma	81%	11	0 / 11	3
CASP3	p.R147C	Melanoma	81%	11	0 / 11	3
ANK3	p.E2335K	Melanoma	81%	11	1 / 10	3
C1orf35	p.R243Q	Non-Small Cell Lung Carcinoma	81%	11	11 / 0	2
AKAP6	p.D987N	Ovarian Carcinoma	81%	11	0 / 11	3
ADH1C	p.S266L	Melanoma	81%	11	0 / 11	3
ABCC4	p.R844L	Prostate Carcinoma	81%	11	0 / 11	3
APBA3	p.R324C	Neuroendocrine Tumour	81%	11	1 / 10	3
CAMKK2	p.T534K	Thyroid Gland Carcinoma	81%	11	0 / 11	3
CDH10	p.R711W	Colorectal Carcinoma	81%	11	4 / 7	3
ARMC4	p.E520K	Melanoma	81%	11	1 / 10	3
CDH15	p.D306N	Esophageal Squamous Cell Carcinoma	81%	11	0 / 11	2
BCL2L14	p.R27C	B-Cell Non-Hodgkins Lymphoma	81%	11	0 / 11	3
ANKRD36	p.E572G	Thyroid Gland Carcinoma	81%	11	0 / 11	3
COL21A1	p.G692E	Melanoma	81%	11	3 / 8	3
CSMD1	p.S1070F	Melanoma	81%	11	0 / 11	2
CYP2C8	p.P300S	Melanoma	81%	11	0 / 11	2
CYP7B1	p.P338S	Melanoma	81%	11	0 / 11	3
DPYS	p.R475Q	Melanoma	81%	11	0 / 11	3
FBN3	p.E1435K	Melanoma	81%	11	1 / 10	3
FMO2	p.R240C	Melanoma	81%	11	0 / 11	3
GABRA2	p.M421I	Melanoma	81%	11	0 / 11	3
GABRA2	p.M361I	Melanoma	81%	11	0 / 11	3
GABRA6	p.H369Y	Melanoma	81%	11	0 / 11	3
GIMAP7	p.E197K	Melanoma	81%	11	0 / 11	3
GRIA1	p.G194E	Melanoma	81%	11	1 / 10	3
GRIN2A	p.E182K	Melanoma	81%	11	1 / 10	3
HBE1	p.R41K	Melanoma	81%	11	0 / 11	2
HBE1	p.S71F	Melanoma	81%	11	1 / 10	2
HIVEP1	p.S1785L	Colorectal Carcinoma	81%	11	2 / 9	3
HRNR	p.T945S	Colorectal Carcinoma	81%	11	0 / 11	2
IL6R	p.D340N	Neuroendocrine Tumour	81%	11	0 / 11	3
JAKMIP2	p.E226K	Melanoma	81%	11	2 / 9	3
KCNN1	p.V10M	Colorectal Carcinoma	81%	11	2 / 9	3
LTBP2	p.T798M	Pancreatic Carcinoma	81%	11	0 / 11	3
MUC4	p.D2645N	B-Cell Non-Hodgkins Lymphoma	81%	11	0 / 11	2
MYC	p.P16S	Burkitts Lymphoma	81%	11	1 / 10	3
MYC	p.P2S	Burkitts Lymphoma	81%	11	1 / 10	3
MYC	p.S264N	Burkitts Lymphoma	81%	11	1 / 10	3
MYC	p.P17S	Burkitts Lymphoma	81%	11	1 / 10	3
NUTM2A	p.E546K	B-Cell Non-Hodgkins Lymphoma	81%	11	0 / 11	3
NUTM2D	p.L491Q	B-Cell Non-Hodgkins Lymphoma	81%	11	0 / 11	3
OR10A6	p.P167S	Melanoma	81%	11	0 / 11	3
OR10C1	p.R260C	Melanoma	81%	11	6 / 5	3
OR10G8	p.R121C	Melanoma	81%	11	1 / 10	3
OR2A5	p.E180K	Melanoma	81%	11	2 / 9	2
OR51A4	p.S95L	Melanoma	81%	11	0 / 11	3
OR52N4	p.S30F	Melanoma	81%	11	2 / 9	3
OR5F1	p.S312F	Melanoma	81%	11	3 / 8	2
P3H1	p.A230V	Esophageal Squamous Cell Carcinoma	81%	11	1 / 10	3
PCDHB8	p.S279F	Melanoma	81%	11	1 / 10	3
PCED1B	p.S343F	Melanoma	81%	11	0 / 11	2
PCLO	p.E322K	Melanoma	81%	11	2 / 9	2
PIK3C2G	p.E1272K	Melanoma	81%	11	2 / 9	3
PLCB4	p.S800F	Melanoma	81%	11	0 / 11	3
RABGGTA	p.T420A	Colorectal Carcinoma	81%	11	0 / 11	3
RGS6	p.R218Q	Melanoma	81%	11	0 / 11	3
SCAP	p.R116C	Melanoma	81%	11	0 / 11	2
SCIN	p.E173K	Melanoma	81%	11	3 / 8	3
SLC5A12	p.R124C	Melanoma	81%	11	2 / 9	3
SLCO1A2	p.S181F	Melanoma	81%	11	3 / 8	3
SPANXC	p.L80H	Non-Small Cell Lung Carcinoma	81%	11	9 / 2	3
SPOCK3	p.E414K	Melanoma	81%	11	1 / 10	3
TBC1D7	p.R140W	Ovarian Carcinoma	81%	11	0 / 11	2
TMTC2	p.S759N	Colorectal Carcinoma	81%	11	11 / 0	3
TNFSF12-TNFSF13	p.R90W	Esophageal Squamous Cell Carcinoma	81%	11	0 / 11	3
TRAT1	p.M82I	Esophageal Squamous Cell Carcinoma	81%	11	0 / 11	3
TRMT12	p.R136W	Kidney Carcinoma	81%	11	2 / 9	2
TTN	p.H4726Y	Melanoma	81%	11	2 / 9	3
UGT2A1	p.G322E	Melanoma	81%	11	1 / 10	3
UGT2B28	p.S110L	Melanoma	81%	11	2 / 9	2
USP40	p.R236H	Esophageal Squamous Cell Carcinoma	81%	11	0 / 11	3
USP40	p.R248H	Esophageal Squamous Cell Carcinoma	81%	11	0 / 11	3
VARS	p.P51S	Esophageal Carcinoma	81%	11	2 / 9	2
VPS13C	p.R3058C	Ovarian Carcinoma	81%	11	0 / 11	3
ZAN	p.L941P	Hepatocellular Carcinoma	81%	11	0 / 11	3
ZIM3	p.H385Y	Melanoma	81%	11	3 / 8	3
OR2T8	p.S87N	Esophageal Squamous Cell Carcinoma	72%	11	0 / 11	4
CPEB2	p.S75R	Esophageal Squamous Cell Carcinoma	72%	11	0 / 11	3
SLCO1C1	p.G725E	Melanoma	72%	11	2 / 9	2
SLCO6A1	p.G37E	Melanoma	72%	11	1 / 10	2
OR2G2	p.M92I	Melanoma	72%	11	0 / 11	2
NUTF2	p.P5T	Biliary Tract Carcinoma	72%	11	0 / 11	4
NUAK1	p.D11G	Thyroid Gland Carcinoma	72%	11	0 / 11	3
NMBR	p.E387K	Melanoma	72%	11	1 / 10	3
NLRP4	p.E875K	Melanoma	72%	11	2 / 9	3
NLRP4	p.G283E	Melanoma	72%	11	1 / 10	4
MYO18B	p.G2299E	Melanoma	72%	11	0 / 11	2
CPE	p.R297W	Melanoma	72%	11	1 / 10	4
MUC5B	p.P2830L	B-Cell Non-Hodgkins Lymphoma	72%	11	0 / 11	4
SPHKAP	p.R1229Q	Melanoma	72%	11	0 / 11	3
SPIN2A	p.R46C	B-Cell Non-Hodgkins Lymphoma	72%	11	0 / 11	3
CNTNAP3B	p.Q743R	B-Cell Non-Hodgkins Lymphoma	72%	11	0 / 11	3
SPTA1	p.E1948K	Melanoma	72%	11	1 / 10	3
MUC4	p.T3822A	B-Cell Non-Hodgkins Lymphoma	72%	11	0 / 11	4
MUC4	p.T2254S	B-Cell Non-Hodgkins Lymphoma	72%	11	0 / 11	4
MUC4	p.A2585V	B-Cell Non-Hodgkins Lymphoma	72%	11	1 / 10	4
MUC17	p.T1241P	B-Cell Non-Hodgkins Lymphoma	72%	11	0 / 11	2
STIM1	p.G534R	Esophageal Squamous Cell Carcinoma	72%	11	0 / 11	4
MUC12	p.S1057P	B-Cell Non-Hodgkins Lymphoma	72%	11	0 / 11	3
MSR1	p.G101E	Melanoma	72%	11	0 / 11	2
MROH2B	p.E1011K	Melanoma	72%	11	0 / 11	4
MROH2B	p.S777F	Melanoma	72%	11	3 / 8	2
SYPL2	p.E69K	Melanoma	72%	11	1 / 10	3
MATR3	p.A105T	Head and Neck Carcinoma	72%	11	3 / 8	4
ARC	p.G32R	Esophageal Squamous Cell Carcinoma	72%	11	0 / 11	3
LY6G6F-LY6G6D	p.D219N	Esophageal Squamous Cell Carcinoma	72%	11	1 / 10	3
LY6G6F	p.D219N	Esophageal Squamous Cell Carcinoma	72%	11	1 / 10	3
LRFN5	p.R445C	Esophageal Squamous Cell Carcinoma	72%	11	1 / 10	3
TIGD4	p.R135C	Melanoma	72%	11	2 / 9	3
LIPI	p.C289S	Kidney Carcinoma	72%	11	0 / 11	3
TLR2	p.D327V	B-Cell Non-Hodgkins Lymphoma	72%	11	3 / 8	3
LCT	p.R1916Q	Colorectal Carcinoma	72%	11	4 / 7	3
KMT2C	p.V656I	Prostate Carcinoma	72%	11	1 / 10	3
CNTNAP3B	p.Q649R	B-Cell Non-Hodgkins Lymphoma	72%	11	0 / 11	3
CNTN5	p.E554K	Melanoma	72%	11	0 / 11	3
ANO4	p.S868L	Melanoma	72%	11	0 / 11	4
KCNQ1	p.P448R	Gastrointestinal Stromal Tumour	72%	11	0 / 11	3
TRIML1	p.S446F	Melanoma	72%	11	1 / 10	4
KCNA1	p.R239H	Ovarian Carcinoma	72%	11	0 / 11	4
TRIML2	p.S396F	Esophageal Squamous Cell Carcinoma	72%	11	0 / 11	3
ACVR1	p.G328V	Glioma	72%	11	0 / 11	4
ISCU	p.F7G	Esophageal Carcinoma	72%	11	0 / 11	2
IL18	p.E192K	Melanoma	72%	11	0 / 11	3
TTBK2	p.S1181L	Melanoma	72%	11	3 / 8	3
PCDHB10	p.S774L	Melanoma	72%	11	0 / 11	2
IGFN1	p.E1952G	B-Cell Non-Hodgkins Lymphoma	72%	11	0 / 11	2
HSPG2	p.G1260A	Bladder Carcinoma	72%	11	0 / 11	3
GPR158	p.S1043F	Melanoma	72%	11	0 / 11	2
TTN	p.R5218Q	Melanoma	72%	11	0 / 11	3
TTN	p.E4260K	Melanoma	72%	11	0 / 11	4
TTN	p.E4143K	Melanoma	72%	11	0 / 11	3
GCSAML	p.E57K	Melanoma	72%	11	0 / 11	2
GABRG1	p.S70L	Melanoma	72%	11	1 / 10	4
FUT7	p.E337Q	Esophageal Squamous Cell Carcinoma	72%	11	2 / 9	3
ADGRE1	p.R132H	Pancreatic Carcinoma	72%	11	0 / 11	4
FRG2C	p.T30S	Thyroid Gland Carcinoma	72%	11	0 / 11	4
AADACL4	p.A266T	Colorectal Carcinoma	72%	11	0 / 11	4
FRG2C	p.D9N	Thyroid Gland Carcinoma	72%	11	0 / 11	3
ZNF679	p.H35Y	Melanoma	72%	11	1 / 10	3
ASTE1	p.A219V	Esophageal Squamous Cell Carcinoma	72%	11	0 / 11	3
FRG1	p.R235Q	Colorectal Carcinoma	72%	11	0 / 11	4
ZNF717	p.N71K	Thyroid Gland Carcinoma	72%	11	0 / 11	3
FBL	p.R74W	Ovarian Carcinoma	72%	11	2 / 9	4
EGFR	p.G719A	Non-Small Cell Lung Carcinoma	72%	11	0 / 11	3
C6orf15	p.A83P	Thyroid Gland Carcinoma	72%	11	0 / 11	3
DPP10	p.S64L	Melanoma	72%	11	0 / 11	3
DOCK3	p.S1188F	Melanoma	72%	11	2 / 9	2
DNAH7	p.R768C	Melanoma	72%	11	0 / 11	3
DNAH5	p.E1926K	Melanoma	72%	11	0 / 11	3
DMC1	p.R129C	Melanoma	72%	11	1 / 10	4
ABCB7	p.E691G	Esophageal Squamous Cell Carcinoma	72%	11	3 / 8	2
DMC1	p.R129C	Melanoma	72%	11	1 / 10	4
CYP2C8	p.R331Q	Melanoma	72%	11	1 / 10	3
SCN11A	p.G821E	Melanoma	72%	11	2 / 9	3
RIPPLY2	p.S110L	Melanoma	72%	11	4 / 7	2
SEMG2	p.S375L	Melanoma	72%	11	0 / 11	2
PTPRD	p.S1489F	Melanoma	72%	11	2 / 9	3
PTPRB	p.R92Q	Esophageal Squamous Cell Carcinoma	72%	11	0 / 11	3
SF3B1	p.E902K	Bladder Carcinoma	72%	11	0 / 11	4
PTPRB	p.R529Q	Melanoma	72%	11	3 / 8	3
PRB3	p.P230S	Colorectal Carcinoma	72%	11	0 / 11	4
POTEE	p.R450K	Thyroid Gland Carcinoma	72%	11	0 / 11	3
POTEE	p.R573K	Thyroid Gland Carcinoma	72%	11	0 / 11	3
SIGLEC6	p.E83K	Melanoma	72%	11	0 / 11	3
POLI	p.D17E	Thyroid Gland Carcinoma	72%	11	0 / 11	3
PKHD1L1	p.G1279E	Melanoma	72%	11	3 / 8	2
PCLO	p.E811K	Melanoma	72%	11	2 / 9	3
CSMD3	p.P218S	Melanoma	72%	11	2 / 9	3
OR7D2	p.R220Q	Melanoma	72%	11	2 / 9	3
OR5H15	p.R122C	Melanoma	72%	11	0 / 11	3
OR52A1	p.R230C	Melanoma	72%	11	2 / 9	4
FCAMR	p.T88R	Ovarian Carcinoma	100%	10	0 / 10	1
VHL	p.H115Y	Kidney Carcinoma	100%	10	2 / 8	1
FMN2	p.F325V	Esophageal Squamous Cell Carcinoma	100%	10	0 / 10	1
USP6	p.E720D	Colorectal Carcinoma	100%	10	0 / 10	1
USH2A	p.G4534E	Melanoma	100%	10	0 / 10	1
UHRF1BP1	p.E321Q	Ovarian Carcinoma	100%	10	0 / 10	1
TUBD1	p.G84R	Ovarian Carcinoma	100%	10	0 / 10	1
TUBB3	p.G223R	Colorectal Carcinoma	100%	10	0 / 10	1
TSGA10	p.K442E	Prostate Carcinoma	100%	10	0 / 10	1
GBF1	p.D1480E	Ovarian Carcinoma	100%	10	0 / 10	1
GIMAP6	p.P22S	Melanoma	100%	10	2 / 8	1
MUC4	p.S3258Y	B-Cell Non-Hodgkins Lymphoma	100%	10	0 / 10	1
GLRA1	p.E328Q	Colorectal Carcinoma	100%	10	0 / 10	1
MUC17	p.S2877T	Esophageal Squamous Cell Carcinoma	100%	10	0 / 10	1
MTX2	p.R167H	Colorectal Carcinoma	100%	10	0 / 10	1
MRGPRX1	p.E311K	Melanoma	100%	10	0 / 10	1
TRIML2	p.S409F	Melanoma	100%	10	1 / 9	1
MR1	p.K65Q	Prostate Carcinoma	100%	10	0 / 10	1
MPP4	p.I227L	Biliary Tract Carcinoma	100%	10	0 / 10	1
TNRC18	p.T1026P	Thyroid Gland Carcinoma	100%	10	0 / 10	1
MOGAT2	p.I171N	Colorectal Carcinoma	100%	10	0 / 10	1
MKRN3	p.V358I	Ovarian Carcinoma	100%	10	0 / 10	1
MBOAT7	p.R5H	Prostate Carcinoma	100%	10	0 / 10	1
MBOAT7	p.A36T	Prostate Carcinoma	100%	10	0 / 10	1
MARS2	p.S256C	Biliary Tract Carcinoma	100%	10	0 / 10	1
LRRC8C	p.G42E	Biliary Tract Carcinoma	100%	10	0 / 10	1
LRRC7	p.P413L	Colorectal Carcinoma	100%	10	0 / 10	1
LRRC31	p.M66T	Ovarian Carcinoma	100%	10	0 / 10	1
LIPM	p.V31A	Ovarian Carcinoma	100%	10	0 / 10	1
HADHA	p.R5W	Colorectal Carcinoma	100%	10	0 / 10	1
HAUS5	p.R299W	Esophageal Squamous Cell Carcinoma	100%	10	0 / 10	1
TNFSF10	p.E252K	Melanoma	100%	10	0 / 10	1
HCRTR2	p.G369E	Melanoma	100%	10	1 / 9	1
LILRA2	p.Q229K	Biliary Tract Carcinoma	100%	10	0 / 10	1
LHCGR	p.T627A	Esophageal Squamous Cell Carcinoma	100%	10	0 / 10	1
HIF1A	p.L361P	Biliary Tract Carcinoma	100%	10	0 / 10	1
LGI4	p.T446M	Colorectal Carcinoma	100%	10	0 / 10	1
LAMA1	p.A25S	Prostate Carcinoma	100%	10	0 / 10	1
KRT9	p.G504D	Biliary Tract Carcinoma	100%	10	0 / 10	1
RAG1	p.R160W	Prostate Carcinoma	100%	10	0 / 10	1
KRT37	p.G13D	Ovarian Carcinoma	100%	10	0 / 10	1
TMPPE	p.D77N	Colorectal Carcinoma	100%	10	0 / 10	1
KIF19	p.Q431L	Hepatocellular Carcinoma	100%	10	0 / 10	1
HTR3D	p.C41F	Colorectal Carcinoma	100%	10	0 / 10	1
HTR6	p.I423M	Biliary Tract Carcinoma	100%	10	0 / 10	1
KDM2B	p.D9N	Ovarian Carcinoma	100%	10	0 / 10	1
KDM2B	p.D240N	Ovarian Carcinoma	100%	10	0 / 10	1
ICE1	p.S1312L	Biliary Tract Carcinoma	100%	10	0 / 10	1
IFITM3	p.Y132H	Glioma	100%	10	0 / 10	1
TICRR	p.T1409I	Prostate Carcinoma	100%	10	0 / 10	1
TEX11	p.M293I	Melanoma	100%	10	0 / 10	1
TCF7L1	p.I314L	Esophageal Squamous Cell Carcinoma	100%	10	0 / 10	1
TBK1	p.E109K	Glioma	100%	10	0 / 10	1
TBCE	p.V508L	Biliary Tract Carcinoma	100%	10	0 / 10	1
TBC1D25	p.G476E	Biliary Tract Carcinoma	100%	10	0 / 10	1
TANC1	p.T607M	Colorectal Carcinoma	100%	10	0 / 10	1
SUV39H2	p.E7K	Biliary Tract Carcinoma	100%	10	0 / 10	1
SULF1	p.N298K	Biliary Tract Carcinoma	100%	10	0 / 10	1
ST8SIA5	p.E102K	Melanoma	100%	10	2 / 8	1
SRPK2	p.D341E	Ovarian Carcinoma	100%	10	0 / 10	1
SMARCC1	p.Y63C	Biliary Tract Carcinoma	100%	10	0 / 10	1
SLC4A3	p.V417I	Biliary Tract Carcinoma	100%	10	0 / 10	1
SLC45A1	p.I288F	Biliary Tract Carcinoma	100%	10	0 / 10	1
SLC1A7	p.E282G	Ovarian Carcinoma	100%	10	0 / 10	1
SLC17A2	p.T298M	Colorectal Carcinoma	100%	10	0 / 10	1
SLC13A3	p.N505S	Colorectal Carcinoma	100%	10	0 / 10	1
BMX	p.N25K	Ovarian Carcinoma	100%	10	0 / 10	1
AP1AR	p.L204R	Colorectal Carcinoma	100%	10	0 / 10	1
C10orf71	p.K223Q	Biliary Tract Carcinoma	100%	10	0 / 10	1
SH3BP5L	p.Q15L	Ovarian Carcinoma	100%	10	0 / 10	1
C6	p.E871K	Melanoma	100%	10	0 / 10	1
C6orf141	p.N48T	Esophageal Squamous Cell Carcinoma	100%	10	0 / 10	1
C6orf89	p.E32Q	Ovarian Carcinoma	100%	10	0 / 10	1
ALPK2	p.P155R	Ovarian Carcinoma	100%	10	0 / 10	1
C7	p.R521C	Prostate Carcinoma	100%	10	0 / 10	1
BEND5	p.S342N	Ovarian Carcinoma	100%	10	0 / 10	1
CA9	p.N198T	Esophageal Squamous Cell Carcinoma	100%	10	0 / 10	1
CACNA1A	p.A1089T	Colorectal Carcinoma	100%	10	0 / 10	1
CACNA1A	p.H508P	Ovarian Carcinoma	100%	10	0 / 10	1
AIFM1	p.E47A	Esophageal Squamous Cell Carcinoma	100%	10	0 / 10	1
CACNA1E	p.E462K	Melanoma	100%	10	0 / 10	1
SERPINB4	p.G253V	Biliary Tract Carcinoma	100%	10	0 / 10	1
SERPINA10	p.E64K	Kidney Carcinoma	100%	10	0 / 10	1
SELENOP	p.K71E	Kidney Carcinoma	100%	10	0 / 10	1
CAPN6	p.R124C	Melanoma	100%	10	2 / 8	1
SELENOP	p.K181R	Kidney Carcinoma	100%	10	0 / 10	1
ADGRG7	p.R119W	Ovarian Carcinoma	100%	10	0 / 10	1
CATSPER2	p.L510P	Prostate Carcinoma	100%	10	0 / 10	1
SCYL2	p.Q715H	Kidney Carcinoma	100%	10	0 / 10	1
ARRDC3	p.L303F	Prostate Carcinoma	100%	10	0 / 10	1
CBFA2T2	p.R26S	B-Cell Non-Hodgkins Lymphoma	100%	10	0 / 10	1
CCDC117	p.D91G	Prostate Carcinoma	100%	10	0 / 10	1
CCDC117	p.D166G	Prostate Carcinoma	100%	10	0 / 10	1
SAXO2	p.K58T	Prostate Carcinoma	100%	10	0 / 10	1
ARHGAP31	p.A129T	Colorectal Carcinoma	100%	10	0 / 10	1
RPAP1	p.P773R	Colorectal Carcinoma	100%	10	0 / 10	1
CD4	p.A319T	Colorectal Carcinoma	100%	10	0 / 10	1
ATM	p.C2337R	Prostate Carcinoma	100%	10	0 / 10	1
CDC42BPB	p.L690P	Biliary Tract Carcinoma	100%	10	0 / 10	1
CDH12	p.T794N	Prostate Carcinoma	100%	10	0 / 10	1
RNF25	p.R348Q	Prostate Carcinoma	100%	10	0 / 10	1
ARAF	p.D286N	Prostate Carcinoma	100%	10	0 / 10	1
RHPN1	p.L527F	Biliary Tract Carcinoma	100%	10	0 / 10	1
CDK5	p.F82I	Prostate Carcinoma	100%	10	0 / 10	1
MAGEA11	p.P99L	Melanoma	100%	10	0 / 10	1
ARHGEF17	p.R1287W	Prostate Carcinoma	100%	10	0 / 10	1
CEACAM6	p.N288K	Colorectal Carcinoma	100%	10	0 / 10	1
CENPF	p.R345S	Prostate Carcinoma	100%	10	0 / 10	1
CEP85L	p.P308S	Melanoma	100%	10	0 / 10	1
RHOA	p.A161V	Bladder Carcinoma	100%	10	2 / 8	1
B3GALNT2	p.R65S	B-Cell Non-Hodgkins Lymphoma	100%	10	0 / 10	1
RGL4	p.H344L	B-Cell Non-Hodgkins Lymphoma	100%	10	0 / 10	1
RBM45	p.I178T	Prostate Carcinoma	100%	10	0 / 10	1
CHST10	p.K68E	Ovarian Carcinoma	100%	10	0 / 10	1
CIC	p.R215W	Glioma	100%	10	0 / 10	1
CLASP1	p.A1211S	Ovarian Carcinoma	100%	10	0 / 10	1
RASA2	p.Q533L	Ovarian Carcinoma	100%	10	0 / 10	1
PTPRT	p.E324K	Melanoma	100%	10	0 / 10	1
PTPRD	p.G197E	Melanoma	100%	10	0 / 10	1
ARPP21	p.G441E	Melanoma	100%	10	0 / 10	1
COPB2	p.S767L	Biliary Tract Carcinoma	100%	10	0 / 10	1
COQ10A	p.L67F	Bladder Carcinoma	100%	10	0 / 10	1
PTGDR2	p.E362D	Esophageal Squamous Cell Carcinoma	100%	10	0 / 10	1
PSMC2	p.A283V	Prostate Carcinoma	100%	10	0 / 10	1
PSG9	p.H295Y	Melanoma	100%	10	0 / 10	1
CREM	p.W3L	Prostate Carcinoma	100%	10	0 / 10	1
BCAN	p.N657T	Esophageal Squamous Cell Carcinoma	100%	10	0 / 10	1
CRTC3	p.R54S	Ovarian Carcinoma	100%	10	0 / 10	1
PSG6	p.E403K	Melanoma	100%	10	0 / 10	1
PSG6	p.E403K	Melanoma	100%	10	0 / 10	1
PRDM16	p.C176Y	Ovarian Carcinoma	100%	10	0 / 10	1
CTSC	p.E192D	Prostate Carcinoma	100%	10	0 / 10	1
CUL3	p.M233R	Prostate Carcinoma	100%	10	0 / 10	1
PRAMEF14	p.I452T	Esophageal Squamous Cell Carcinoma	100%	10	0 / 10	1
PMFBP1	p.E145K	Melanoma	100%	10	2 / 8	1
PLCB4	p.E1104K	Melanoma	100%	10	0 / 10	1
PLCB4	p.M995I	Melanoma	100%	10	3 / 7	1
PIM1	p.E79D	B-Cell Non-Hodgkins Lymphoma	100%	10	1 / 9	1
PID1	p.S160F	Melanoma	100%	10	2 / 8	1
PHF21B	p.E320K	Colorectal Carcinoma	100%	10	0 / 10	1
DCLRE1A	p.L730V	Ovarian Carcinoma	100%	10	0 / 10	1
DDX23	p.R351S	Ovarian Carcinoma	100%	10	0 / 10	1
PGM3	p.M29R	Prostate Carcinoma	100%	10	0 / 10	1
BCHE	p.P102S	Biliary Tract Carcinoma	100%	10	0 / 10	1
PDS5A	p.M849I	Prostate Carcinoma	100%	10	0 / 10	1
DIPK1A	p.I326T	Biliary Tract Carcinoma	100%	10	0 / 10	1
DLL4	p.C200G	Biliary Tract Carcinoma	100%	10	0 / 10	1
PDS5A	p.R879S	Prostate Carcinoma	100%	10	0 / 10	1
DNAH14	p.R28H	Biliary Tract Carcinoma	100%	10	0 / 10	1
ZNF91	p.L1164A	Esophageal Carcinoma	100%	10	0 / 10	1
ADAMTS8	p.G649R	Biliary Tract Carcinoma	100%	10	0 / 10	1
DNAH5	p.E4498K	Melanoma	100%	10	0 / 10	1
DNAH6	p.R2336G	Prostate Carcinoma	100%	10	0 / 10	1
ZNF804A	p.S968F	Melanoma	100%	10	7 / 3	1
ZNF711	p.D662N	Melanoma	100%	10	1 / 9	1
PDS5A	p.D873N	Prostate Carcinoma	100%	10	0 / 10	1
ZNF41	p.E40Q	Ovarian Carcinoma	100%	10	0 / 10	1
PDIK1L	p.S91F	Melanoma	100%	10	0 / 10	1
PDE7A	p.I364V	Ovarian Carcinoma	100%	10	0 / 10	1
ZFPM2	p.E286K	Melanoma	100%	10	0 / 10	1
TANC2	p.G543E	Biliary Tract Carcinoma	100%	10	0 / 10	1
SSC5D	p.L1459P	Biliary Tract Carcinoma	100%	10	0 / 10	1
ZBED9	p.M912I	Colorectal Carcinoma	100%	10	0 / 10	1
NBPF20	p.Y2906H	Thyroid Gland Carcinoma	100%	10	0 / 10	1
P3H2	p.H375R	Ovarian Carcinoma	100%	10	0 / 10	1
OR5D16	p.S266Y	Biliary Tract Carcinoma	100%	10	0 / 10	1
OR4D11	p.V306M	Prostate Carcinoma	100%	10	0 / 10	1
XIRP2	p.N10T	Prostate Carcinoma	100%	10	0 / 10	1
OLFM2	p.R241W	Esophageal Squamous Cell Carcinoma	100%	10	0 / 10	1
EGR2	p.D411H	B-Cell Non-Hodgkins Lymphoma	100%	10	0 / 10	1
WSB2	p.K95N	Ovarian Carcinoma	100%	10	0 / 10	1
WNT11	p.S215A	Ovarian Carcinoma	100%	10	0 / 10	1
NUP210L	p.V1123M	Biliary Tract Carcinoma	100%	10	0 / 10	1
NOTCH1	p.I1680N	B-Lymphoblastic Leukemia	100%	10	0 / 10	1
NISCH	p.E18D	Esophageal Squamous Cell Carcinoma	100%	10	0 / 10	1
WFDC11	p.F16L	Biliary Tract Carcinoma	100%	10	0 / 10	1
ERC2	p.E815K	Melanoma	100%	10	3 / 7	1
WDR45B	p.C138W	Colorectal Carcinoma	100%	10	0 / 10	1
NFXL1	p.R815G	Ovarian Carcinoma	100%	10	0 / 10	1
EYS	p.V435I	Biliary Tract Carcinoma	100%	10	0 / 10	1
NCOR2	p.F2163V	Esophageal Squamous Cell Carcinoma	100%	10	0 / 10	1
FAM174B	p.S69N	Thyroid Gland Carcinoma	100%	10	0 / 10	1
NBPF20	p.V4824A	Thyroid Gland Carcinoma	100%	10	0 / 10	1
FAM83C	p.V23G	Thyroid Gland Carcinoma	100%	10	0 / 10	1
MYORG	p.V172M	Colorectal Carcinoma	100%	10	0 / 10	1
MUC6	p.T1678I	B-Cell Non-Hodgkins Lymphoma	100%	10	0 / 10	1
FARS2	p.N143K	Biliary Tract Carcinoma	100%	10	0 / 10	1
MUC4	p.A3673S	B-Cell Non-Hodgkins Lymphoma	100%	10	0 / 10	1
VPS13C	p.I1263M	Ovarian Carcinoma	100%	10	0 / 10	1
FBXO5	p.E97V	Biliary Tract Carcinoma	100%	10	0 / 10	1
DNAH5	p.P4209S	Melanoma	90%	10	3 / 7	2
APBB1	p.S242F	Melanoma	90%	10	0 / 10	2
ARHGEF33	p.E105K	Esophageal Squamous Cell Carcinoma	90%	10	0 / 10	2
BAP1	p.G185R	Kidney Carcinoma	90%	10	0 / 10	2
ADH1B	p.G5E	Melanoma	90%	10	1 / 9	2
ACTC1	p.E318K	Melanoma	90%	10	0 / 10	2
AGBL1	p.P434S	Melanoma	90%	10	2 / 8	2
ADAM2	p.P694S	Melanoma	90%	10	1 / 9	2
ANK3	p.K571N	Neuroendocrine Tumour	90%	10	0 / 10	2
ADAM29	p.P36S	Melanoma	90%	10	2 / 8	2
APBB1	p.S22F	Melanoma	90%	10	0 / 10	2
APBB1	p.S7F	Melanoma	90%	10	0 / 10	2
C10orf71	p.G363E	Melanoma	90%	10	0 / 10	2
C7	p.G173E	Melanoma	90%	10	0 / 10	2
C8orf34	p.E145K	Melanoma	90%	10	1 / 9	2
CACNA1C	p.S916F	Melanoma	90%	10	2 / 8	2
CAPZA3	p.R82Q	Melanoma	90%	10	2 / 8	2
CATSPERB	p.H417Y	Melanoma	90%	10	0 / 10	2
CD2	p.G114E	Melanoma	90%	10	0 / 10	2
CDAN1	p.V1162L	Pancreatic Carcinoma	90%	10	0 / 10	2
CDH9	p.F715C	Esophageal Squamous Cell Carcinoma	90%	10	0 / 10	2
CEACAM5	p.S599F	Melanoma	90%	10	2 / 8	2
CFAP58	p.R663H	Colorectal Carcinoma	90%	10	0 / 10	2
CNTNAP4	p.G426E	Melanoma	90%	10	4 / 6	2
CROCC	p.R347W	Non-Small Cell Lung Carcinoma	90%	10	8 / 2	2
DENND5A	p.G771D	Kidney Carcinoma	90%	10	0 / 10	2
DNAH5	p.S2050F	Melanoma	90%	10	1 / 9	2
DNAH7	p.E2840K	Melanoma	90%	10	3 / 7	2
DNAH8	p.R2505Q	Melanoma	90%	10	2 / 8	2
DPYD	p.P789S	Melanoma	90%	10	1 / 9	2
DSG4	p.D152N	Melanoma	90%	10	0 / 10	2
DYNC1H1	p.S802F	Melanoma	90%	10	0 / 10	2
EFCAB6	p.M1250I	Esophageal Squamous Cell Carcinoma	90%	10	0 / 10	2
ELAVL2	p.R155C	Melanoma	90%	10	4 / 6	2
ENPP3	p.R102C	Melanoma	90%	10	0 / 10	2
EPS8L1	p.E310K	Esophageal Squamous Cell Carcinoma	90%	10	0 / 10	2
ERN2	p.T154P	Biliary Tract Carcinoma	90%	10	0 / 10	2
FAT4	p.P2805L	Melanoma	90%	10	1 / 9	2
FKBP9	p.R161Q	Glioma	90%	10	0 / 10	2
FMN2	p.P1175S	Melanoma	90%	10	6 / 4	2
FMN2	p.S846F	Melanoma	90%	10	1 / 9	2
FREM3	p.E633K	Melanoma	90%	10	1 / 9	2
FRMD4B	p.P368S	Melanoma	90%	10	0 / 10	2
GABRE	p.S217F	Melanoma	90%	10	3 / 7	2
GALP	p.M105I	Melanoma	90%	10	0 / 10	2
GOLGA6L2	p.E556G	Colorectal Carcinoma	90%	10	0 / 10	2
GPR83	p.P379S	Melanoma	90%	10	0 / 10	2
HBD	p.D48N	Melanoma	90%	10	0 / 10	2
HRG	p.P204L	Ovarian Carcinoma	90%	10	0 / 10	2
JAKMIP2	p.E357K	Melanoma	90%	10	1 / 9	2
KANK4	p.R653C	Melanoma	90%	10	0 / 10	2
KANK4	p.R9C	Melanoma	90%	10	0 / 10	2
KAT2A	p.Y690C	Hepatocellular Carcinoma	90%	10	0 / 10	2
KAZN	p.S216T	Thyroid Gland Carcinoma	90%	10	0 / 10	2
KCNH7	p.D966N	Melanoma	90%	10	0 / 10	2
KLRC3	p.W19P	Esophageal Carcinoma	90%	10	0 / 10	2
KMT2C	p.R886C	Thyroid Gland Carcinoma	90%	10	0 / 10	2
KNTC1	p.S2209L	Prostate Carcinoma	90%	10	0 / 10	2
LRRIQ4	p.E132K	Melanoma	90%	10	0 / 10	2
MAGEC1	p.P695S	Melanoma	90%	10	1 / 9	2
MAP3K21	p.G99R	Melanoma	90%	10	5 / 5	2
MGAM	p.S708F	Melanoma	90%	10	1 / 9	2
MROH2B	p.R834W	Melanoma	90%	10	0 / 10	2
MUC16	p.S2327F	Melanoma	90%	10	0 / 10	2
MUC4	p.S1189G	B-Cell Non-Hodgkins Lymphoma	90%	10	0 / 10	2
MUC4	p.T1487M	B-Cell Non-Hodgkins Lymphoma	90%	10	0 / 10	2
MUC5B	p.A4267V	Kidney Carcinoma	90%	10	0 / 10	2
MUC6	p.R1363H	Esophageal Squamous Cell Carcinoma	90%	10	0 / 10	2
MUC6	p.S1741N	B-Cell Non-Hodgkins Lymphoma	90%	10	0 / 10	2
MXRA5	p.G160E	Melanoma	90%	10	0 / 10	2
MYC	p.S249N	Burkitts Lymphoma	90%	10	0 / 10	2
MYH1	p.S1739F	Melanoma	90%	10	0 / 10	2
MYH4	p.S1739F	Melanoma	90%	10	3 / 7	2
MYO3A	p.E1543K	Melanoma	90%	10	1 / 9	2
NBPF9	p.E178V	Colorectal Carcinoma	90%	10	0 / 10	2
NBPF9	p.E178V	Colorectal Carcinoma	90%	10	0 / 10	2
NKX2-4	p.A331D	Biliary Tract Carcinoma	90%	10	0 / 10	2
NLRP10	p.H474Y	Melanoma	90%	10	1 / 9	2
OR4C6	p.R231W	B-Cell Non-Hodgkins Lymphoma	90%	10	0 / 10	2
OR51G2	p.S248F	Melanoma	90%	10	0 / 10	2
OR5R1	p.E196K	Melanoma	90%	10	0 / 10	2
OR6V1	p.E194K	Melanoma	90%	10	2 / 8	2
PCDH15	p.S1630F	Melanoma	90%	10	0 / 10	2
PLB1	p.N493K	Kidney Carcinoma	90%	10	0 / 10	2
PLCZ1	p.E105K	Melanoma	90%	10	1 / 9	2
PLEKHG2	p.R1293Q	Colorectal Carcinoma	90%	10	0 / 10	2
POM121L12	p.G188E	Melanoma	90%	10	1 / 9	2
PRAMEF4	p.R96C	Melanoma	90%	10	0 / 10	2
PTPRT	p.E840K	Melanoma	90%	10	0 / 10	2
PTPRT	p.E436K	Melanoma	90%	10	0 / 10	2
RGPD4	p.E1352K	Melanoma	90%	10	1 / 9	2
RNF213	p.V2720I	Prostate Carcinoma	90%	10	0 / 10	2
RP1	p.P240S	Melanoma	90%	10	0 / 10	2
RUNX1T1	p.H129Y	Melanoma	90%	10	0 / 10	2
SFPQ	p.E269K	Neuroendocrine Tumour	90%	10	1 / 9	2
SH3RF3	p.C278S	Ovarian Carcinoma	90%	10	0 / 10	2
SLC44A5	p.M490I	Melanoma	90%	10	0 / 10	2
SLC7A2	p.S162L	Melanoma	90%	10	0 / 10	2
SOGA3	p.E182D	Esophageal Squamous Cell Carcinoma	90%	10	0 / 10	2
STK10	p.R775C	Esophageal Squamous Cell Carcinoma	90%	10	0 / 10	2
TACC3	p.P417S	Melanoma	90%	10	1 / 9	2
TBC1D21	p.R246H	Esophageal Squamous Cell Carcinoma	90%	10	0 / 10	2
TBC1D2B	p.P290L	Melanoma	90%	10	3 / 7	2
THSD7B	p.S323F	Melanoma	90%	10	0 / 10	2
THSD7B	p.S292F	Melanoma	90%	10	0 / 10	2
THSD7B	p.S231F	Melanoma	90%	10	0 / 10	2
TMC4	p.A20G	Bladder Carcinoma	90%	10	0 / 10	2
TMC4	p.A20G	Bladder Carcinoma	90%	10	0 / 10	2
TMC5	p.R396G	Neuroendocrine Tumour	90%	10	0 / 10	2
TPO	p.E657K	Melanoma	90%	10	0 / 10	2
TTN	p.E3753K	Melanoma	90%	10	1 / 9	2
UBQLN3	p.P178T	Hepatocellular Carcinoma	90%	10	0 / 10	2
UGT1A5	p.E88K	Melanoma	90%	10	0 / 10	2
VWA5B2	p.R844W	Esophageal Squamous Cell Carcinoma	90%	10	0 / 10	2
VWA8	p.S821L	Esophageal Squamous Cell Carcinoma	90%	10	0 / 10	2
WDR62	p.S1253P	Kidney Carcinoma	90%	10	0 / 10	2
XPOT	p.R166H	Esophageal Squamous Cell Carcinoma	90%	10	1 / 9	2
RNF217	p.R477C	Melanoma	80%	10	1 / 9	2
GLRB	p.P191S	Melanoma	80%	10	0 / 10	2
AP3B2	p.R95C	Melanoma	80%	10	3 / 7	3
RP1	p.R338Q	Melanoma	80%	10	0 / 10	3
CD22	p.V331M	Esophageal Squamous Cell Carcinoma	80%	10	0 / 10	3
OR5AC2	p.G6E	Melanoma	80%	10	0 / 10	2
BCL2	p.G47D	B-Cell Non-Hodgkins Lymphoma	80%	10	4 / 6	2
RUNX1T1	p.D235N	Melanoma	80%	10	1 / 9	3
FAM90A1	p.R168C	Esophageal Squamous Cell Carcinoma	80%	10	0 / 10	3
S100A7	p.G92R	Melanoma	80%	10	0 / 10	3
SACS	p.D1443N	Colorectal Carcinoma	80%	10	0 / 10	3
MUC4	p.A4238T	Thyroid Gland Carcinoma	80%	10	0 / 10	3
SCN1A	p.G880E	Melanoma	80%	10	2 / 8	3
OR5M8	p.R228H	Ovarian Carcinoma	80%	10	0 / 10	3
ATF5	p.L141P	Thyroid Gland Carcinoma	80%	10	0 / 10	3
FAM149A	p.S66W	Esophageal Squamous Cell Carcinoma	80%	10	0 / 10	2
NCOR2	p.E1271K	Colorectal Carcinoma	80%	10	2 / 8	3
NEBL	p.D964N	Melanoma	80%	10	0 / 10	2
OR8H1	p.T180M	Colorectal Carcinoma	80%	10	1 / 9	2
CACTIN	p.R426C	Kidney Carcinoma	80%	10	0 / 10	3
ECE2	p.E519K	Melanoma	80%	10	0 / 10	3
MUC6	p.T2023K	B-Cell Non-Hodgkins Lymphoma	80%	10	0 / 10	3
PAPPA	p.P772S	Melanoma	80%	10	0 / 10	2
AOX1	p.R1073C	Esophageal Squamous Cell Carcinoma	80%	10	0 / 10	2
C14orf180	p.T153A	Rhabdomyosarcoma	80%	10	0 / 10	2
SH3RF2	p.D218N	Melanoma	80%	10	1 / 9	3
PAPPA2	p.G332E	Melanoma	80%	10	0 / 10	3
ATP2B2	p.R732Q	Melanoma	80%	10	0 / 10	3
EBF4	p.N342K	Esophageal Squamous Cell Carcinoma	80%	10	2 / 8	2
DUSP27	p.R259W	Esophageal Squamous Cell Carcinoma	80%	10	1 / 9	3
DUSP26	p.R100Q	Esophageal Squamous Cell Carcinoma	80%	10	0 / 10	3
AC187653.1	p.N225K	B-Cell Non-Hodgkins Lymphoma	80%	10	0 / 10	3
SLC24A3	p.E410K	Melanoma	80%	10	3 / 7	3
ADAM7	p.S169F	Melanoma	80%	10	0 / 10	3
ESX1	p.R196Q	Melanoma	80%	10	1 / 9	3
PCED1B	p.E171K	Melanoma	80%	10	2 / 8	2
ZSCAN4	p.S311L	Melanoma	80%	10	4 / 6	2
PCF11	p.S590R	Hepatocellular Carcinoma	80%	10	0 / 10	3
YEATS2	p.E1301K	Esophageal Squamous Cell Carcinoma	80%	10	0 / 10	3
SPAG17	p.E1946K	Melanoma	80%	10	0 / 10	3
ADGRV1	p.S4503G	Hepatocellular Carcinoma	80%	10	0 / 10	3
SPOP	p.M117V	Endometrial Carcinoma	80%	10	0 / 10	3
MUC4	p.A3438T	B-Cell Non-Hodgkins Lymphoma	80%	10	0 / 10	3
SPTA1	p.D1438N	Melanoma	80%	10	0 / 10	3
DPYD	p.S204F	Melanoma	80%	10	0 / 10	3
DNAH9	p.P2099S	Melanoma	80%	10	0 / 10	3
EEF1AKMT4-ECE2	p.E637K	Melanoma	80%	10	0 / 10	3
DEUP1	p.E145K	Melanoma	80%	10	2 / 8	2
PELP1	p.L798P	Thyroid Gland Carcinoma	80%	10	0 / 10	3
STON1-GTF2A1L	p.R1154C	Melanoma	80%	10	0 / 10	2
PDE3B	p.R674C	Esophageal Squamous Cell Carcinoma	80%	10	0 / 10	3
A3GALT2	p.D237N	Esophageal Squamous Cell Carcinoma	80%	10	0 / 10	3
NLRP11	p.P1016S	Melanoma	80%	10	2 / 8	3
DCC	p.G55E	Melanoma	80%	10	0 / 10	2
DAB1	p.V315I	Esophageal Squamous Cell Carcinoma	80%	10	0 / 10	3
ADAMTS18	p.P861S	Melanoma	80%	10	1 / 9	3
PIM1	p.K24N	B-Cell Non-Hodgkins Lymphoma	80%	10	0 / 10	3
NLRP5	p.E1173K	Melanoma	80%	10	0 / 10	3
EPHA7	p.S225F	Melanoma	80%	10	0 / 10	2
ANKRD30A	p.H969Y	Melanoma	80%	10	5 / 5	2
TBC1D5	p.S615F	Melanoma	80%	10	0 / 10	3
TBC1D9	p.R509W	Esophageal Squamous Cell Carcinoma	80%	10	0 / 10	2
CYP2C9	p.P402S	Melanoma	80%	10	2 / 8	3
CYP2C18	p.G372E	Melanoma	80%	10	2 / 8	3
ZNF831	p.P1591S	Melanoma	80%	10	2 / 8	3
TCF7L2	p.P256L	Colorectal Carcinoma	80%	10	0 / 10	3
PLEKHD1	p.V83I	Colorectal Carcinoma	80%	10	0 / 10	3
MUC12	p.T3994K	B-Cell Non-Hodgkins Lymphoma	80%	10	0 / 10	3
THEMIS	p.G258E	Melanoma	80%	10	0 / 10	3
CYLC2	p.E266K	Melanoma	80%	10	4 / 6	3
ZNF195	p.R530I	Endometrial Carcinoma	80%	10	1 / 9	3
WDR35	p.R113Q	Colorectal Carcinoma	80%	10	0 / 10	2
PPIL6	p.E21Q	Esophageal Squamous Cell Carcinoma	80%	10	0 / 10	2
ABCA12	p.V1277M	Esophageal Squamous Cell Carcinoma	80%	10	1 / 9	3
TLL1	p.P366S	Melanoma	80%	10	2 / 8	2
CXCL5	p.E89K	Melanoma	80%	10	0 / 10	3
ZNF385D	p.R358Q	Melanoma	80%	10	0 / 10	2
APOBR	p.R1018C	Melanoma	80%	10	0 / 10	3
ATP11B	p.L367F	Esophageal Squamous Cell Carcinoma	80%	10	0 / 10	3
IGSF21	p.G343R	Melanoma	80%	10	0 / 10	3
INAVA	p.A364P	Bladder Carcinoma	80%	10	0 / 10	2
NPAP1	p.S887F	Melanoma	80%	10	2 / 8	2
PRR27	p.P94S	Melanoma	80%	10	0 / 10	2
ZNF564	p.R497I	Colorectal Carcinoma	80%	10	2 / 8	2
PRSS58	p.E76K	Melanoma	80%	10	0 / 10	2
TMEM200A	p.M431I	Melanoma	80%	10	0 / 10	3
TMEM260	p.V366I	Biliary Tract Carcinoma	80%	10	0 / 10	3
ACTRT1	p.E117K	Melanoma	80%	10	0 / 10	3
PSG4	p.R88I	Endometrial Carcinoma	80%	10	0 / 10	3
APOBEC3H	p.R171G	Bladder Carcinoma	80%	10	0 / 10	3
NRG3	p.E490K	Melanoma	80%	10	0 / 10	3
NTRK3	p.D576N	Melanoma	80%	10	1 / 9	2
CRB1	p.F630V	Gastric Carcinoma	80%	10	0 / 10	3
MYH2	p.E878K	Melanoma	80%	10	2 / 8	2
CRB1	p.F11V	Gastric Carcinoma	80%	10	0 / 10	3
MUC20	p.I75V	B-Cell Non-Hodgkins Lymphoma	80%	10	0 / 10	3
KHDC4	p.R472W	Esophageal Squamous Cell Carcinoma	80%	10	1 / 9	3
KHNYN	p.P227L	Melanoma	80%	10	0 / 10	2
KIAA1217	p.P331S	Melanoma	80%	10	2 / 8	2
EFNB2	p.R182H	Bladder Carcinoma	80%	10	0 / 10	3
CPXM2	p.R304C	Esophageal Squamous Cell Carcinoma	80%	10	0 / 10	3
PTGER3	p.N366S	Esophageal Squamous Cell Carcinoma	80%	10	0 / 10	3
OR10AG1	p.S58F	Melanoma	80%	10	0 / 10	2
ABCA4	p.R1963C	Melanoma	80%	10	0 / 10	3
ZNF585A	p.S409L	Melanoma	80%	10	0 / 10	3
GLI3	p.G1168R	Esophageal Squamous Cell Carcinoma	80%	10	1 / 9	2
HLA-DQA2	p.E198K	Non-Small Cell Lung Carcinoma	80%	10	8 / 2	2
HK3	p.R475H	Colorectal Carcinoma	80%	10	1 / 9	3
KRTAP12-2	p.S29R	Esophageal Carcinoma	80%	10	2 / 8	2
KRTAP22-2	p.P31L	Kidney Carcinoma	80%	10	0 / 10	3
HIVEP1	p.A457T	Esophageal Squamous Cell Carcinoma	80%	10	1 / 9	3
LAMC1	p.R359C	Melanoma	80%	10	0 / 10	3
MUC4	p.P3442A	B-Cell Non-Hodgkins Lymphoma	80%	10	0 / 10	3
HHLA2	p.G53E	Melanoma	80%	10	1 / 9	3
BDP1	p.P884L	Melanoma	80%	10	0 / 10	2
HDC	p.R358C	Melanoma	80%	10	0 / 10	2
LIN7A	p.E41K	Melanoma	80%	10	8 / 2	2
GZMA	p.S227F	Melanoma	80%	10	1 / 9	2
LPAR1	p.P83S	Melanoma	80%	10	0 / 10	2
APOB	p.S4244F	Melanoma	80%	10	2 / 8	2
LRP1B	p.P2819S	Melanoma	80%	10	2 / 8	2
WDR87	p.E1933K	Melanoma	80%	10	1 / 9	3
OR1F1	p.G233E	Melanoma	80%	10	1 / 9	2
TSHZ2	p.E114K	Melanoma	80%	10	0 / 10	3
GRM5	p.R524Q	Esophageal Squamous Cell Carcinoma	80%	10	0 / 10	3
TREM2	p.A28V	Esophageal Squamous Cell Carcinoma	80%	10	0 / 10	2
MAGEA10	p.P53S	Melanoma	80%	10	0 / 10	2
OR2W1	p.R122C	Melanoma	80%	10	0 / 10	2
TRHR	p.G108E	Melanoma	80%	10	0 / 10	2
NALCN	p.R1722Q	Colorectal Carcinoma	80%	10	0 / 10	3
MAGI2	p.G465E	Melanoma	80%	10	0 / 10	2
APOBEC3H	p.R171G	Bladder Carcinoma	80%	10	0 / 10	3
CHPF	p.T464M	Esophageal Squamous Cell Carcinoma	80%	10	0 / 10	2
APOBEC3H	p.R171G	Bladder Carcinoma	80%	10	0 / 10	3
OR4K1	p.E196K	Melanoma	80%	10	2 / 8	3
CFAP53	p.R61C	Melanoma	80%	10	0 / 10	3
CDHR1	p.P812S	Non-Small Cell Lung Carcinoma	80%	10	9 / 1	3
APLP2	p.E222D	Biliary Tract Carcinoma	80%	10	0 / 10	3
RNF123	p.L842V	Non-Small Cell Lung Carcinoma	80%	10	10 / 0	3
MMP2	p.A16V	Colorectal Carcinoma	80%	10	1 / 9	3
NBPF10	p.L44V	Thyroid Gland Carcinoma	80%	10	0 / 10	2
MORC1	p.E795K	Melanoma	80%	10	2 / 8	3
GPCPD1	p.S431F	Melanoma	80%	10	2 / 8	3
GOLGA6L6	p.K481E	Hepatocellular Carcinoma	80%	10	0 / 10	3
GNB1	p.I80T	B-Cell Non-Hodgkins Lymphoma	80%	10	2 / 8	2
APOBEC3H	p.N15K	Kidney Carcinoma	80%	10	0 / 10	2
MGAM	p.P1091L	Melanoma	70%	10	2 / 8	3
TSFM	p.N169I	Prostate Carcinoma	70%	10	0 / 10	3
GRIK2	p.E441K	Melanoma	70%	10	0 / 10	2
GRIK2	p.E479K	Melanoma	70%	10	0 / 10	2
MRI1	p.Q18H	Biliary Tract Carcinoma	70%	10	0 / 10	4
MSR1	p.E105K	Melanoma	70%	10	0 / 10	4
MUC16	p.E7966K	Melanoma	70%	10	2 / 8	4
GLRA1	p.R30H	Colorectal Carcinoma	70%	10	1 / 9	4
FAT3	p.E4470K	Melanoma	70%	10	0 / 10	3
MUC4	p.P2562S	B-Cell Non-Hodgkins Lymphoma	70%	10	0 / 10	3
MUC4	p.L3105F	Esophageal Squamous Cell Carcinoma	70%	10	1 / 9	3
MUC4	p.R3974P	B-Cell Non-Hodgkins Lymphoma	70%	10	0 / 10	3
MUC4	p.S2503Y	B-Cell Non-Hodgkins Lymphoma	70%	10	0 / 10	3
TTN	p.E15097K	Melanoma	70%	10	0 / 10	3
TTN	p.P1871S	Melanoma	70%	10	4 / 6	2
TUBA3C	p.R243Q	Melanoma	70%	10	0 / 10	3
ZNF780A	p.R539C	Melanoma	70%	10	0 / 10	4
MYH1	p.D1435N	Melanoma	70%	10	3 / 7	2
MYH2	p.E1269K	Melanoma	70%	10	2 / 8	2
UGT2B7	p.P155S	Melanoma	70%	10	0 / 10	2
MYO18B	p.R2546Q	Esophageal Squamous Cell Carcinoma	70%	10	0 / 10	4
FAM83D	p.R317Q	Colorectal Carcinoma	70%	10	3 / 7	3
NALCN	p.A1555V	Colorectal Carcinoma	70%	10	3 / 7	2
FAM186B	p.R623H	Colorectal Carcinoma	70%	10	0 / 10	4
UNC5D	p.R860Q	Melanoma	70%	10	0 / 10	4
UNC80	p.V1286I	Colorectal Carcinoma	70%	10	0 / 10	4
NETO1	p.R276Q	Melanoma	70%	10	0 / 10	3
NFASC	p.R71Q	Melanoma	70%	10	0 / 10	4
EPHB1	p.V322I	Pancreatic Carcinoma	70%	10	0 / 10	4
UNC80	p.E3034K	Esophageal Squamous Cell Carcinoma	70%	10	0 / 10	3
NLRP11	p.R566C	Melanoma	70%	10	0 / 10	3
NOTCH2NLA	p.S165F	Melanoma	70%	10	0 / 10	3
EP300	p.I997V	Gastrointestinal Stromal Tumour	70%	10	0 / 10	4
NYAP2	p.M372I	Melanoma	70%	10	0 / 10	2
OR10G4	p.R121C	Melanoma	70%	10	4 / 6	3
OR14C36	p.M8I	Melanoma	70%	10	0 / 10	4
OR14K1	p.M312I	Melanoma	70%	10	4 / 6	3
OR2T4	p.M19L	Melanoma	70%	10	0 / 10	3
USP26	p.L364F	Non-Small Cell Lung Carcinoma	70%	10	9 / 1	3
EDN1	p.C15F	Thyroid Gland Carcinoma	70%	10	0 / 10	3
OR52A1	p.G147E	Melanoma	70%	10	4 / 6	4
OR52E5	p.R299Q	Esophageal Squamous Cell Carcinoma	70%	10	0 / 10	2
OR5AS1	p.P283S	Melanoma	70%	10	2 / 8	3
EDAR	p.S80F	Melanoma	70%	10	2 / 8	3
OR6C3	p.G270E	Melanoma	70%	10	1 / 9	2
VPS13B	p.R3113C	Melanoma	70%	10	0 / 10	4
OR8D4	p.R53C	Melanoma	70%	10	1 / 9	4
PAPPA	p.D1131N	Melanoma	70%	10	2 / 8	4
PCDHA8	p.E639K	Melanoma	70%	10	0 / 10	3
PCDHGB4	p.A327V	Colorectal Carcinoma	70%	10	1 / 9	3
PCLO	p.R4044Q	Melanoma	70%	10	0 / 10	4
DSCAM	p.E368K	Melanoma	70%	10	0 / 10	3
PENK	p.S153F	Melanoma	70%	10	0 / 10	2
DEFB114	p.R28C	Melanoma	70%	10	0 / 10	3
DCC	p.E403K	Melanoma	70%	10	0 / 10	4
PKHD1L1	p.S1468F	Thyroid Gland Carcinoma	70%	10	0 / 10	4
VWA3B	p.E721K	Melanoma	70%	10	0 / 10	4
ZNF835	p.S179L	Melanoma	70%	10	1 / 9	4
CTAGE6	p.R409Q	Melanoma	70%	10	0 / 10	2
CSMD3	p.R100Q	Melanoma	70%	10	0 / 10	4
CRTC3	p.R365H	Colorectal Carcinoma	70%	10	0 / 10	4
PSKH2	p.V161I	Prostate Carcinoma	70%	10	1 / 9	3
PTCH2	p.A436V	Prostate Carcinoma	70%	10	1 / 9	4
PTEN	p.F341V	Endometrial Carcinoma	70%	10	3 / 7	2
PTGS1	p.S529F	Melanoma	70%	10	2 / 8	2
CNKSR2	p.T1032M	Prostate Carcinoma	70%	10	0 / 10	4
PTPRD	p.P1257L	Prostate Carcinoma	70%	10	0 / 10	4
CNGA4	p.R216C	Hepatocellular Carcinoma	70%	10	0 / 10	4
RAD17	p.N522K	Thyroid Gland Carcinoma	70%	10	0 / 10	4
CLVS2	p.R59Q	Esophageal Squamous Cell Carcinoma	70%	10	1 / 9	4
RBFOX1	p.E222K	Melanoma	70%	10	0 / 10	3
RBFOX1	p.E222K	Melanoma	70%	10	0 / 10	3
CFAP61	p.D195N	Melanoma	70%	10	0 / 10	4
WDR87	p.E2264K	Colorectal Carcinoma	70%	10	1 / 9	4
RIOK3	p.R98C	Prostate Carcinoma	70%	10	0 / 10	3
WFDC1	p.V118G	Thyroid Gland Carcinoma	70%	10	0 / 10	4
CDH24	p.R747Q	Esophageal Squamous Cell Carcinoma	70%	10	0 / 10	2
RPGRIP1L	p.S886L	Melanoma	70%	10	0 / 10	3
RXFP3	p.R394H	Colorectal Carcinoma	70%	10	2 / 8	3
CD163L1	p.G1317E	Melanoma	70%	10	0 / 10	2
CATSPERB	p.R269C	Melanoma	70%	10	0 / 10	3
SDHA	p.T196I	Colorectal Carcinoma	70%	10	10 / 0	4
SEC23B	p.P433L	Rhabdomyosarcoma	70%	10	0 / 10	2
CAPN8	p.R671C	Esophageal Squamous Cell Carcinoma	70%	10	1 / 9	4
CAMTA2	p.R9P	Thyroid Gland Carcinoma	70%	10	0 / 10	3
SEMA3E	p.E712K	Melanoma	70%	10	0 / 10	4
SERPINB2	p.E271K	Melanoma	70%	10	3 / 7	4
SERPINB3	p.E198K	Melanoma	70%	10	2 / 8	3
CACNA1E	p.E1724K	Melanoma	70%	10	3 / 7	4
WWOX	p.A211T	Colorectal Carcinoma	70%	10	2 / 8	3
SHISA3	p.G103S	Prostate Carcinoma	70%	10	0 / 10	4
BICRAL	p.T870M	Esophageal Squamous Cell Carcinoma	70%	10	1 / 9	4
AQP7	p.T310M	B-Cell Non-Hodgkins Lymphoma	70%	10	0 / 10	4
SLC17A8	p.S89F	Melanoma	70%	10	0 / 10	3
ANKRD30A	p.E990K	Melanoma	70%	10	1 / 9	4
ANKRD30A	p.E1046K	Melanoma	70%	10	2 / 8	3
AMY2A	p.H230R	Non-Small Cell Lung Carcinoma	70%	10	10 / 0	4
AMY2A	p.H230R	Non-Small Cell Lung Carcinoma	70%	10	10 / 0	4
SPHKAP	p.E943K	Melanoma	70%	10	4 / 6	3
SPTA1	p.R1281C	Melanoma	70%	10	0 / 10	4
AGXT2	p.E405K	Melanoma	70%	10	5 / 5	2
ST6GAL2	p.S152F	Melanoma	70%	10	0 / 10	3
AFM	p.G331E	Melanoma	70%	10	1 / 9	2
STAC	p.R43Q	Melanoma	70%	10	6 / 4	4
ZAN	p.P738L	Melanoma	70%	10	0 / 10	3
STRADB	p.D407G	Colorectal Carcinoma	70%	10	0 / 10	4
ADRA2B	p.A105T	Colorectal Carcinoma	70%	10	2 / 8	4
ADGRV1	p.G2009E	Melanoma	70%	10	0 / 10	2
SVEP1	p.S2388F	Melanoma	70%	10	0 / 10	3
SYNE1	p.R6883C	Colorectal Carcinoma	70%	10	0 / 10	4
ADGRB3	p.P1178S	Melanoma	70%	10	2 / 8	2
ZBED9	p.R1075Q	Melanoma	70%	10	0 / 10	4
ADAM18	p.S244F	Melanoma	70%	10	2 / 8	2
ACTR10	p.R342Q	Colorectal Carcinoma	70%	10	4 / 6	4
ABTB2	p.R437C	Esophageal Squamous Cell Carcinoma	70%	10	1 / 9	3
ABCB5	p.R493Q	Esophageal Squamous Cell Carcinoma	70%	10	0 / 10	3
APOB	p.R2012Q	Melanoma	70%	10	4 / 6	4
TH	p.R356H	Kidney Carcinoma	70%	10	0 / 10	4
THEMIS	p.P328S	Melanoma	70%	10	1 / 9	3
ZNF208	p.G59E	Melanoma	70%	10	0 / 10	4
ZNF229	p.D201N	Prostate Carcinoma	70%	10	1 / 9	3
TMC2	p.R430C	Melanoma	70%	10	0 / 10	3
IFT52	p.P340S	Melanoma	70%	10	2 / 8	3
ITGA8	p.E718K	Melanoma	70%	10	0 / 10	2
ITGB6	p.R739C	Melanoma	70%	10	0 / 10	3
TMEM158	p.G21R	Esophageal Squamous Cell Carcinoma	70%	10	1 / 9	4
KCNH5	p.E562K	Melanoma	70%	10	2 / 8	3
KCNH7	p.P506S	Melanoma	70%	10	1 / 9	3
KCNJ3	p.P329S	Melanoma	70%	10	0 / 10	2
KCNN3	p.P63H	B-Cell Non-Hodgkins Lymphoma	70%	10	1 / 9	4
KCNT2	p.E143K	Melanoma	70%	10	0 / 10	4
HYDIN	p.R2498C	Esophageal Squamous Cell Carcinoma	70%	10	0 / 10	4
HTT	p.S1674L	Colorectal Carcinoma	70%	10	1 / 9	4
HSPA12B	p.A215S	Biliary Tract Carcinoma	70%	10	2 / 8	4
KLC3	p.E84K	Esophageal Squamous Cell Carcinoma	70%	10	1 / 9	4
KLHL13	p.S371L	Melanoma	70%	10	1 / 9	4
TNIK	p.T790M	Prostate Carcinoma	70%	10	0 / 10	3
HOMER1	p.T189N	Colorectal Carcinoma	70%	10	9 / 1	4
HIST1H2BH	p.E114Q	Esophageal Squamous Cell Carcinoma	70%	10	0 / 10	4
LIFR	p.E391K	Melanoma	70%	10	0 / 10	4
LRCH1	p.Q34H	B-Cell Non-Hodgkins Lymphoma	70%	10	0 / 10	3
LRP1B	p.L1562F	Colorectal Carcinoma	70%	10	2 / 8	3
GUCY1A1	p.R614Q	Melanoma	70%	10	0 / 10	2
GUCY1A1	p.R614Q	Melanoma	70%	10	0 / 10	2
MAGEB4	p.R15H	Esophageal Squamous Cell Carcinoma	70%	10	0 / 10	3
MAGEC1	p.I178L	Colorectal Carcinoma	70%	10	0 / 10	4
GRIN2A	p.A1395V	Esophageal Squamous Cell Carcinoma	70%	10	0 / 10	4
GRIN2A	p.R1281W	Esophageal Squamous Cell Carcinoma	70%	10	0 / 10	4
GRIK2	p.E441K	Melanoma	70%	10	0 / 10	2
MEFV	p.E485K	Melanoma	70%	10	1 / 9	3

Ranked by specificity, then recurrence. Click a mutation for its full cancer-type & tissue breakdown.

Resources

Cancer-specific neoantigens

Cancer-specific neoantigens